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Abstract 
The use of lanthanide complexes for the detection of biologically relevant species such as 
anions, pH and metal ions has grown significantly over the past decade.  Such probes offer 
significant advantages over conventional probes; sharp narrow emission lines encode detailed 
spectral information and allow ratiometric analysis, and their luminescence is long-lived 
allowing selective spectral acquisition.  Many lanthanide-based probes operate in aqueous 
media, but few have been applied to intracellular measurements.   
 
The introductory chapter considers the design of lanthanide based probes for cellular 
applications.  The fundamentals of lanthanide emission are discussed, and how the ligand 
structure needs to be carefully constructed to maximise emission efficiency.  Reported 
bicarbonate- and pH-responsive probes, both lanthanide based and non-lanthanide based, are 
reviewed, leading to a set of proposed novel probe structures. 
 
The synthesis of these probes with further reasoning behind their design is described in 
chapter two.  The chapter concludes with an overview of the complexes in terms of their 
emission spectral form, hydration number, HPLC and mass spectrometry properties. 
 
Chapter three presents work on bicarbonate-responsive probes.  Through a series of spectral 
titrations, affinity constants for a range of anions were assessed.  A high selectivity for 
bicarbonate was observed over other oxy-anions, and in the presence of protein.  The complexes 
exhibited a mitochondrial localisation profile, and the europium luminescence intensity was 
modulated reversibly in response to pCO2.  The terbium analogues showed negligible change 
under such conditions, and thus a europium to terbium emission intensity ratio could be used to 
calibrate pCO2.  This principle was also applied to the analysis of bicarbonate levels in simulated 
biological fluid, and in a serum sample. 
 
Several pH-responsive complexes are described in chapter four.  Key aspects of pH-probe 
design were highlighted in early examples, leading to the final set of probes based on reversible 
sulphonamide ligation.  Spectral titrations were performed to assess pKa values, and the use of 
europium to terbium emission intensity ratios was again found to offer a convenient method for 
assessing pH.  Unprecedented changes in CPL were found in response to pH in these systems, 
and gem values could be used to report upon pH.  The complexes were observed to exhibit a 
lysosomal distribution. 
 
Finally, chapter five contains experimental procedures for each compound synthesised, as 
well as general experimental procedures.   
 
Both sets of complexes described in this thesis show great promise for use as well-defined 
intracellular probes of bicarbonate or pH. 
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1 Introduction 
This review chapter starts with an introduction to the lanthanides, paying particular attention 
to europium and terbium, and discusses their characteristic luminescence properties.  It 
considers the rational design of responsive lanthanide probes, considering the structural 
features they possess, and through examples from the literature, the various methods through 
which their luminescence output can be modulated.  Aspects of the cellular uptake, localisation, 
and toxicity of such complexes are reviewed. The mitochondria and lysosomes are introduced, 
and methods of selectively targeting them.  Finally, after a short discussion of non-lanthanide 
optical pH- and bicarbonate-responsive probes, previous work on their lanthanide analogues is 
overviewed, discussing the basis and providing the aims for the work presented in this thesis. 
1.1 Lanthanides 
The lanthanoids are generally referred to as the elements of lanthanum and the f-block series 
from cerium to lutetium.  In nature, they are found almost exclusively in their trivalent oxidation 
state, and are known as the lanthanides.  Their unique luminescent properties have facilitated 
their use in a wide range of applications and are increasingly finding use as bio-probes.3 
1.1.1 Luminescence properties of the lanthanides 
Luminescence spectra of the lanthanides are characterised by sharp peaks. The wavelength is 
largely independent of their local coordination environment, but the fine structure and relative 
intensities are highly sensitive. The luminescence arises from f-f transitions, so all the 
lanthanides are luminescent with the exception of lanthanum and lutetium, which have no 
unpaired f electrons.  These 4f electrons are shielded by full 5p and 5s/6s sub-shells which 
inhibits the participation of 4f electrons in chemical bonding.  This leads to a negligible 
interaction with ligand orbitals; the ligand-field splitting is small (~100 cm-1).4  This explains the 
observation that upon complexation or change in coordination environment, there is neither a 
broadening nor a shift in the wavelength of emission. 
 
As the 4f electrons are not available for bonding they have little influence on the 
stereochemistry adopted by ligands.  Instead, geometry is ruled largely by steric repulsion of the 
ligands, and coordination numbers of 8-9 are usually preferred. 
 
The f-f transitions are parity forbidden, this has two main consequences.  It leads to long 
luminescent lifetimes, of the order of µs (for Yb, Nd) to ms (Eu, Tb).  This is advantageous as it 
                                                                                                                                                                                        ONE: INTRODUCTION 
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allows the use of time-gated data acquisition (Fig.  1).  This is particularly useful in biological 
systems to circumvent the large amount of relatively short lived fluorescence which may be 
observed from proteins and other biomolecules.  Applying a short time delay between the 
excitation pulse and data acquisition allows the selective detection of lanthanide luminescence.  
Time-gated measurements increase sensitivity, and lead to improved signal-to-noise and signal-
to-background ratios.  These forbidden transitions also give rise to very low extinction 
coefficients (<1 M-1 cm-1)5 so optical irradiation is insufficient to directly populate the excited 
state.  High intensity lasers can be used to directly populate europium (457 nm, 7F0  5D2) and 
terbium (488 nm, 7F6  5D4) excited states.6  However, in practice they seldom used and the 
process of sensitised emission is employed (Section 1.3.3).7  
 
Although every Ln(III) ion is luminescent (except La, Lu), to be useful as an optical probe 
there is a requirement for a sufficient energy gap between the ground and first excited states in 
order to maximise luminescence over non-radiative processes.  A small energy gap facilitates 
undesired non-radiative processes such as coupling to solvent vibrational modes.7, 8  Europium, 
gadolinium and terbium have suitably large energy gaps (12,300, 32,200 and 14,800 cm-1 
respectively), however gadolinium emits in the UV range making it unsuitable for biological 
applications.  This leaves both europium and terbium as lanthanides suitable to be used in 
optical probes. 
1.1.2 Emission of europium and terbium 
Europium emits in the red region of the spectrum, terbium in the green (Fig.  2).  The emissive 
state of the Eu(III) ion is 5D0, and there exists a number of transitions from this state leading to 
Fig.  1:  The principle of time-gated detection.1 
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the bands observed.  The strongest transitions are 5D0  7F1 and 5D0  7F2.  The ΔJ = 2 manifold 
is ‘electric-dipole allowed’, and is hypersensitive to the local coordination environment.  Its 
intensity is enhanced in high symmetry and by the presence of polarisable donor groups such as 
carbonate or serine. The ΔJ = 1 manifold is magnetic-dipole allowed and displays less change in 
intensity as a function of the coordination environment.9  This forms the basis for ratiometric 
analysis, whereby the ΔJ = 1 manifold is used as an internal calibration, allowing the ratio of the 
ΔJ = 2 / ΔJ = 1 to determine the concentration of a given analyte. 
 
The Tb(III) emissive state is 5D4, and the four main emission bands are commonly observed 
arising from decay to the 7FJ (J = 3-6) ground states.  The 5D4  7F5 transition, centred usually at 
545 nm is the most intense.  There are further bands centred at ~650 nm and ~690 nm but 
these are usually extremely weak and of no use in analysis. 
 
The 5D0 emissive state of europium is non-degenerate, therefore europium spectra are easier 
to interpret.10  The ΔJ = 0 band in europium spectra is a direct indicator of the number of distinct 
europium coordination sites.  For the ΔJ = 1 manifold, two bands indicate a Cn symmetric 
complex while the presence of three bands indicates a complex with less symmetry. There are 
many transitions within each of the terbium bands and so little information on local symmetry 
can be gleaned from these.   
 
 
Fig.  2:  Partial energy level diagram and typical emission spectra for Eu(III) (left) and Tb(III) (right). 
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Table 1:  Transitions from the emissive states of Eu(III) and Tb(III).11 
Transition 
Spectral 
region (nm) 
Relative intensity Comments 
Terbium    
5D4 ⟶7F6 485-500 Medium-strong Moderate sensitivity to ligand environment 
 ⟶7F5 540-555 Strongest Best probe transition 
 ⟶7F4 580-595 Medium Moderate sensitivity to ligand environment 
 ⟶7F3 615-625 Medium-weak Some structure under high resolution 
 ⟶7F2 645-655 Weak Too weak to be of use 
Europium    
5D0 ⟶7F0 578-580 Weak Non-degenerate, appears as a single sharp line 
 ⟶7F1 585-600 Strong Sharp and structured under high resolution; up to 3 
transitions observed 
 ⟶7F2 610-630 Strong Exhibits hypersensitivity to ligand environment 
 ⟶7F3 645-660 Very weak Always very weak 
 ⟶7F4 680-705 Medium Intensity and structure very sensitive to ligand 
environment 
1.1.3 Sensitised emission 
Sensitised emission is required due to the very low molar extinction coefficients of the 
lanthanides.12  A simplified Jablonski diagram best illustrates the desired pathway to lanthanide 
luminescence (Fig.  3).  Unwanted competitive deactivating pathways will be described in 
Section 1.2.  The initial step is absorption of a photon which excites the sensitiser to a 
vibrationally excited level, Sn.  Non-radiative decay quickly brings this to the lowest vibrational 
energy level of S1.  Intersystem crossing to the T1 manifold of the sensitiser can then occur.  The 
rate of intersystem crossing is particularly effective in lanthanide complexes as the heavy atom 
Fig.  3:  A simplified Jablonski diagram representing sensitised 
lanthanide emission. 
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effect leads to a significant amount of spin-orbit coupling.13   Non-radiative decay follows to the 
lowest excited T1 level.  From the T1 manifold, energy transfer to the lanthanide excited state is 
desired.14  Non-radiative decay again brings this to the lowest excited emissive level.  Finally, 
from the lanthanide excited state, emission occurs in the form of lanthanide luminescence. 
 
The luminescence quantum yield is defined as the number of photons emitted as lanthanide 
luminescence per photon absorbed by the sensitiser.15  The overall quantum yield is maximised 
by optimising the pathway outlined above.  This is achieved through both careful consideration 
of ligand design (Section 1.3) and by minimising competitive deactivating processes (Section 
1.2).  The process of sensitised emission is additionally advantageous as it leads to a large 
Stokes’ shift, and thus allows a greater resolution of incident light from emitted luminescence.16 
1.1.4 Circularly polarised luminescence 
Circularly polarised luminescence (CPL) spectroscopy is based upon the differential emission 
of left- and right-handed circularly polarised light, and is a direct probe of the chirality of the 
excited emissive state.17, 18  It can be considered as the emission analogue of circular dichroism 
spectroscopy.  Lanthanide complexes are particularly suitable for CPL spectroscopy as they 
exhibit relatively large gem values, often in the range 0.1 – 0.4.19   This is associated with 
magnetic-dipole allowed transitions that exhibit relatively large rotatory strength to dipole 
ratios.20   
 
The rotatory strength of a given transition is related to the magnitude and sign of the CPL 
associated with that transition.  The dipole strength is influential in determining the intensity of 
the total luminescence.  The ratio of the rotatory strength (Rab) to dipole strength (Dab) thus 
gives an indication of the magnitude of the luminescence dissymmetry factor associated with a 
given transition.21   
 
    
    
|   |
  [Eq. 1]  
 
The rotatory and dipole strengths relate to the size and relative orientation of the 
corresponding electronic and magnetic transition dipole moments.  Hence, if the electronic and 
magnetic transition moments of a given transition are orthogonal, the rotatory strength will be 
zero, and no CPL is observed.  The relationship between the luminescence dissymmetry factor 
and the electronic and transition dipole moments is given by [Eq. 2] where Mab is the magnetic 
transition dipole of the transition between states a and b, Pab is the electronic transition 
associated with this transition and τab is the angle between the two vectors.   
                                                                                                                                                                                        ONE: INTRODUCTION 
 -18- 
 
    
 |         |
|   |
  [Eq. 2] 
 
The angle between the magnetic and electronic dipole transition moment vectors, τAB, will 
also influence the magnitude of gem.  For 8-coordinate complexes, or the analogous 9-coordinate 
complex in which one face is capped, the CPL is predicted to exhibit a sin4θ dependence, where 
θ is the twist angle about the principle axis.19  Hence, at 45° there will be no CPL, and the 
maximum CPL is observed when this angle is 22.5°.  The fact that this angle is determined by the 
local helicity at the lanthanide centre partially accounts for the sensitivity of CPL spectra of 
lanthanide complexes to complex coordination geometry and stereochemistry, and 
intermolecular interactions with chiral analytes.6 
 
Experimentally, the measured parameter is ΔI(λ), from which the emission dissymmetry 
factors, gem(λ) can be calculated using [Eq. 3-4].18 
 
   ΔI(λ) = IL(λ) – IR(λ)  [Eq. 3] 
   gem(λ) = 2ΔI(λ) / I(λ)  [Eq. 4] 
   I(λ) = IL(λ) + IR(λ)  [Eq. 5] 
 
For europium spectra, the ΔJ = 0 transition gives no CPL, as this transition is not magnetic-
dipole allowed.  There can be no mixing of the 5D0 and 7F0 states due to the axial crystal field 
term, accounting for the electric dipole intensity of the transition, being of odd parity.  The 
largest gem values are associated with magnetic dipole allowed transitions that have weak 
electronic dipole character.19  For europium this is invariably observed with the ΔJ = 1 transition, 
reflecting the predominantly magnetic dipole characteristics of this transition, compared to the 
predominantly electric dipole characteristic of the other higher energy europium bands.19  As 
such, the best probes of CPL and larger gem values are usually associated with the ΔJ = 1 
transition, even though ΔI may be larger for the ΔJ = 2 manifold. 
 
For terbium spectra, where the strongest emission usually arises to the 7F5 band, the largest 
gem values are found both with the 5D4 to 7F5 and 5D4 to 7F3 transitions, as these are calculated to 
have most magnetic dipole character. 
 
CPL spectra of europium complexes are the easiest to interpret, due to the non-degeneracy of 
the emissive 5D0 state outlined in Section 1.1.2.  However, if sensitivity is an issue, it may be the 
terbium analogue which proves most useful due to their higher quantum yield. 
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1.2 Luminescence deactivation pathways 
Considering the mechanistic pathway for sensitised lanthanide emission, there are three 
excited states that may be perturbed, each of which leads to a reduction of the overall lanthanide 
luminescence quantum yield.  Fig.  4 summarises potentially deactivating pathways, occurring 
from the sensitiser singlet state (1sens-Ln), sensitiser triplet state (3sens-Ln) and excited 
lanthanide state (sens-*Ln), each of which may serve to reduce the observed lanthanide 
luminescence.   To maximise the quantum yield it is necessary to have a fast rate of intersystem 
crossing and energy transfer, particularly with respect to the rates of these deactivating 
processes.   
 
In addition to the processes shown above in Fig.  4, other factors are capable of affecting the 
intensity of the signal.  Perhaps most relevant in a biological context is the unwanted co-
excitation of biomolecules.  Proteins can strongly absorb light with wavelengths around 280 nm, 
with a decreasing efficiency up to around 340 nm, mainly due to the presence of tryptophan, 
tyrosine and cysteine amino acid residues.  If this corresponds to the absorption of the 
sensitiser, then protein absorption will be competitive and it will be necessary to use higher 
intensity incident irradiation in order to achieve the same luminescence output.  This may be 
potentially damaging to the fluorophore or cell.  Additionally, the fluorescence output from 
proteins or small molecules such as biotin (λmax = 620 nm) may interfere with the output from 
the probe molecule. 
1.2.1 Quenching of the sensitiser singlet state 
Both the singlet and triplet excited states of the sensitiser can be quenched.  The singlet 
excited state can be quenched by electron or charge transfer processes that can occur intra- or 
inter-molecularly.13  For example, collisional interaction with halide anions such as iodide can 
1
sens - Ln 
3
sens - Ln 
Fig.  4:  Deactivating pathways following excitation of the sensitiser (kET is the rate constant for 
electron transfer; keT is the rate constant for energy transfer).  
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deactivate this state.  Modest degrees of quenching of the chromophore singlet excited state via 
charge transfer interactions between electron rich residues in a protein and the chromophore 
excited state have also been reported.22  Furthermore, the chromophore could undergo a 
reversible reaction such as protonation, or binding of a metal ion, which may change the energy 
level of this singlet state.  This can be used advantageously however, as selecting an appropriate 
excitation wavelength may lead to pH dependent luminescence.23 
1.2.2 Quenching of the sensitiser triplet state 
The triplet excited state of the sensitiser is susceptible to quenching by molecular oxygen.23  
This again has been proven advantageous in the design of O2 responsive sensors.  The 
deactivation processes lead to relaxation of the sensitiser to the ground state and the formation 
of singlet oxygen.  Localisation of such terbium probes in cells and the subsequent singlet oxygen 
formation can be used to induce regioselective cell death.24  Other deactivating pathways from 
this state include back-intersystem crossing to the singlet excited state.  However, this can be 
avoided by designing a complex with a singlet-triplet energy gap of more than 2000 cm-1, in 
order to create a significant thermal barrier that prevents this process from occurring at room 
temperature.20  
 
The intermediate chromophore triplet state can be quenched by electron rich species such as 
ascorbate and urate by electron or charge transfer processes.25  Urate and ascorbate can quench 
via exciplex formation between the electron-poor sensitising chromophore and the electron-rich 
reductant.25  Terbium is more sensitive to this mechanism of quenching than europium as 
exciplex formation creates a broad band of lower energy than the sensitiser T1 state, to which 
reversible energy transfer occurs more efficiently for Tb compared to Eu systems.26-28  
Complexes which are susceptible to these quenching mechanisms may therefore be difficult to 
observe by microscopy in cellulo, although may be strongly emissive in vitro where such species 
may not be present.  
1.2.3 Quenching of the lanthanide excited state 
The lanthanide excited state is prone to deactivation through vibrational energy transfer by 
energy matched X-H oscillators (X = O, N, C), resulting in a decrease in both luminescence 
intensity and lifetime.29  This is most significant for water bound solvent molecules or bound 
amino or amide NH groups from the ligand.  These quenching mechanisms can be minimised by 
utilising octa-or nona-dentate ligands, which limit the number of bound water molecules. 
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Quenching of the lanthanide excited state may also occur by transfer of energy to acceptor 
groups with closely matching energy.  This is the principle exploited in FRET applications; the 
acceptor must be close in space (within about 9 nm) and the energy overlap must be sufficient.30 
 
In aqueous solution, quenching by directly coordinated water molecules is often the major 
process.  Quenching can be attributed to weak coupling between f-electronic states of the 
europium and terbium ions and the third and fourth vibrational overtones of bound O-H 
oscillators respectively (Fig.  5).  Europium complexes are more sensitive than terbium due to 
coupling to the lower O-H overtone.  The O-D oscillators resonate at a lower energy than the 
corresponding O-H equivalent, and it has been established that quenching is significantly 
reduced in D2O as the Franck-Condon overlap factor with the metal emissive state is less 
favourable.31  The vibrational stretching frequencies of amine NH bonds (3,300 cm-1) are similar 
in energy to the OH group (3,400 cm-1) so can also quench the emissive state; again, this is less 
pronounced for terbium.  It is possible to estimate the solution hydration state for a given 
complex from measurements of the rate constants for depopulation of the lanthanide excited 
state in D2O and H2O.29, 32, 33 
1.3 The design of responsive lanthanide probes 
As discussed in Sections 1.1.1 and 1.1.2, europium and terbium are arguably the two best 
suited lanthanides for use in responsive lanthanide probes.  The ligand framework is often based 
on the 12-N-4 macrocycle, cyclen, which is used extensively in medicinal inorganic chemistry.  
Fig.  5:  Energy level diagram of Eu(III), Tb(III), compared to idealised vibrational 
energy levels of O-H and O-D oscillators. 
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Ligands based on cyclen are able to form stable metal complexes with a range of transition metal 
and lanthanide ions and have found extensive use in medical imaging and radiotherapy.  
Substitution of the four ring nitrogens can take place with the heterocyclic sensitising unit, and 
then either two or three carboxylate, phosphinate or amide arms, each of which is capable of 
interacting with the central lanthanide ion (Fig.  6).  A separate pH responsive unit can be 
incorporated at the final ring nitrogen position, to generate an effective pH-responsive probe. 
1.3.1 The chromophore 
A number of spectroscopic requirements exist that a chromophore for Eu(III) and Tb(III) 
sensitisation should fulfill.  Primarily, it should possess a high molar absorption coefficient at an 
appropriate excitation wavelength.  The singlet state should ideally lie below 29,000 cm-1, giving 
an excitation wavelength of above 340 nm thereby minimising unwanted co-excitation of 
biologically active molecules; the high extinction coefficient should be associated with light 
absorption in this range.  A small singlet-triplet energy gap of < 7,000 cm-1 is required to allow 
an efficient rate of intersystem crossing to populate the triplet state, minimising the time spent 
in the singlet state thus limiting the potential for unwanted depopulation of this state by ligand 
fluorescence.20  The triplet excited state should lie at least 2,000 cm-1 above the lanthanide 
excited state in order to give a fast rate of energy transfer and allow efficient population of this 
lanthanide excited state.20  A smaller energy difference would lead to a decreased lifetime and 
emission due to thermally activated back energy transfer. To enhance the rate of intramolecular 
energy transfer the sensitiser should be close in space to the lanthanide centre.34  This is most 
readily achieved by allowing at least one point of direct coordination.  This can also help inhibit 
the possibility of quenching by electron transfer by shielding the lanthanide centre. 
 
Fig.  6:  Representation of the general structure of a ligand for a responsive 
lanthanide probe.  The core cyclen structure (blue) is appended with a sensitising 
chromophore (green) and pendant arms (red).  The substituent on the fourth 
cyclen nitrogen, R, (purple) may be hydrogen, a third pendant arm, or a pH sensing 
moiety. 
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Examples of suitable chromophores include azathioxanthones,35 azaxanthones,35 acridones,36, 
37 m-terphenyls,38 phenanthroline derivatives,39 pyrene40 and tetraazatriphenylenes.28  The 
properties of some of the sensitisers used in complexes discussed in this introduction are 
highlighted in Table 2. 
 
Table 2:  Chromophores used for the sensitisation of lanthanide emission.  Quantum yields and lifetimes 
refer to the corresponding DO3A complex analogues. 
 
 
 
 
 
λmax 
356 nm 
ε / cm-1 
10,100 
ET / cm-1 
20,950 
ϕEu 
14% 
τEu 
1.00 ms 
  
Pyrazoyl-1-azaxanthone 
 
 
 
 
 
λmax 
345 nm 
ε / cm-1 
10,100 
ET / cm-1 
23,450 
ϕEu 
1.2% 
τEu  
0.70 ms 
 
 
 
 
 
 
 
 
 
 
 
 
λmax 
347 nm 
ε / cm-1 
8,300 
ET / cm-1 
23,800 
ϕEu 
18% 
τEu 
1.05 
ϕTb 
40% 
τTb  
1.56 ms 
 
 
 
 
λmax 
336 nm 
ε / cm-1 
6,900 
ET / cm-1 
24,800 
ϕEu 
6.9% 
τEu 
0.57 
ϕTb 
24% 
τTb 
1.82 ms 
 
 
 
 
λmax 
336 nm 
ε / cm-1 
5,700 
ET / cm-1 
24,900 
ϕEu 
8% 
τEu 
0.60 
ϕTb 
12% 
τTb 
1.89 ms 
 
 
 
 
λmax 
375 nm 
ε / cm-1 
5,300 
ET / cm-1 
23,800 
ϕEu 
2.2% 
τEu 
0.51 
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Triazophthalazine 
 
 
λmax 
304 nm 
ε / cm-1 
2,400 
ET / cm-1 
23,600 
ϕEu 
62% 
 
 
 
 
 
  
1,10-Phenanthroline 
 
 
 
λmax 
278 nm 
ε / cm-1 
14,760 
ET / cm-1 
22,100 
ϕEu 
21% 
τEu 
0.24 
ϕTb 
11% 
τTb 
0.31 ms 
 
 
 
 
λmax 
410 nm 
ε / cm-1 
5,300 
ET / cm-1 
21,050 
ϕEu 
5% 
τEu 
0.37 
  
 
The azathioxanthone chromophore fulfills some of these criteria.  The absorption wavelength 
lies in the range of 370 – 380 nm with a small singlet-triplet energy gap, typically around 3,500 
cm-1.  Possessing a triplet energy of 23,500 ± 500 cm-1, they are well suited to sensitising 
europium emission but lie at the very limit (at room temperature) for terbium sensitisation.  
Degassing the solution leads to an improvement for terbium emission.35  This is consistent with 
back energy transfer from the lanthanide excited state to the aryl triplet state, reported when 
the triplet to terbium excited state energy level gap is under 2,500 cm-1. 
 
Azaxanthones arguably offer an improvement.35  They have a fast rate of intersystem crossing 
with <4% ligand-based fluorescence observed.  It is possible to introduce alkyl and carboxy 
groups onto the 7-position without perturbing the triplet energy or enhancing the tendency to 
fluoresce and introduction of these groups potentially allows conjugation to biomolecules.  They 
are equally suited to terbium sensitisation as to europium, giving them the edge over 
azathioxanthones.  
1.3.2 Ligand selection and consideration of the metal ion coordination geometry 
The ligand needs to form a complex that is both kinetically and thermodynamically stable to 
find use in responsive cellular probes.  This aspect is addressed by using an appropriately 
functionalised cyclen derived ligand. 
 
Water molecules within the inner coordination sphere will lead to a reduction in emission 
intensity and lifetime as discussed in Section 1.2.3.  It is therefore necessary to keep this number 
to a minimum and as such, hepta- or octadentate ligands are preferred, leaving just one or two 
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bound water molecules.  These are nonetheless essential, as responsive probes require vacant 
coordination sites to allow for anion ligation or pH dependent binding to the metal centre. 
 
Anion affinity is enhanced when there is direct ligation to a charged metal centre.  The affinity 
of a lanthanide complex towards a given anion may be controlled by varying the ligand steric 
demand and the overall charge of the ligand and its resulting complex.  For example, inclusion of 
a sterically demanding pyridyl-bound 2-azaxanthone moiety in structure [Eu·L12]3+ favours 
citrate chelation but inhibits bicarbonate binding.41, 42  The inclusion of sterically bulky pendant 
arms may inhibit anion binding by increasing steric demand at the metal centre. 
 
 It is the nature and polarisability of the group occupying the position on or close to the 
principle axis which determines the magnitude of B02, which controls the degree of splitting in 
the ΔJ = 1 manifold and intensity of the ΔJ = 2 band, in addition to the dipolar NMR shift.  
Crucially, replacement of the donor group which occupies the axial position will result in 
significant changes or modulation in the emission spectrum.  Only small changes in spectral form 
were observed when [Eu·L14]3+ was titrated with various anions (bicarbonate, citrate, lactate, 
phosphate).2  Consideration of emission lifetimes were consistent with a ternary product with 
[Eu·L12]3+ 
[Eu·L14]3+ [Eu·L13]3+ 
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no bound waters, indicating that binding of the anion was indeed taking place.  With [Eu·L13]3+, 
significant spectral changes were observed upon addition of the same anions at the same typical 
extracellular concentrations.2  This contrasting behaviour can be rationalised in terms of the 
nature of the coordination polyhedron and the axial donor. In [Eu·L14]3+, the benzylic amide 
oxygen has been suggested to occupy the capping position in both the di-aqua and anion ternary 
adduct, with anion addition taking place at two positions in the plane of the square antiprism.  In 
contrast, a capping water molecule becomes displaced by anion chelation in the case of 
[Eu·L13]3+. 
1.3.3 Chirality of lanthanide complexes 
Chiral complexes may adopt a  Δ or Λ configuration where the NCCO torsion angle is +30° or -
30° respectively, with the four ring NCCN torsion angles being either δ  or λ, corresponding to 
+60° or -60° respectively.  These can be graphically represented by considering the simple DOTA 
framework (Fig.  7 and Fig.  8).   
These four stereoisomers are related as two enantiomeric pairs.  Arm rotation can be 
inhibited by introducing chiral centres into the pendant arms.  The Δ- λλλλ and Λ- δδδδ isomers 
adopt a monocapped square antiprismatic geometry and interconversion between these 
diastereomeric conformations in solution occurs through cooperative ring inversion followed by 
rearrangement of the coordination polyhedron (Fig.  8).43 
Fig.  7:  Representation of the torsion angles involved in 
cyclen complexes. 
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1.4 Responsive lanthanide probes 
Responsive lanthanide probes exhibit a change in their emission profile, circularly polarised 
luminescence or lifetime upon interaction with the analyte of interest.  For use as responsive 
probes for cellular imaging it is imperative that they are water soluble and fully functional in 
aqueous solution.  The following two subsections detail classes of signalling and consider 
different approaches to modulating the form of the lanthanide emission. 
1.4.1 Signalling methods 
Fluorescent or luminescent responsive probes can report an event in three main ways (Fig.  
9).  First, they may exhibit an increase or decrease in the emission intensity of a peak in 
response to an analyte, or much better, by modulation of the intensity ratio of a pair of emission 
bands.  The former method has severe limitations. In order for it to provide quantitative 
information, the precise concentration of the probe also needs to be known.  Therefore, this 
method is more suited to define qualitative trends, except for simple cases where it may be 
possible to assess complex concentration accurately.  Ratiometric analysis is independent of 
probe concentration, so can be used to give quantitative results in complex systems such as live 
cell imaging where the precise probe concentration is unknown.  A third, but lesser used 
approach, utilises the probes radiative lifetime as the reporter.  This parameter is also 
Δ(λλλλ) Λ(λλλλ) 
Λ(δδδδ) Δ(δδδδ) 
Fig.  8:  Representation of the four possible stereoisomers of [LnDOTA]-. 
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concentration independent but the method suffers from potential dynamic quenching processes, 
which can also reduce the observed lifetime (Section 1.2). 
1.4.2 Ratiometric probes 
Ratiometric probes can be constructed by the coupling of two separate reporters.44, 45  
Measuring the dynamic emission response of one reporter and calibrating against a second 
whose emission is invariant with respect to the analyte leads to a ratiometric response.46  This 
may require two differing sets of excitation and emission wavelengths limiting temporal 
resolution, and if the two reporters are not covalently linked they may exhibit a non-
homogenous distribution, so any data obtained may be inaccurate.47  Alternatively, the process 
of resonance energy transfer can be used if the excited state of the first reporter group is 
coupled to that of the second probe.48  A responsive output will be obtained if interaction with 
an analyte interferes with this process.  Use of this method may be limited if the probes have 
differing susceptibilities to photobleaching or quenching mechanisms. 
 
Responsive europium and terbium complexes potentially offer an attractive solution to these 
problems by performing ratiometric analysis on pairs of emission wavelengths or bands.  For 
example, a ratiometric analysis has been defined by monitoring the change in the ratio of the ΔJ 
= 2 band, which is hypersensitive to the ligand environment against the relative insensitive ΔJ = 
1 band upon anion binding.  The chromophore is the same in each case, so that only one 
excitation wavelength is required. 
Fig.  9:  Three idealised methods of signalling a binding event 
using responsive probes 
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It is also possible to perform ratiometric analysis using the europium and terbium analogues 
of a common ligand in tandem.  The first report detailing this method involved an assay for 
measuring uric acid.27  Urate binding selectively quenched the terbium excited state of [Ln·L15]3- 
by electron transfer from the urate anion, and a ratio of the europium emission at 616 nm to the 
terbium emission at 546 nm allowed a calibration of the urate concentration.  Europium and 
terbium complexes of the same ligand exhibit the same degree of solubility and localisation 
profile and so do not experience the potential limitations of a non-homogenous localisation, 
compared to other dual probes.  Additionally, a single excitation wavelength is required. 
1.4.3 Approaches to modulating the emission 
Most responsive lanthanide probes work on the basis of one of four principles:1  
1) the analyte binds directly to the lanthanide centre, displacing one or more bound water 
molecules, thus modulating the intensity and /or form of spectral luminescence;  
2) the analyte binds to the chromophore, altering the energy transfer process to the 
lanthanide; 
3) the analyte causes the chromophore to move closer to, or bind directly to the lanthanide, 
causing an enhancement of emission intensity; 
4) the analyte otherwise causes a change in the inner-sphere hydration number. 
 
A relatively simple approach to this fourth method of responsive probe involves a 
displacement assay to monitor Fe(II).  The europium emission of [Eu·L16]3+ is switched off 
following addition of the Fe(II) ion through displacement of the BPS sensitiser, which has a high 
affinity for Fe(II).49  The number of coordinated water molecules increases from zero to two.  
Although the probe responds selectively to Fe(II) ions and works in a buffered aqueous solution 
[Ln·L15]3- 
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at physiological pH, the output is not ratiometric as it relies simply upon a switching off of 
emission as the sensitising unit is removed.  This limits its use in any cellular systems as it is not 
possible to accurately know the probe concentration. 
 
A further example of a probe capable of sensing biologically relevant cations under mimicked 
physiological conditions is the europium based zinc-selective sensor, [Eu·L17].50  The probe is 
based upon a DO3A framework, incorporating a chromophoric bis-picolyl unit for binding zinc.  
Upon zinc chelation the probe undergoes a conformational change, and the number of 
coordinated water molecules switches from zero to two.  With overall quenching, presumably 
due to the increased solvation at the europium centre deactivating the lanthanide excited state, 
the form as well as intensity of europium emission spectra changes, particularly in the ligand 
sensitive ΔJ = 4 band.  This allows a ratiometric analysis.   
 
The third example mentioned above related to modulation of the sensitiser-lanthanide 
distance.  As the quantum yield of lanthanide luminescence is highly dependent upon this, it can 
be used as the basis for modulating emission.  The highly selective potassium sensor, [Tb·L18], 
works in this way.51  An azaxanthone sensitiser is linked via a lariat ether to a phenyl moiety.  In 
the absence of potassium, the flexibility of the arm keeps the sensitiser far away from the 
terbium ion, and Tb(III) luminescence is very weak.  Upon potassium binding, a cation-π 
interaction with the arene brings the azaxanthone into close proximity to the terbium ion, 
allowing efficient sensitisation.  This leads to a 26-fold increase in luminescence intensity.  The 
[Eu·L17] 
[Eu·L16]3+  
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major limitations of this work relate to its applicability in aqueous media and the inability to 
perform a ratiometric analysis. 
 
An improved potassium probe, [Eu·L19] using a phenanthridine-based antenna has 
subsequently been reported, involving ratiometric analysis.51  Effectively using time-gated 
detection, a binding affinity of 0.33(4) µM was calculated, which is well suited to the clinically 
relevant range of 0-10mM.  This probe relies upon coordination of the phenanthridine nitrogen 
to potassium, which modifies the excited state energy levels of the antenna.  This in turn affects 
the excitation spectral profile, allowing a ratiometric quantification of potassium concentration. 
 
Two terbium lanthanide systems, [Tb·L20] and [Tb·L21], have been reported for the time-gated 
detection of H2O2 in living systems.52  A chemoselective H2O2-mediated oxidation of a boronate 
protected probe with H2O2 uncages a pendant aniline or phenol antenna which is better able to 
[Eu·L19] 
 
[Tb·L20] 
[Tb·L18] 
[Tb·L21] 
 
 [Tb·L
20] 
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sensitise terbium emission.  In the absence of H2O2, the boronate-capped aromatic is electron 
withdrawing and a poor sensitiser.  Reaction with H2O2 generates an electron rich phenol or 
aniline.  The enhanced sensitisation leads to a 6-fold increase in luminescence intensity in vitro.  
The probe demonstrated a high selectivity for H2O2 over other biologically relevant reactive 
oxygen species such as superoxide or nitric oxide.  Further, the probe was able to detect elevated 
levels of H2O2 production in live RAW 264.7 macrophages during an oxidative immune response 
using time gated spectroscopy, taking advantage of the long-lived lanthanide luminescence.  This 
example does offer considerable room for improvement; in particular longer wavelength 
excitation is desirable.  Additionally, in order to obtain quantifiable data, the kinetics of the 
boronate oxidation reaction need to be established as well as the local probe concentration.  
These limitations further highlight the need to develop probes which are ratiometric in their 
response. 
 
Approaches based upon direct analyte binding to the metal centre, and analyte binding to the 
chromophore will be discussed in detail in Section 1.9, focusing on bicarbonate and pH 
responsive systems. 
1.5 Uptake mechanism, subcellular localisation and toxicity  
It is necessary to have a good understanding of the mechanism by which the probes enter the 
cells in order to influence the design of novel complexes.53  Additionally, an understanding of 
features that exert an influence on the subcellular localisation, and factors to avoid cellular 
toxicity should also be considered. 
1.5.1 Uptake mechanism of lanthanide complexes 
There are a number of classes of uptake mechanism by which substances are able to enter 
into cells.54  Passive transport does not require energy input, the driving force is the movement 
of molecules down a concentration gradient.  In contrast, active transport requires the input of 
Fig.  10:  Classes of uptake mechanism 
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energy.  Primary active transport involves specific membrane-bound channels to transport 
species.  Secondary active transport requires the use of an ion gradient, established by the 
simultaneous transport of a second species.  The third class of active transport is vesicular in 
nature and can be further sub-divided into two classes.55  Endocytosis and exocytosis56 are 
essentially the reverse of one another, moving substances into, and out of a cell respectively. 
 
For lanthanide complexes entering a cell, endocytosis is the class of interest, and this may 
occur via a number of different mechanisms (Fig.  11). Phagocytosis involves the transport of 
large (>0.5 µm) multimolecular particles such as dead cells, bacteria and viruses.57  Pinocytosis 
involves the uptake of extracellular fluid along with any particles this contains, again this can 
occur via a number of different methods.  Clathrin-mediated endocytosis is arguably the best 
Fig.  11:  Endocytotic uptake mechanisms. 
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understood mechanism, this is the principal process for the internalisation of proteins, 
membrane-localised receptors and ion-channels.  Another mechanism involves carveolae.58  
These are flask shaped invaginations of the cell membrane that are able to internalise by a 
process termed potocytosis.59  Lastly, macropinocytosis is a non-specific mechanism where 
ligand-binding to a receptor is not required, unlike the two methods mentioned above.60  In 
macropinocytosis, vesicles are formed via the ruffling of the membrane in response to cell 
surface simulation. 
 
The method of entry for related series of lanthanide complexes has been reported.61  Evidence 
for an energy dependent, active-uptake method was established; at 4 °C, uptake of the 
complexes was greatly reduced compared to 37 °C.62  This correlated with other work which had 
shown that molecules in the region of 1 kDa, similar to the lanthanide complexes, are greatly 
hindered in movement by passive diffusion.63 
 
To determine the specific mode of endocytosis, cells were treated with a variety of drug 
molecules to selectively block or enhance different uptake pathways (Fig.  12).  This revealed 
that macropinocytosis was the mechanism via which the lanthanide complexes entered cells.64  
This is reasonable, as it is unlikely to be a receptor mediated process, given the broad range of 
complexes with differing geometries, charge and lipophilicities that have been observed to enter 
cells. 
 
One final observation that is relevant at his point is the time dependent nature of uptake of 
the complexes.  The cellular uptake of complexes based on [Eu·L22]3+ incorporating an 
Fig.  12:  Inhibition pathways for various uptake mechanisms. 
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azaxanthone chromophore was studied as a function of time.  It was shown that substitution at 
the 7-position greatly influenced the rate of uptake.  The carboxymethyl derivative showed a 
very fast rate of uptake, clearly visible after just 2 minutes.  In comparison, the corresponding 
carboxylate only showed localisation after one hour.22 
 
1.5.2 Subcellular localisation of lanthanide complexes 
Out of the range of complexes from Durham, subcellular localisation can be classified into four 
categories: localisation to the lysosomes; localisation to the mitochondria with subsequent 
trafficking to the lysosomes (Fig.  13);2 simultaneous localisation to the lysosomes and 
mitochondria;65 and nucleolar localisation.66  Nucleolar localisation appears to be due to 
increased membrane permeability induced by necrotic conditions or administration of very high 
[Eu·L22]3+ 
Fig.  13:  Epifluorescence microscopy images for [Eu·L13]3+: 50 μM complex, 
4 h incubation (left set of images); 50 μM complex, 24 h incubation (right set of 
images). Images reveal a mitochondrial localisation profile after 4 h and a profile 
consistent with migration of the complex from the mitochondria to the perinuclear 
endosomes/lysosomes after 24 h. Upper images: Eu(III) complex; centre images: 
Mitotracker GreenTM; lower images: merged image (scale bars 20 microns).2 
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concentrations of the complex itself, and is discussed briefly in the following section.  
Mitochondrial and lysosomal distributions are briefly discussed in Sections 1.6.2 and 1.6.4 
respectively. 
 
1.5.3 Toxicity of lanthanide complexes 
In general, all the complexes studied at Durham have been shown to have low toxicity at the 
concentrations used in microscopy experiments.  Complex toxicity is generally assessed through 
the MTT assay, which is a colourimetric assay based on the reduction potential of the 
mitochondrial reductase enzymes.67  It is discussed in detail in Section 1.23.  It is essential that 
the probes do not interfere with cellular functions.  The few reported probes which have 
exhibited some significant toxicity can be rationalised in terms of their structure, and avoided in 
future designs.68  The complexes which localised to the mitochondria did not appear to perturb 
the MMP, in line with being non-toxic.2  It is relevant to assess the toxicity at the organelle to 
which the probes is localising, as this is where the toxic effects are most likely to be observed. 
 
Certain complexes were initially reported to exhibit a nucleolar distribution, but this result 
was found to be concentration dependent.  At lower complex concentrations of [Eu·L23]3-, for 
example, a lysosomal distribution was often observed.  It appears that the nucleolar distribution 
may be associated with a loss of cell viability, possibly caused by using excessive concentrations 
of the complex.69  Deliberate permeabilisation of the membrane was also shown to induce this 
localisation pattern, as loss of membrane integrity is one of the first events of necrosis.64  This 
rationale also may be invoked to explain cellular distribution results reported by others e.g. the 
lanthanide complexes of Barton.70 
1.6 Cellular organelles 
1.6.1 Mitochondria 
Mitochondria are found in eukaryotic cells where their key function is the production of 
energy through oxidative phosphorylation.  They serve additional functions including 
[Eu·L23]3- 
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intracellular Ca2+ homeostasis,71 and play a key role in apoptosis.72  Mitochondrial dysfunction is 
believed to be an important factor in a number of diseases.  Presently, the exact function of the 
mitochondria and the possible processes of disease are only partially understood.  Through 
careful and considerate design of probes that target the mitochondria and report on a certain 
biomolecule or process, a deeper understanding of the mechanisms and regulation process can 
be gained.  
1.6.2 Targeting the mitochondria 
The simplest probes which target the mitochondria are cell permeable fluorescent dyes such 
as rhodamine 12373 (24) and tetramethylrosamine (25).74 They serve simply as a stain, 
highlighting the localisation of the mitochondria within the cell, but do not report upon any 
activity or function.  Further, they are not retained within the mitochondria when the cells are 
washed. 
 
The commercially available MitoTracker probes such as MitoTracker Green FM, (26), offer 
many advantages over these.  For example, it is significantly more photostable and gives a 
brighter, more selective signal at lower concentrations.  They enter the cell by passive diffusion 
across the plasma membrane, accumulating within the cell regardless of the mitochondrial 
24 
24 
26 
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membrane potential.  They contain a mildly thiol-reactive chloromethyl moiety which appears to 
be responsible for keeping the probe within the mitochondria.  The MitoTracker series still offer 
no probe of function but are an effective marker of localisation. 
 
Derivitisation of boronic acids with the lipophilic triphenylphosphonium (TPP) cation results 
in accumulation of the compounds within the mitochondria.  TPP is able to pass rapidly through 
biological membranes, resulting in a several-hundred-fold accumulation within the 
mitochondria in vivo.75  By covalently attaching bioactive functionalities to the TPP cation, these 
probes can then also be delivered.  This has been put to particular use in a mass spectrometry 
ratiometric probe for hydrogen peroxide, 27.76   TPP additionally helps facilitate the sensitive 
detection by mass spectrometry.77 
 
A strong relationship has been established between the structure of the chromophore and its 
mode of linkage to cyclen and observed cellular localisation profile.  The azaxanthone moiety 
incorporated into some lanthanide complexes has also been shown to dictate a mitochondrial 
localisation.  The europium complex, [Eu·L13]3+, belongs to a small class of complexes that show 
a mitochondrial distribution at time-points of 5 min to 12 h with subsequent trafficking to the 
[Eu·L28]3+ [Eu·L
13]3+ [Eu·L29]3+ 
 
27 
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lysosomes at extended time points.2  This accords with the absence of toxicity observed for these 
complexes.  [Eu·L28]3+ and [Eu·L29]3+ exhibit a simultaneous mitochondrial and lysosomal 
distribution, and so are probably of less use as selective cellular probes.65  
1.6.3 Lysosomes 
The lysosomes are acidic compartments within cells, containing a number of hydrolytic 
enzymes which break down unwanted waste.  The interior of a lysosome has a pH of around 4.5 
– 6.0, contrasting with a cytosolic pH of around 7.2.  The lower pH maintains ideal conditions for 
these hydrolytic enzymes to work.78 
1.6.4 Targeting the lysosomes 
Complementary to the MitoTracker series of probes, are the LysoTracker and LysoSensor 
series.  LysoTracker probes exist as subcellular stains, whilst the LysoSensor probes are 
responsive probes that function as acidic organelle selective pH indicators.  With a high 
selectivity for acidic organelles, they localise well to the lysosomes and effective labeling occurs 
at nanomolar concentrations.  They consist of a fluorophore linked to a weak base, which is 
partially protonated at neutral pH and can freely permeate organelles.  Once within the 
lysosomes, the weak base is protonated, leading to retention of the probe within the organelle.  
The protonation of LysoSensor Green DND-189, 30, suppresses the fluorescence quenching of 
the dye caused by photoinduced electron transfer quenching of the S1 excited state by the 
morpholine nitrogen lone pair.   This results in an increase in fluorescence intensity.  Some 
LysoSensor probes are dual emission probes, allowing ratiometric imaging.  A potential 
drawback with this set of probes is that they may localise in membranes.  If so, this would only 
allow qualitative and semi-quantitative comparisons of organelle pH.  Additionally, although the 
probes are taken up within seconds into live cells, the probes can induce an alkalising effect, 
therefore it is not recommended to dose for longer than 5 minutes.  These are significant issues, 
and as such there is a need for a reliable, non-perturbing probe of lysosomal pH. 
 
30 
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A number of lanthanide based probes that preferentially localise to the lysosomes have been 
reported.  Out of the ~80 emissive lanthanide complexes characterized in Durham over the past 
few years, over 80% have been shown to exhibit an endosomal/lysosomal distribution.68  This 
appears to be the default localisation for complexes.  Complexes containing azaxanthone 
chromophores commonly exhibit this localisation profile.  A crucial linkage mode involves a 
methylene group. 
1.6.5 Measuring lysosomal pH 
There exists a certain amount of controversy regarding measurements of lysosomal pH.  A 
hypothesis has been promulgated that increased levels of ceramide in cystic fibrosis models 
result from defective lysosomal acidification, and is linked to mutation of the cystic fibrosis 
trans-membrane conductance regulator protein.79  This was subsequently refuted when 
different pH probes were used.80  These required deliberate cellular permeabilisation to enable 
lysosomal localisation of the probe.  This exemplifies the need for an improved, reliable 
ratiometric pH probe that targets the lysosomes without perturbing membrane permeability or 
cellular homeostasis.   
 
Organellar pH can be affected by several mechanisms, including the activities of H+-pump and 
H+-leak pathways, buffer capacity, membrane potential and cytoplasmic ionic content.  Elevated 
lysosomal pH has been noted in several lysosomal storage diseases.81  There are over fifty of 
these hereditary metabolic disorders that cause defects in lysosomal function.  Most commonly, 
mutations occur in the lysosomal hydrolase enzymes that degrade various cellular 
macromolecules. 82  It has been found that lysosomes in some tumour cells have a lower pH than 
normal lysosomes, while other tumour cells have been found to contain lysosomes with higher 
pH.83, 84  The defective pH regulation of the lysosomes of human breast cancer cells,85 and the 
elevated lysosomal pH in neural ceroid lipofuscinoses are further examples.86 
1.7 Bicarbonate 
1.7.1 Physiological role of bicarbonate 
Bicarbonate fulfills many roles in biological systems.  It is a substrate in photosynthesis, it 
helps maintain the pH of biological fluids and it is generated during cellular respiration from 
carbon dioxide.87  Glycolysis, and the citric acid cycle take place within the matrix of the 
mitochondria, and produce mitochondrial carbon dioxide, which is rapidly converted to 
bicarbonate by the action of carbonic anhydrase enzymes.  A challenge is to monitor the real-
time changes in these concentrations, and bicarbonate-selective optical probes potentially offer 
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a solution.  They could offer an insight into signaling mechanisms that regulate, or are regulated 
by these changes in concentration. 
 
It has been shown that changes in bicarbonate concentration stimulate adenyl cyclase activity, 
the enzyme responsible for production of cyclic-AMP.  It has been suggested that soluble adenyl 
cyclase is a regulator of oxidative phosphorylation of mitochondrial enzymes, allowing 
respiration to keep pace with changes in nutritional availability.  If the reducing equivalents 
produced by the Kreb’s cycle are not efficiently used, then reactive oxygen species levels may 
increase causing oxidative damage.88 
1.7.2 Bicarbonate levels in serum 
Accurate measurement of serum bicarbonate levels is critical in assessing metabolic acidosis, 
abnormally increased hydrogen ion concentration.  Low serum bicarbonate concentrations in a 
dialysis patient with end-stage renal disease, almost always indicates metabolic acidosis.89  
There are concerns regarding the accuracy when such measurements are made due to effects of 
blood collection techniques, shipping concerns, effects of analysis time and the impact of assay 
methodology.90  At present, there are two distinct assays for determining bicarbonate levels 
based on either enzymatic methods or ion-selective electrodes.  There is some discrepancy 
between the values reported by each technique.  This underscores the need for a cellular probe 
or method to detect bicarbonate concentrations. 
1.7.3 Competing anionic species in biological samples 
There exist a number of anions that will be present in varying concentration in biological 
systems which can compete with bicarbonate for binding to the metal centre.  Oxy-anions such 
as citrate, lactate or phosphate have all been shown to bind to lanthanide complexes.  Citrate for 
example, has been shown to bind very strongly to triply positively charged lanthanide 
complexes on account of its own triple negative charge.  In extracellular fluid, for example, some 
typical concentrations are listed below (Table 3): 
 
Table 3:  Typical extracellular concentrations of some common anions. 
Anion Concentration / mM 
bicarbonate 25 
lactate 2.3 
citrate 0.13 
phosphate 0.9 
chloride 120 
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Control of the steric demand at the metal centre, and both overall and peripheral charge on 
the complex should enable a degree of control towards the competitive binding.  The affinities 
towards bicarbonate, citrate, phosphate and lactate for a number of complexes reported in the 
literature are summarised below, Fig.  14. 
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1.7.4 Bicarbonate in marine systems 
Calcifying algae are responsible for the bulk of global CaCO3 production with coccolithophorid 
phytoplankton accounting for a half of oceanic calcium carbonate production.91 These 
coccolithophores, such as Emiliania huxleyi, extrude elegant calcium carbonate crystalline 
structures termed coccoliths. Dissolved bicarbonate is the main carbon source for calcification.  
Ocean pH levels are currently 8.1 but are predicted to drop as atmospheric CO2 levels rise.92, 93  
Oceanic carbonate levels are predicted to drop as ocean acidity increases, perturbing the 
saturation state for calcium carbonate.94 
 
Calcium carbonate formation occurs in intracellular vesicles to which both Ca2+ and HCO3- 
need to be transported.  These routes and mechanisms for transport are currently unknown.95  
No direct measurement of local bicarbonate concentrations is possible, as a selective 
bicarbonate probe is not available.  Estimates are made based upon putative local pH and 
estimated total inorganic carbon levels, with the assumption that the intracellular maximum is 2 
mM, the same as that in seawater.  These pH measurements stem from a small number of studies 
using pH responsive fluorophore probes.92, 96  The estimated values fell in the range 7-8 with two 
distinct environments observed, with ~50% apparently in vesicles at pH 8 and ~ 50% at pH 7.  
The development of both bicarbonate and pH responsive probes which are able to enter 
coccolithophores, therefore, may lead to a better understanding of these processes. 
1.8 Reported optical probes for bicarbonate and pH 
There are numerous techniques for the selective detection of anions, or the determination of 
pH.  For example, optical spectroscopy, NMR spectrometry, MRI spectrometry and mass 
spectrometry are all techniques with which it is possible to design responsive probes.  
Luminescent lanthanide complexes represent just one subset of optical probes.  It is appropriate 
to consider reported responsive fluorescent probes, and some of the examples recently 
developed for bicarbonate and pH will now be discussed. 
1.8.1 Bicarbonate sensing 
Synthetic anion sensors are usually engineered to have differing size/geometric properties 
that are complementary to the target anion.97  Usually this is achieved using positively charged 
receptors with appropriately positioned hydrogen bond donors or acceptors.98  Most synthetic 
receptors utilise an anion recognition group with a covalently attached chromophore or 
fluorophore.  Hydrogen bonding interactions are particularly effective for anions in non-aqueous 
solvents.  Amides,99 ureas100 and thioureas101 have been successfully utilised in this respect.  
There exist very few examples of receptors for the bicarbonate anion.  As an example probe 41, 
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based on the carboxylurea unit, showed selectivity for acetate as well as bicarbonate but only 
functioned in DMSO, containing 0.5% water.102  The major challenge lies in creating anion-
specific probes which are effective in water. 
 
Anion recognition is of great relevance in biological chemistry, yet most reported anion 
sensors work only in non-aqueous solvents.  This is perhaps not surprising given the large free 
energies of hydration which anions possess [ΔGhyd (HCO3- -335 kJ mol-1, H2PO4- -465 kJ mol-1], 
and that their speciation is often pH dependent.  These features combine to make it difficult to 
create selective synthetic receptors for a given anion. 
 
Fluorescent organic nanoparticales, based on 42, provides a rare example of an anion sensor 
which operates in water.103  They showed good water solubility and exhibited specificity for 
bicarbonate over other anions.  They function as a turn-off sensor, with a linear decrease in 
emission intensity with increasing bicarbonate concentration in the range 10 µM to 1 mM.  This 
prevents any application in biology, as bicarbonate concentrations are typically an order of 
magnitude greater. 
1.8.2 Lysosomal pH 
An example of an intramolecular charge transfer fluorescent probe for lysosomal pH has been 
reported.104  The thiazole, 43 was constructed involving a conjugating ethylene bridge between a 
benzathiazole and a pyridine group to form a D-π-A fluorophore in which the pyridine group is 
used as the H+ binding moiety.  The probe exhibited excellent switching over the relevant pH 
range for lysosomes with an emission enhancement of 22-fold over the range 3 to 6, with a pKa 
of 4.22, closely matching to that expected for acidic organelles.  The probe was selective for H+ 
43 
41 42 
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over a range of other biologically relevant cations.  An advantage of this probe over other 
fluorescent pH responsive probes was an improved, larger, Stokes shift.  The small Stokes shift 
of many fluorescent probes limits their applicability due to excitation interference.  The location 
of the probe inside macrophage cells was observed by confocal microscopy, but the punctuated 
fluorescence also appeared associated with the nucleus and cell membrane.  It is likely that 
selectivity for the lysosomes is a problem and no quantitative data was given. 
 
A successful example, utilising a ratiometric approach, involved mesoporous silica 
nanoparticles (MSNs) doped with acid sensitive rhodamine-lactam and fluorescein 
isothiocyanate (FITC) (44).105   Under single wavelength excitation, rhodamine emission 
increased with increasing pH whilst fluorescein emission decreased.  This probe showed greater 
sensitivity than previous fluorescein based probes, attributed to the inverse pH responses 
shown by the two components.  The pH-responsive range of 3.5 – 6 overlapped well with that 
expected for lysosomes.  The MSNs are readily internalised into cells by endocytosis, and this 
probe accumulated in the lysosomes.  Flow cytometry was successfully used to monitor pH 
changes in the lysosomes of cells. 
 
Many BODIPY based probes have also been studied.106  A series based on 45 with tunable pKa 
are non-fluorescent at neutral pH and highly fluorescent at a pH below ~4.107  The probes were 
44 
45 
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shown to selectively label the lysosomes, and upon treatment of cells with chloroquine, known 
to induce an increase in lysosomal pH, the fluorescence signal decreased by ~80% accordingly.  
Although it is useful to be able to easily tune affinity through simple structural modification, 
these probes again highlight a drawback with organic based fluorophores in that their broad 
featureless emission does often not allow for ratiometric imaging, so that intracellular pH 
calibration is difficult. 
1.9 Reported responsive lanthanide probes for bicarbonate and 
lysosomal pH 
1.9.1 Bicarbonate responsive lanthanide probes 
Anion binding to responsive lanthanide probes works on the principle of reversible binding of 
an anion to a charged metal centre.  This can be signaled by a change in the lanthanide emission 
spectral form, circular polarisation or lifetime following displacement of one or two coordinated 
water molecules.   A series of emissive europium complexes has been reported in which their 
anion affinity and cellular localisation is described.2  Those which showed sensitivity towards 
anion binding typically contained a water molecule in the axial position (Section 1.3.2).  Binding 
of each anion gave rise to unique characteristics in the corresponding emission spectra.   
 
The measured affinity constant for [Eu·L13]3+ was highest for citrate, and at their common 
extracellular concentrations, citrate competes with bicarbonate for europium coordination.2  
This highlights the issue, and potential problem of selectivity towards bicarbonate.  In a triply 
positively charged complex such as this, electrostatics may favour triply charged citrate anions 
over singly or doubly charged anions such as bicarbonate or carbonate, respectively.     Addition 
of protein caused a 10-fold reduction in emission intensity, and lifetimes measurements were 
consistent with displacement of one bound water molecule. 
 
Bicarbonate binding to a europium complex has also been signaled by modulation of 
circularly polarised luminescence (CPL).108  Significant changes in the circular polarisation of the 
ΔJ = 2 and ΔJ = 1 bands accompanied reversible bicarbonate binding for a series of europium 
probes, associated with a change in local helicity at the metal centre.  Upon bicarbonate binding, 
a reduction in the CPL intensity and alteration of the twist angle was observed.  A titration of gem, 
at a fixed wavelength, as a function of added bicarbonate revealed a similar variation to that 
observed for the emission intensity ratio change. 
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1.9.2 pH responsive lanthanide probes 
Several pH responsive europium and terbium complexes have been synthesised and studied 
over the last decade.  Early systems such as [Eu·L46]3+ operated on the basis that the first excited 
states of aromatic fluorophores may be quenched by photoinduced electron transfer from 
oxidisable groups such as amines.  Protonation of the amine, or binding of the amine to a metal 
will inhibit this leading to a large increase in fluorescence intensity.109  If the fluorophore in 
question acts as the sensitiser to lanthanide emission, this will lead to an increase in the 
quantum yield.  It is possible to control the pH range over which this switch operates by varying 
the basicity of the amine.  This is readily achieved by structural modification. 
 
Protonation of the phenanthridine in the europium complex [Ln·L47] led to a strong increase 
in luminescence through this process.110  The complex showed an on-off emission by 
perturbation of the singlet excited state of the sensitiser.  In contrast, the terbium analogue 
showed a quenching of emission upon protonation, as the efficiency of back energy transfer to 
the sensitiser triplet state greatly increases due to a lowering of the triplet energy level.111  This 
also affected the lifetime of emission.  Excitation spectroscopy was used enabling a ratiometric 
output to be obtained.112 
 
Dansyl113 and quinolyl114 sensitising groups have also been incorporated into lanthanide 
complexes in order to achieve pH sensitive emission.  Protonation of the dimethylamino group 
on the naphthyl ring of the dansyl group (below pH ~5) in [Eu·L48]3- favours population of the 
triplet state at 20,600 cm-1, promoting europium emission.  With the quinolyl complex, [Eu·L49] 
protonation increases the efficiency of energy transfer to the lanthanide leading to a large 
enhancement of emission intensity.  The drawbacks with each probe are the large amounts of 
ligand fluorescence, an unsuitable excitation wavelength and a lack of sensitivity. 
 
[Ln·L47] [Eu·L46]3+ 
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More recently, an improved class of single-component lanthanide pH probes has been 
developed, based on a change in hydration state at the lanthanide centre involving sulfonamide 
ligation.115  Deprotonation of the sulfonamide enables direct coordination to the metal centre, 
causing a change in the intensity and lifetime of lanthanide emission upon displacement (Fig.  
15).   
 
The first examples of these probes were developed around ten years ago.115  It was shown that 
the pKa of the sulfonamide binding could be tuned by variation of the para-aryl substituent.  
These initial probes, such as [Eu·L50], were excited via the aryl sulfonamide.  This is not ideal 
however, as upon binding the chromophore is brought closer to the lanthanide, enhancing the 
efficiency of the energy transfer process, leading to increased emission intensity.  With two 
processes contributing, ratiometric analysis is not feasible, as the distance of the sensitising 
moiety from the lanthanide centre is also pH dependent.  Anionic arms were added in order to 
suppress interference from endogenous anions or protein.  When glutarate arms were used, a 
Fig.  15:  Representation of the mode of action of pH-
dependent sulfonamide ligation. 
[Eu·L48]3- [Eu·L49] 
[Eu·L50] 
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third distinct europium emission spectral form was observed, arising from competitive 
carboxylate binding forming a 7-membered chelate.  This can be suppressed, by extending the 
alkyl chain length, or increasing electron density on the sulfonamide nitrogen, such as in the p–
OMe phenyl analogue.   
 
More recently, europium complexes have been synthesised containing a methyl sulfonamide 
moiety, and a separate heterocyclic sensitising chromophore unit which remains constantly 
bound to the metal centre.66, 69   This allowed accurate ratiometric analysis to be performed upon 
excitation of [Eu·L51]+ at 380 nm.   The emission intensity ratio at 680 nm / 587 nm was 
measured and there was an 80% change over the pH range 4.5 – 8 associated with reversible 
sulfonamide binding.  The distinct appearance of a sharp band at 680 nm at pH 8 was ascribed to 
sulfonamide nitrogen ligation, and has been observed in related systems.  The problems with the 
previous sulfonamide probes were obviated as there is no aryl moiety on the sulfonamide and 
the binding of the sensitiser throughout pH switching does not change.  The complex did exhibit 
some sensitivity to anions and proteins but a calibration was still possible in human serum.  The 
calibration curve could be constructed giving a protonation constant of 7.2 in the intracellular 
medium.  
1.10 Objective - Requirements for a pH or bicarbonate responsive 
lanthanide probe 
 
The aim of this project was to design and synthesise a new class of pH and bicarbonate 
responsive probes.  The compounds must meet a number of criteria: 
 
1) The probe must be water soluble and fully functional in aqueous solution to allow use as a 
cellular probe. 
 
[Eu·L51]+ 
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2) The probe must be sensitive to the analyte over the appropriate biological concentration 
range for that particular organelle; 
a. For the mitochondrially localising bicarbonate probes, the bicarbonate 
concentration is in the region of 10 – 40 mM 
b. Lysosomal pH is in the range 4.5 – 6, so the pKa of this probe should lie 
approximately in the middle of this range 
 
3) The observed spectral change over this range should be sufficient to allow ratiometric 
analysis to be performed.  Ideally this would occur using a pair of emission bands, or 
alternatively examining the emission arising from the europium versus terbium analogues 
of a common ligand. 
 
4) The change in the ratio of these bands should also be significant, to increase the accuracy 
of any measurements made. 
 
5) The probe should resist quenching, either by endogenous proteins or electron rich 
species. 
 
6) The probe must exhibit a selective and well defined localisation, either mitochondrial or 
lysosomal. 
 
7) The binding should be fully reversible. 
 
8) The probe should be both thermodynamically and kinetically stable. 
 
9) The probe should be non-toxic (at least in the order of magnitude that the probe will be 
administered to cells), there is a need to probe normal cellular behavior and function, and 
not the behavior of a stressed or dying cell induced by the application of the probes 
themselves. 
 
10) The probe must be selective for the desired analyte.  For example, there will be many 
other anions present and selectivity for bicarbonate is required against a competing 
background of these.  The same applies for pH, it should resist interference from 
endogenous anions and protein. 
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11) The probe should, ideally, be highly luminescent. 
 
The following chapter details the synthetic aspects of these complexes and the reasoning 
behind their design.  The subsequent chapters detail the results from the mitochondrial 
bicarbonate probes and lysosomal pH probes. 
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2 Synthetic Aspects and Photophysical 
Characterisation 
2.1 Synthesis of the bicarbonate responsive probes 
2.1.1 The starting point 
The responsive europium complex [Eu·L13]3+, was published in 2008.  It showed a large 
spectral change in its emission profile in response to bicarbonate (or citrate) allowing 
ratiometric analysis.  It is non-toxic to cells and exhibited an unprecedented localisation to the 
mitochondria.   
 
Preliminary work studying the azaxanthone analogue of [Eu·L13]3+, [Eu·L1]3+, incubated in 
HeLa cells under a varying atmospheric CO2 concentration, revealed a decrease in emission 
intensity as the level of atmospheric CO2 decreased, and hence mitochondrial bicarbonate 
concentration was reduced.116  It was thought that within the mitochondrial environment, the 
complex existed as carbonate adducts but also with a significant proportion of a citrate bound 
species.  Notwithstanding the carbonate/citrate selectivity issues, the results suggest the probe 
could find use as a responsive probe for bicarbonate (or citrate) within the mitochondria. 
 
It was proposed, therefore, to design a new ligand, taking the attractive features of this probe 
and increasing the selectivity towards bicarbonate whilst maintaining the mitochondrial 
localisation profile.  This localisation would hopefully be achieved by retaining the sensitising 
[Eu·L13]3+ 
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azaxanthone unit with the amide linkage to the cyclen.  It was decided to switch the 
azathioxanthone for an azaxanthone, as this would additionally allow the terbium analogues to 
be synthesised and minimise concomitant fluorescence from the ligand.  To increase the 
selectivity for bicarbonate against other anions, particularly citrate, it was decided this may 
most readily be achieved by varying the overall charge and/or size of the complex, through 
structural modification of the pendant arms.  A range of related complexes was therefore 
proposed, with differing geometric constraints, where it was possible to easily vary the overall 
complex charge from +3, to -2.   
 
The series of complexes, [Ln·L2-5] embrace a range of europium and terbium complexes with 
ligands containing an amide linked azaxanthone unit and pendant arms derived from alanine or 
glutamic acid amino acid residues.  This allows some variation of steric demand at the metal 
centre, and hydrolysis of the ethyl ester groups leads to the variation in complex charge.  The 
original ligand, L1, was also re-synthesised with an azaxanthone sensitiser, to enable the terbium 
complex to be synthesised.  
[Eu·L1]3+ 
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2.1.2 Overall strategy 
The synthesis of L1 has been reported, and initially involved synthesising the amino-
azaxanthone intermediate in five steps.  The pendant arms were separately synthesised, before 
using them to di-alkylate the precursor cyclen-di-CBZ. Deprotection of the two CBZ protecting 
groups, followed by mono-BOC protection and then alkylation of the last remaining cyclen NH 
with ethyl bromoacetate. This could then be deprotected using lithium hydroxide to allow 
coupling with the amino-azaxanthone.  BOC deprotection with TFA, and finally complexation 
gave the europium complex, the overall process is outlined in Scheme 1. 
 
This exact strategy could not be replicated for the synthesis of [Ln·L2-5], as the lithium 
hydroxide hydrolysis step would remove all the alkyl esters present, including those on the 
pendant arms and chromophore.  Modifications to the scheme were made to avoid this step, and 
the synthetic route used to prepare [Ln·L2-5] is described below.  This new route was then used 
as the preferred method when synthesising L1.  In essence, it involves a similar principle of 
creating the azaxanthone moiety in one strand, whilst simultaneously building up the 
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macrocyclic framework with the pendant arms during a series of protection steps, selective 
mono-alkylations and deprotections, before metal complexation of the final ligand.   
2.1.3 Synthesis of the chromophore 
The synthesis of 2-aminomethylazaxanthone, 57, has previously been reported.2  This method 
was followed with a slight deviation from the original route when synthesising the mono-
brominated derivative.  In summary, methyl-4-hydroxybenzoate was deprotonated with sodium 
methoxide and coupled with 2-chloro-6-methylnicotinic acid in the melt at 155 °C.  Electrophilic 
cyclisation of the product of this reaction, 52, with PPA yielded 7-methoxycarbonyl-2-methyl-1-
azaxanthone, 53.  This step gave the lowest yield (45%) during the stage of chromophore 
synthesis, largely due to the unavoidable, partial hydrolysis of the methyl ester group during the 
work-up.  This proved difficult to extract from the inorganic phosphate salts produced, due to 
the challenging solubility properties.  It was possible to recover some of this hydrolysed side-
product material and increase the final yield by lowering the pH of the work-up to ~pH 2, and 
then extracting the hydrolysed azaxanthone-carboxylic acid with DCM.  This could be re-
esterified using methanolic HCl to yield the desired product, 53. 
 
Previously, the selective mono-bromination step had been the lowest yielding step, being 
obtained in just 14% yield, due to formation of the di-brominated side-product during the 
benzylic bromination step.2 Difficulties were also encountered in separation of the desired 
product by column chromatography.  Initially the same route was followed, but it became clear 
that it was never possible to obtain greater than a ~35% conversion to the desired mono species 
at any point, and the resulting chromatographic purification was difficult as each of the three 
products ran close together, leading to isolated yields of no more than 15 - 20%.  Methodology 
has been established whereby this dibrominated side product can be converted back to the 
mono-brominated and/or non-brominated precursors using diethyl phosphite.117  Through 
refinement of this process by careful control of reaction temperature and reducing the reaction 
time and number of equivalents of phosphite and base, it became possible to selectively obtain 
the desired mono-brominated product, with no formation of the original non-brominated 
precursor.  Additionally, it was relatively easy to deliberately and selectively di-brominate from 
53, by using 2.5 equivalents of NBS, driving this dibromination to completion.  These reactions 
were easily monitored by 1H-NMR spectroscopy, observing the aromatic proton at the 3-
position, which resonates at 8.6 ppm, 8.7 ppm and 8.8 ppm in the non-, mono- and di-
brominated species respectively.  No evidence of the tri-brominated species was ever observed, 
presumably due to steric inhibition.  Given the difficulty in separation by column 
chromatography between the three species, this two-step process became the preferred method, 
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with an overall yield of 69% for the two steps, a significant improvement and a much simpler 
purification process. 
 
The following two steps accessing the 2-aminomethylazaxanthone, 57, derivative followed 
literature procedures, first using potassium phthalimide in a Gabriel reaction, followed by 
cleavage with methanolic hydrazine to yield the amino product after work-up.118  
 
Scheme 2:  Synthesis of the azaxanthone chloroamide, 59. 
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Previously, it was at this stage that the azaxanthone was coupled with the macrocyclic 
framework.  However, given that this reaction was not applicable for this novel series of probes, 
the final stage was to couple with the NHS activated ester of chloroacetic acid, 58, itself easily 
made in one step, to yield the final azaxanthone product, 59.  It was important that the activated 
ester was used in high purity for this reaction to proceed cleanly.  It was possible to purify this 
final compound by successive washing with saturated bicarbonate solution, followed by water. 
2.1.4 Synthesis of the macrocyclic framework 
The ligand macrocyclic framework is built up over a series of protection selective alkylation 
and deprotection steps.  This process starts with cyclen, and its selective N-alkylation at the 1,7-
positions under pH control using benzyl chloroformate (Scheme 3).119   
 
The chiral pendent arms are easily made (Scheme 4).  The glutamic acid arms were 
commercially available as their ethyl ester hydrochloride salts.  For the alanine based pendent 
arms, formation of the ethyl ester, 61, was achieved by refluxing in ethanol after dry HCl, 
generated in situ by dropping concentrated sulphuric acid onto NaCl, had been passed through 
to saturate the solution.  Alkylation with bromacetyl bromide yields the chiral pendent arm, 62. 
 
The introduction of the two desired chiral pendant arms into the macrocycle was undertaken 
by N-alkylation of di-CBZ cyclen, 60, in acetonitrile in the presence of potassium carbonate.  The 
CBZ protecting-groups were subsequently removed by hydrogenation using a palladium 
Scheme 3:  Synthesis of Di-CBZ cyclen, 60. 
Scheme 4:  Synthesis of the ethyl ester protected, acetyl bromide pendant arm, 62. Scheme 4:  Synthesis of the ligands, L1 and L2. 
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hydroxide on carbon catalyst.  Initially, it was hoped to selectively mono-alkylate the 
intermediate 66 (67 or 68) with the α-chloroamide azaxanthone, 59.  However, the formation of 
the tetra-substituted product could not be avoided and this occurred to a significant extent as 
deduced by 1H-NMR spectroscopy and ESMS product analysis.  Given that the amide-
azaxanthone took a number of steps to synthesise and the amounts were quite precious, a 
Scheme 4:  Synthesis of the ligands, L1, L2, and L3.  
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secondary route was undertaken that was considered to be more efficient with respect to this 
material.  This involved mono-protection of one of the cyclen secondary amine position in 66, 67 
or 68 with BOC2O.  Again, the formation of the tetra-substituted product with two BOC groups 
could not be avoided.  However, separation of the desired product by column chromatography 
was achieved allowing isolation of the desired mono-protected species.  This route was 
additionally more economical, because the unwanted tetra-substituted side-product could be 
recycled back into the trans pendant arm compound through BOC deprotection using TFA in a 
near quantitative yield.  After obtaining the desired mono-BOC protected species 69, 70 and 71, 
alkylation with the α-chloroamide-azaxanthone could be undertaken.  The most efficient 
reaction conditions found involve using DIPEA as the base, in acetonitrile at 60 °C overnight.  
Column chromatography of the reaction mixture on silica gel was required to purify this 
product, Finally, deprotection of the BOC protecting-group with TFA afforded the final ligand in a 
quantitative yield. 
 
This route (Schemes 2 and 4) was different to that previously used, driven by the need to 
avoid the lithium hydroxide deprotection step.  It is relevant to point out that the new route 
offers an improvement in terms of yields and ease of synthesis.  In particular, the overall yield to 
the amino-azaxanthone was increased from 1.0% to 11%; arguably, this is the limiting process 
in the total synthesis.  
2.1.5 Formation of the lanthanide(III) complexes 
The complexation of the neutral ligands, L1, L2 and L4 was carried out by refluxing in 
acetonitrile with the triflate salt of the given lanthanide ion.  It is possible to monitor the extent 
of complexation relatively easy, particularly with these azaxanthone chromophores, by 
observing the increase in intensity of the characteristic lanthanide emission by luminescence 
spectroscopy. Initially, there is a large broad emission centred at ~450 nm corresponding to 
ligand fluorescence but the relative intensity decreases as the lanthanide spectral intensity 
grows.  At completion, the fluorescence from the ligand is negligible for the azaxanthone 
derivatives, with an intense emission from the lanthanide complex, confirming that the 
complexation is complete. 
 
 The complexes then need to be purified.  Excess lanthanide salts can be removed by 
increasing the pH of the solution to 10 with concentrated KOH solution, at which point the 
lanthanide salts precipitate as Ln(OH)3.  Care needs to be taken to avoid increasing the pH too 
far above this as this can result in decomplexation of the lanthanide from the macrocycle.  The 
solution was then filtered to remove the precipitate and the pH of the solution adjusted back to 
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neutral, and lastly lyophilised.  Finally, the complexes were converted to their chloride salts, 
using anion exchange resin to enhance their water solubility.  
 
In some cases, this pH adjustment to remove excess lanthanide was performed using 
ammonium hydroxide and reacidifying with acetic acid.  This avoids the formation of potassium 
chloride salts as the products of neutralisation are volatile, and will be removed when 
lyophilising. 
 
 The related complexes, [Ln·L3] and [Ln·L5]2-, have zero or two negative charges.  For these, it 
was first necessary to hydrolyse the ester groups in each ligand.  This was most readily achieved 
using 0.1 M KOD, adding a small amount of MeOD to initially solubilise the ligand.  The 
deuterated solvent allows monitoring of the extent of the reaction by 1H-NMR spectroscopy.  
Once complete hydrolysis of the ethyl esters, and the methyl ester of the azaxanthone 
chromophore was confirmed, the pH was adjusted back to neutral, and the solution passed 
through a cation exchange resin. 
 
With these anionic ligands, complexes were formed in aqueous solution using lanthanide 
acetate salts.  The pH of the solution was adjusted to around 5.5 to facilitate efficient 
complexation.  Once complete, the excess lanthanide salt was removed by pH adjustment. 
2.2 The design and synthesis of pH-responsive emissive probes 
2.2.1 Introduction 
Previous work has shown that pH responsive lanthanide complexes can be synthesised which 
are non-toxic, cell-permeable and give a ratiometric output in response to pH through 
modulation of emission spectral form.66  However, none has satisfied both the requirement of 
showing an unambiguous lysosomal localisation, coupled with an appropriate pKa for pH-
responsive within this cellular compartment. 
 
The aim was to develop a pH responsive lanthanide complex that would target the lysosomes 
selectively, having a pKa of around 5, to operate effectively over the lysosomal pH range.  Several 
complexes were proposed and the reasoning behind the design of each one is outlined below. 
The synthetic details for each of these complexes follows.  In practice, the performance of each 
complex was analysed sequentially, i.e. before the next synthesis was proposed, based on the 
previous set of results.  
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2.2.2 Probes involving sulfonamide ligation 
The complex [Eu·L9]3+ is based on a disubstituted-phenylmethylamide ligand and 
incorporates a dpqC chromophore.  The related complex containing three of these pendant arms 
has been shown to exhibit a lysosomal distribution.26, 61  It was postulated that replacement of 
the amide pendant arm trans to the dpqC chromophore by a pH sensing moiety might not alter 
this localisation profile, and would allow pH sensing.  This hypothesis was based on the 
knowledge that it is the nature of the sensitising group, rather than the structure of the pendant 
arms, which most readily dictates the localisation.22  The para-methoxy sulfonamide pH arm was 
selected as it had been shown to be suitable for pH-dependent ligation to europium 
complexes.115  It offers a pKa in the range 5.5 to 6.0.  
 
The complex [Eu·L10]3+, closely resembles a set of pH probes which have recently been shown 
to be cell permeable, and exhibit a pH dependent ratiometric output over the range pH 6 - 7, 
albeit with some interference from endogenous anions and protein.66, 69  Modifications were 
suggested to make the complex more amenable to lysosomal pH sensing. Firstly, switching to an 
azaxanthone instead of an azathioxanthone would minimise concomitant ligand fluorescence 
and potentially allow both europium and terbium analogues to be synthesised.  Secondly, the use 
of alanine based pendant arms allows the overall charge of the complex to be easily varied 
through ester hydrolysis, and so allow a greater control, minimising interference from 
competing anionic species by varying charge repulsion on encounter.   
Fig.  16:  Representation of sulfonamide pH dependent 
ligation. 
[Eu·L9]3+ [Eu·L10]+ 
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2.2.3 Probes involving reversible carboxylate ligation 
The rationale behind the design of the complex [Eu·L11]3- is quite different from the above two 
systems.  It uses a different class of pendent arm to provide the pH response, and the 
chromophore is a non-coordinating azathioxanthone.   
 
In previous probes, glutarate arms have been introduced in conjunction with a sulfonamide to 
reduce interference from anions and protein.66  The desired pH response in these complexes 
originates from reversible sulfonamide binding.  In this instance however, the glutarate arms 
can also compete with sulfonamide ligation, forming a stable 7-membered chelate with the metal 
centre.   
 
It is anticipated that a complex including three of these arms, without any other arms capable 
of pH dependent binding will benefit from the anionic protecting properties they have, and 
utilise the pH depending binding of the carboxylate group only to generate a ratiometric change 
in the europium emission spectrum.  In addition, glutaric acid, possessing a terminal carboxylate 
pKa of 4.4, should be well suited to assessing lysosomal pH in the desired range.   
 
The second difference with this probe concerns the sensitising unit. This azathioxanthone is 
non-coordinating with the linkage to the macrocycle occurring through the 7-position, rather 
than the 2-position as in every previous example in this chapter.  The reasoning for this feature 
Fig.  17:  Representation of the effect of carboxylate binding 
to the lanthanide centre. 
[Eu·L11]3- 
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is to avoid potential problems with distance dependent energy transfer.  If the chromophore unit 
were directly bound to the lanthanide centre as in 9 and 10, it is possible that ligation of the pH 
dependent arm could increase steric demand at the metal centre and cause the pyridine nitrogen 
in the chromophore to be displaced, i.e. becoming unbound.  This would lead to two processes 
contributing to any change in the emission profile; first, a change in the coordination sphere due 
to ligation of the pH arm and second, a change in coordination due to removal of the sensitising 
unit with a corresponding decrease in the efficiency of the energy transfer step.115  By using a 
chromophore which is not bound, the lanthanide-chromophore distance should remain constant 
and not contribute to changes in the intensity of the emission spectrum associated with binding 
by the pH dependent moiety. 
2.2.4 Probes based on a pH dependence of competitive bicarbonate and 
sulfonamide binding 
The final approach was to use the bicarbonate probes e.g. [Ln·L1-5], discussed in the previous 
section as a starting point.  The probe on which these are based showed a lysosomal localisation 
at extended time-points post incubation, i.e. around 12 – 24 h.   
 
It was hypothesised that, if a pH dependent sulfonamide was incorporated onto the remaining 
free cyclen NH, bicarbonate binding would compete with sulfonamide binding giving a pH-
dependent emissive response over an extended pH range.120  This structural change would 
obviously need not to perturb the localisation profile in order to work.  Variation of the 
sulfonamide substituent would also allow the charge density on the nitrogen to be varied, 
allowing tuning of the pH range over which the probe could operate.   
 
 
[Ln·L6-8]3+ 
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2.2.5 Synthesis of the pH responsive series of probes 
For the synthesis of [Eu·L9]3+, the trans-phenylmethylamide dpqC framework had previously 
been synthesised and was available.  It was only necessary to alkylate with the sulfonamide.  The 
general procedure for introducing the sulfonamide binding moiety involves the in situ formation 
of an N-sulfonylaziridine, and its subsequent ring opening reaction with the secondary amine of 
the cyclen ring.  Potassium carbonate was used as the base, and the product was purified by 
column chromatography on silica gel.  Complexation of the final ligand was achieved using 
europium triflate . 
 
The synthesis of [Eu·L10]3+ followed a similar procedure.  The trisubstituted, trans-alanine 
azaxanthone had already been synthesised. All that was required was to alkylate the remaining 
secondary amine site with the sulfonamide, using the previous procedure, followed by 
lanthanide ion complexation.  These reactions proceeded in good yield.  
 
The synthesis of the complex [Eu·L11]3- required a different approach as it is not based on a 
trans-amide system, and its synthesis does not proceed through the trans-di-CBZ intermediate.  
Two synthetic routes towards the final complex were considered, and each was attempted.  
First, monoalkylation of cyclen with the bromomethyl chromophore was carried out followed by 
trialkylation with the glutarate arm (Scheme 5).  In the alternative route (Scheme 6), 
trialklylation was carried out first followed by alkylation of the fourth remaining cyclen NH with 
the bromomethyl chromophore.   
 
Thus, in the first route (Scheme 4), cyclen was trialkylated with (S)-2-bromopentanedioic acid 
5-benzyl ester 1-tert-butyl ester.  This reaction produced reasonably significant quantities of the 
di- and tetra-substituted side products and so column chromatography was required to separate 
the desired tri-substituted product.  The final cyclen NH position was alkylated with the 
bromomethyl chromophore in the presence of potassium carbonate.  Deprotection of the 
glutarate arms then took place in two steps.  Firstly, the benzyl groups were removed using 
lithium hydroxide.  Hydrogenation could not be used in this instance as the sulphur in the 
[Eu·L9]3+ 
[Eu·L10]+ 
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chromophore interfered with the palladium catalyst.  After the benzyl groups were removed the 
BOC groups could be removed using TFA.  Complexation of the ligand with europium acetate 
afforded the final complex after the standard work up procedures.   
 
The azathioxanthone was initially monoalkylated with cyclen, using 10 equivalents of cyclen.  
Sodium bicarbonate was used as the base offering slightly milder conditions than the potassium 
carbonate usually used in these alkylations.  Excess cyclen was recovered by washing with 
water.  This mono-alkylated product was alkylated in order to introduce the pendant arms.  (S)-
2-Bromopentanedioic dimethyl ester was used this time and this had two advantages.  First, it 
could be deprotected in a single step using lithium hydroxide, and second, the dimethyl ester is a 
Scheme 4:  The synthetic route towards [Eu·L11]3- via the first route. 
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cheaper starting product than the benzyl-tert butyl ester precursor.  This route resulted in the 
desired ligand which was complexed with europium as before. 
 
Finally, the series based on bicarbonate probes were made.  Taking the final ligand from the 
bicarbonate synthesis steps, alkylation with the desired sulfonamide precursor in the presence 
of potassium carbonate, followed by complexation, gave the final complexes.  Three different 
sulfonamides were made, to cover a range of pH values. 
2.3 Photophysical characterisation of the bicarbonate probes 
2.3.1 Emission spectral analysis 
The full emission spectrum of [Ln·L2]3+, is shown in Fig.  18.  The very fast rate of intersystem 
crossing observed for these azaxanthone systems is highlighted by the negligible amount of 
ligand fluorescence observed over the region 400 – 550 nm.  The form of the emission spectrum 
is very similar to that observed previously with structurally related europium complexes of tri-
amide ligands.2 
 
Scheme 5:  The synthetic route towards [Eu·L11]3- via the second, more efficient, route. 
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At 579 nm, a rather weak ΔJ = 0 transition was observed and the magnetic-dipole allowed ΔJ = 
1 manifold around 590-595 nm appeared as two closely spaced emission bands.  The 
hypersensitive ΔJ = 2 manifold was centred at 616 nm and appeared as one intense transition, 
while the ΔJ = 3 and ΔJ = 4 (680-710 nm) transitions were of lower intensity. 
 
Unsurprisingly, the form and splitting patterns of the emission spectra for the series [Ln·L1-4] 
were similar, as only the periphery of the ligand structure has changed.  The immediate metal 
coordination environment which determines the form of the spectrum is identical in each case.  
There are slight differences in emission intensity, most notably, a reduction by a factor of around 
two in the overall emission intensity for [Ln·L3] and [Ln·L5]3-.  These are the two complexes 
which are not positively charged.  Each spectrum was recorded at pH 5.5 after bubbling argon 
through the solution to ensure that the concentration of dissolved bicarbonate was minimised.  
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Fig.  18:  Full emission spectrum of [Ln·L2]3+ (H2O, pH 5.5, 25 µM complex, 298 K, λex = 332 nm). 
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2.3.2 Estimation of the complex hydration state, q 
The decay of the intensity of the europium emission at 616 nm in H2O and D2O is shown in Fig.  
19.  Each profile was taken using the same concentration of complex.  It can be observed that in 
D2O a more intense emission was apparent that decays more slowly. These effects result from 
the less efficient energy transfer from the 5D0 excited state to D2O oscillators.  By plotting the 
natural logarithm of the emission intensity vs. time, the reciprocal of the gradient gives the 
radiative decay constant, k.  
 
The q value of a complex is a measure of the inner sphere hydration number, and indicates the 
number of water molecules directly bound to the metal centre in the solution state.  To calculate 
this value, the excited state lifetime was first measured in H2O.  Following lyophilisation, the 
complex was re-dissolved in D2O, and left overnight to allow exchange of bound H2O to D2O.  The 
complex was again lyophilised, and re-dissolved in fresh D2O, and the excited state lifetime was 
measured again.  Due to the differences in the rates of energy transfer to H2O and D2O 
oscillators, the hydration state can be calculated according to the following equations, [Eq. 6] 
and [Eq. 7], where the terms 0.25 and 0.06 reflect the quenching effect of unbound water 
molecules and n is the number of coordinated secondary amide groups, reflecting the quenching 
effect of the proximate NH oscillators.32, 33 
 
 ' 1.2 0.25 0.075Euq k n     [Eq. 6] 
 ' 5 0.06 0.01Tbq k n      [Eq. 7] 
 
 
Fig.  19:  Representative excited state decay profiles for lanthanide emission as a function of delay time 
in D2O (blue) and H2O (red).  The reciprocal of the gradient of ln(intensity) vs. delay time gives the 
radiative decay constant. 
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Table 4:  Rate constants, k, (± 10%) and lifetimes (τ), observing radiative decay of the lanthanide excited 
state (at 616 nm for Eu(III), 545 nm for Tb(III)) (295 K, 50 µM complex) and derived hydration numbers, 
q (± 20%). 
Complex kH2O / ms-1 τ / ms kD2O / ms-1 τ / ms q 
[Eu·L1]3+ 3.85 0.26 1.56 0.64 2.2 
[Tb·L1]3+ 0.87 1.15 0.40 2.50 2.1 
[Eu·L2]3+ 3.85 0.26 1.73 0.58 2.0 
[Tb·L2]3+ 0.90 1.11 0.41 2.44 2.2 
[Eu·L3] 3.86 0.26 1.48 0.68 2.3 
[Tb·L3] 0.90 1.11 0.39 2.56 2.3 
[Eu·L4]3+ 2.08 0.48 0.88 1.14 0.9 
[Tb·L4]3+ 0.81 1.24 0.51 1.96 1.0 
[Eu·L5]2- 2.69 0.37 1.33 0.75 1.1 
[Tb·L5]2- 0.82 1.21 0.42 2.39 1.5 
 
 
For [Eu·L1-3], a q value of two was obtained.  There exists no difference in q value for the 
europium and terbium complexes of the same ligand.  Thus, in the solution state, two water 
molecules are bound to the metal centre.  Hence the lanthanide ion is nine-coordinate, with 
binding to the seven nitrogen and oxygen donors of the heptadentate ligand.  For [Eu·L4,5] the q 
value is one, indicating just a single bound water molecule.  Accordingly, the excited state 
lifetime for this complex is longer than for [Eu·L1], as there is less quenching from the energy 
matched OH oscillators with just a single bound water.  This reduced hydration number 
presumably results from an increase in the steric demand at the metal centre, by virtue of the 
presence of the more bulky glutamic acid based pendant arms.   
2.3.3 HPLC analysis of lanthanide complexes 
All complexes were examined by reverse phase HPLC analysis to establish homogeneity.  This 
analysis was also used to ensure that complexation of the ligand by the metal was complete.  It 
also offers a useful check that hydrolysis has gone to completion, particularly when it is 
necessary to hydrolyse 3 or 5 esters per ligand.  The retention times are slightly different for 
each potential semi-hydrolysed product and GC-MS was used to assign peaks when required.  
The hydrophobic side chains on the column aid separation of relatively hydrophobic complex 
species.  Hence, the hydrolysed complexes, which are more hydrophilic eluted at shorter 
retention times (eg. compare [Eu·L2]3+ at 9.4 minutes and [Eu·L3] at 8.8 min. (Table 5) 
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Table 5:  HPLC retention times of Ln(III) complexes (295 K, see experimental section for details).  The 
terbium analogues gave very similar retention times. 
Complex retention time (min) 
[Eu·L1]3+ 10.0 
[Eu·L2]3+ 9.4 
[Eu·L3] 8.8 
[Eu·L4]3+ 10.3 
[Eu·L5]2- 8.6 
 
 
2.3.4 Mass spectrometry analysis of the lanthanide complexes 
Mass spectrometry data was used to characterise each lanthanide complex and confirm that 
complexation has taken place.  In contrast to terbium which exists only as 159Tb, europium has a 
characteristic isotope profile.  A comparison of the observed profile to the calculated isotopic 
distribution of each complex was found to be in good agreement, indicating complexation had 
occurred.  A representative example is shown in Fig.  20.  This data is for [Eu·L6]3+, the pH 
responsive methyl sulfonamide complex.  The sulfonamide is deprotonated and bound to the 
metal, so a doubly charged complex at half mass is observed. 
 
Fig.  20:  Calculated (left) and observed (right), accurate mass spectral data for [Eu·L6]3+. 
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2.4 Photophysical characterisation of the pH-responsive probes 
2.4.1 Emission spectral characteristics 
Emission spectra for all the pH-responsive complexes are shown below, recording at limiting 
low and high pH values, for the europium and terbium analogues.  For the para-trifluoromethyl 
complexes, the europium and terbium complexes were examined in solution together, and so the 
spectra here shows a mix of the two ([Eu·L8]3+ and [Tb·L8]3+). 
 
The europium spectra of the methyl-sulfonamide para-methoxy-phenylsulfonamide pH 
responsive complexes are similar in spectral form.  The most obvious difference is the drastic 
reduction in emission intensity for [Eu·L7]3+, by a factor of around 10 at high pH.  There is a small 
change in emission form, most noticeably with a small peak appearing within the ΔJ = 2 manifold 
at 625 nm at higher pH.  With the para-trifluoromethyl- derivative, [Eu·L8]3+, this ΔJ = 2 band is 
fully resolved into two peaks of roughly equal intensity, but again with an overall decrease in 
emission intensity.  The terbium complexes of the same ligands show contrasting behaviour 
however.  For the methyl-sulfonamide complex, [Tb·L6]3+, there is approximately a doubling in 
increase in emission intensity at higher pH, and the two main bands around 545 nm (ΔJ = -1) are 
also clearly resolved into two main components at this pH.  The para-methoxy- and para-
trifluoromethyl-sulfonamide complexes, [Tb·L7]3+ and [Tb·L8]3+,  exhibit an identical form to the 
methyl- complex, but intriguingly the overall emission intensity decreases, by a factor of around 
4.  
 
 
0
10
20
30
40
50
60
70
570 620 670 720
In
te
n
si
ty
 
wavelength / nm 
0
5
10
15
20
570 620 670 720
In
te
n
si
ty
 
wavelength / nm 
pH 3 
[Eu·L6]3+ 
pH 9 
[Eu·L6-H]2+ 
                                                                             TWO: SYNTHETIC ASPECTS AND PHOTOPHYSICAL CHARACTERISATION 
 -73- 
 
 
 
 
 
0
10
20
30
40
50
460 510 560 610
In
te
n
si
ty
 
wavelength / nm 
0
20
40
60
80
100
460 510 560 610
In
te
n
si
ty
 
wavelength / nm 
0
20
40
60
80
100
120
140
570 620 670 720
In
te
n
si
ty
 
wavelength / nm 
0
2
4
6
8
10
570 620 670 720
In
te
n
si
ty
 
wavelength / nm 
0
10
20
30
40
50
60
70
80
460 510 560 610
In
te
n
si
ty
 
wavelength / nm 
0
2
4
6
8
10
460 510 560 610
In
te
n
si
ty
 
wavelength / nm 
0
10
20
30
40
50
60
70
80
450 500 550 600 650 700
In
te
n
si
ty
 
wavelength / nm 
0
5
10
15
20
25
30
450 500 550 600 650 700
In
te
n
si
ty
 
wavelength / nm 
pH 3 
[Tb·L6]3+ 
pH 3 
[Eu·L7]3+ 
pH 9  
[Tb·L6-H]2+ 
pH 9  
[Eu·L7-H]2+ 
pH 3 
[Tb·L7]3+ pH 9 
[Tb·L7-H]2+ 
pH 3 
[Ln·L8]3+ 
pH 9 
[Ln·L8-H]2+ 
                                                                             TWO: SYNTHETIC ASPECTS AND PHOTOPHYSICAL CHARACTERISATION 
 -74- 
The dpqC sulfonamide [Eu·L9]3+ exhibits relatively little change in the form of its spectra and 
the pH extremes.  The ΔJ = 1 and ΔJ = 4 bands were identical in form, with just a small change in 
the relative intensities of the splitting observed within the ΔJ = 2 manifold.  It was therefore not 
examined any further as a pH probe as the pH-dependent emission spectral changes were too 
small to be of use. 
 
 
The azaxanthone-methylsulfonamide complex, [Eu·L10]+ is slightly unusual in that the 
emission intensity increased and then subsequently decreased upon varying the pH from 3 to 9.  
The form of the spectra at the two pH limits is markedly different.  There is less splitting at high 
pH, suggesting a higher degree of symmetry in the sulfonamide bound species. 
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The total emission spectrum of [Eu·L11]3+ is dominated by ligand fluorescence at 450 nm.  
Lanthanide emission was still observed but there appeared to be very little change in the form of 
emission over the entire pH range.  Again, this spectral invariance led to this system not being 
examined in greater detail. 
 
 
 
 
 
2.4.2 Estimation of complex hydration states, q 
Inner sphere hydration numbers for the pH-responsive complexes were calculated by 
measuring the relevant excited state lifetimes in H2O and D2O, at the limiting pH values.  The 
rates of decay, both at low and high pH (Table 6) suggest that within the series [Ln·L6-8]3+ , the 
complexes were behaving quite differently from one another.  The behaviour of [Ln·L7]3+ is most 
clear, and shows a switching from one bound water molecule to none upon sulfonamide ligation 
at higher pH.  This correlates with the observations made with the bicarbonate series which had 
two bound water molecules.  Presumably, the steric hindrance associated with the sulfonamide 
moiety means only a single bound water molecule can be accommodated, rather than two in the 
unbound form. 
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Table 6:  Radiative decay constants, luminescence lifetimes and calculated q values for the complexes 
[Ln·L6]3+ to [Ln·L11]3+. 
 pH 3 pH 9 
Complex 
kH2O / 
ms-1 
τ / ms 
kD2O / 
ms-1 
τ / ms q 
kH2O / 
ms-1 
τ / ms 
kD2O / 
ms-1 
τ / ms q 
[Eu·L6]3+ 1.64 0.61 1.03 0.98 0.2 2.15 0.46 1.03 0.96 0.8 
[Tb·L6]3+ 0.81 1.24 0.64 1.56 0.5 0.76 1.58 0.63 1.32 0.3 
[Eu·L7]3+ 2.09 0.48 0.78 1.28 1.0 1. 41 0.71 0.99 1.01 -0.1 
[Tb·L7]3+ 0.73 1.37 0.51 1.96 0.8 0.58 1.72 0.53 1.89 -0.1 
[Eu·L8]3+ 1.67 0.60 0.72 1.39 0.6 2.06 0.49 1.02 0.98 0.7 
[Tb·L8]3+ 0.75 1.34 0.49 2.06 0.9 0.75 1.34 0.55 1.81 0.6 
[Eu·L9]3+ 2.96 0.34 1.02 0.98 1.9 1.83 0.55 0.86 1.16 0.7 
[Eu·L10]+ 2.37 0.42 0.92 1.08 1.4 1.90 0.52 0.75 1.34 0.5 
[Eu·L11]3- 1.91 0.52 0.97 1.03 0.8 1.57 0.64 0.92 1.08 0.5 
 
 
The dpqC para-methoxyphenyl sulfonamide complex, [Eu·L9]3+ showed a clear switching from 
two bound water molecules at low pH, to one at higher pH.  Again this behaviour correlates with 
a single water molecule being displaced upon sulfonamide ligation at higher pH values. 
 
The other complexes exhibit non-integral q values.  This could mean that at a given pH, there 
exists a mixture of species of differing q value, and so an average value is observed. 
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3 Bicarbonate Probes for the Mitochondria 
3.1 Introduction 
Monitoring real-time changes of bicarbonate concentrations within the mitochondrial region 
of cells is important to gaining an understanding of signalling mechanisms involved in the Krebs 
cycle and glycolysis.121  Syntheses of a range of lanthanide based optical probes, possessing 
varying steric demand and charge were described in chapter two. 
 
This chapter details work aiming to probe the concentration of bicarbonate by use of either a 
ratiometric analysis of a pair of emission bands within each spectrum, or use the relative 
emission intensity between europium and terbium analogues of a common ligand.   The series of 
probes were evaluated towards relevant bioactive oxy-anions and protein, through a series of 
spectral titrations, allowing estimates of their binding constants.  Subsequent competition 
experiments were undertaken to investigate selectivity of the response to bicarbonate in the 
presence of biologically relevant molecules.  Finally, microscopy experiments examined the 
localisation of the complexes in the mitochondria and how changes in the emitted light by the 
probes varied as a function of pCO2.   
3.2 Spectral titrations and calculation of apparent affinity constants 
To assess the binding of the complexes towards bicarbonate and various other oxy-anions, a 
series of spectral titrations was performed.  Incremental amounts of the anion, as a concentrated 
stock solution, were added to a solution of the complex so that the total volume change did not 
[Ln·L2]3+  R = CO2Et, R’ = OMe 
[Ln·L3]  R = CO2-, R’ = O- 
[Ln·L4]3+  R = CO2Et, R’ = OMe 
[Ln·L5]  R = CO2-, R’ = O- 
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exceed 5%.  A 0.1 M NaCl background was used in order to maintain a constant ionic strength 
when adding the anions as their sodium salts.  This sodium chloride concentration was chosen to 
mimic that found at a typical extracellular value.  The number of data points taken was typically 
around 15, ensuring that the curved part of the binding plot was well represented. The 
concentration range spanned from zero, up to the limiting value, where no change appeared to 
occur either in the emission spectral form or intensity. 
 
The pH of the solution was carefully controlled by adjusting the anion stock solutions to the 
designated pH, as well as that of the initial complex solution.  It was then assumed that small 
additions of the stock solution at the same pH to the complex solution caused no significant 
change.  Measurements of pH taken at the start and end of the titration indicated this was true, 
and the pH fluctuated by no more than ± 0.05 units. 
 
A further consideration took account of dissolved bicarbonate that is naturally present 
through the equilibrium with atmospheric CO2.122  To minimise this uncertainty as far as 
possible, all solutions, with the obvious exception of the bicarbonate stock, were lowered in pH 
to around 5, bubbled under gentle agitation with argon for ten minutes and then increased back 
to the desired pH with freshly made concentrated potassium hydroxide solution.  Bicarbonate 
stock solutions were freshly made with distilled, degassed water. 
 
The data obtained was plotted, overlaying each spectrum obtained, so that changes to the 
form and intensity were easily observed.  Ratiometric analysis was performed to allow binding 
affinities to be calculated.  It is possible to take the ratio in a number of ways; by using a pair of 
individual emission wavelengths (such as 616 nm / 594 nm), by using a pair of emission bands 
(most commonly the ΔJ = 2/ΔJ = 1 ratio comparing the hypersensitive ΔJ = 2 band to the 
relatively insensitive ΔJ = 1 band), or alternatively, indicated at the end of the chapter, by using a 
red/green (or europium/terbium) emission intensity ratio.  
  
The emission spectra for the titration of [Eu·L2]3+ with sodium bicarbonate (Fig.  21) is 
representative, adding a bicarbonate concentration up to 30 mM.  Note, that at this final 
bicarbonate concentration, the limiting spectral form has been reached, and the bicarbonate 
concentration is at or above the level found at typical extracellular levels.  In general, every 
titration was continued until these criteria were met. 
 
A large significant increase in emission intensity was observed across the emission spectrum, 
particularly within the ΔJ = 2 manifold.  The maxima of the ΔJ = 2 transition shifts very slightly 
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upon bicarbonate binding from 614 nm to 616 nm.  Small changes to the spectral form are 
evident, most notable within the ΔJ = 1 band. 
 
There are hundreds of possibilities for performing ratiometric analysis on  pairs of individual 
wavelengths.  Previous reports have sometimes utilised pairs of wavelengths which are very 
close to one another (eg 615 nm / 617),66 but there are potential issues here such as that the 
emission slits typically being used are 1.5 nm, so there is some overlap if the two wavelengths 
are only 2 nm apart.  Preferentially therefore, wavelengths were selected in different manifolds, 
and a plot of 617.5 nm / 590 nm is shown in Fig.  18.  Fitting this data to a 1:1 binding model, 
allows an estimation of the apparent binding constant, log K.  This was calculated to be 3.80 ± 
0.05, using a linear least-squares fitting algorithm, developed in Microsoft Excel.  The quoted 
error is the standard error to the observed data, using the jack-knife procedure. 
Fig.  21:  Variation of the Eu(III) emission spectrum for [Eu·L2]3+, following addition of 
sodium bicarbonate (H2O, pH = 7.40 ± 0.05, 0 – 30 mM sodium bicarbonate, 40 µM complex, 
298 K, I = 0.1 M NaCl, λex = 332 nm).  Inset shows the magnified ΔJ = 1 region, highlighting the 
change in spectral form and intensity, and the appearance of an apparent isoemissive point 
at 590 nm. 
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Any pair of wavelengths that yield a reasonable binding curve should result in the same value 
for the binding constant and this is the case here comparing Fig.  22a and Fig.  22b, within the 
experimental error.  When deciding on the ratio to use, a wavelength was often selected that 
showed the greatest change against another wavelength which remains constant or nearly 
constant, a so-called isoemissive point. In the example shown above, 617.5 nm is the maxima of 
the hypersensitive ΔJ = 2 band, whilst 590 nm is an isoemissve point within the ΔJ = 1 band.  The 
main advantage of calculating affinities using individual wavelengths is that it is possible to take 
advantage of the very fine structural changes often observed upon anion binding or as a result of 
a change in the coordination sphere.  The overriding disadvantage is that in less emissive 
samples, the signal-to-noise ratio will be greatly reduced and may lead to larger errors.  This will 
also be the case in microscopy experiments, where using individual wavelengths will simply not 
be possible.  The signal from a 50 µM sample in a 1 ml cuvette will be much stronger then that 
observable in a cell on a confocal microscope.  Furthermore, the resolution of a lambda scan on 
such equipment is limited to 3 nm and so such high resolution spectra are not possible to obtain. 
 
Calculating integrated area ratios offer a solution.  Integrating, and taking a ratio of a pair of 
whole bands takes account of the decreased intensity in microscopy and allows less emissive or 
quenched samples to give a more reliable result.  In microscopy, it also allows two wider 
channels to be set up, maximising the signal observed and simplifying the acquisition time and 
experimental procedure.  More details regarding this will follow at the end of the chapter.  For 
europium spectra, it is often best to take a ratio of the ΔJ = 2/ΔJ = 1 bands, as the ΔJ = 2 band is 
hypersensitive and should show a large change compared to the magnetic dipole allowed ΔJ = 1 
band, which shows far less change.  Plotting this ratio as a function of bicarbonate concentration 
Fig.  22b:  Plot of intensity ratio (ΔJ = 2/ΔJ = 1) 
with [HCO3-], allowing calculation of the apparent 
binding constant. 
log K = 3.80 ± 0.05 
Fig.  22a:  Plot of intensity ratio (617.5 nm/590 
nm) with [HCO3-], allowing calculation of the 
apparent binding constant. 
log K = 3.85 ± 0.05 
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again allows an affinity constant to be estimated.  Within the error, this was found to be the 
same as for that obtained using individual wavelengths. 
 
The change in the observed ratio is another important factor which should be considered. In 
the integrated area analysis above, the change in intenisty ratio is from approximately 1.75 to 
3.75, which is sufficiently large to allows accurate measurements to be made. 
3.3 Binding of bicarbonate to the complexes 
3.3.1 Binding of bicarbonate to the europium complexes  
Each of the complexes [Eu·L1-4] was assessed with respect to bicarbonate binding.  The form 
of the limiting emission spectra of the bicarbonate bound adduct in each case was very similar to 
that for [Eu·L2]3+ in Fig.  16 .  The same analysis of the data was performed each time for 
consistency, i.e. taking the ΔJ = 2/ ΔJ = 1 intenisty ratio.  The apparent binding constant was 
calculated, along with the corresponding increase this ratio generated, the intensity increase 
within the hypersensitive ΔJ = 2 band, and the overall increase in europium luminescence are 
provided in Table 7.   
 
Table 7:  Affinity constants of the europium(III) complexes for bicarbonate with the corresponding 
increase in the ΔJ = 2/ΔJ = 1 ratio, increase in ΔJ = 2 luminescence and increase in overall europium (III) 
luminescence (298 K, I = 0.1 M NaCl, pH = 7.40 ± 0.05). 
complex log K 
Ratio 
increase % 
ΔJ = 2 
increase % 
Overall 
intensity 
increase % 
[Eu·L1]3+ 3.50 ± 0.05 95 410 265 
[Eu·L2]3+ 3.85 ± 0.05 120 365 52 
[Eu·L3] 2.75 ± 0.05 120 265 140 
[Eu·L4]3+ 3.60 ± 0.05 85 255 160 
 
The three triply positively charged complexes all yielded broadly similar binding constants, 
while the log K value for the zwitterionic complex was approximately one unit lower.  This 
accords with the electrostatic nature of binding.  The bicarbonate anion is less inclined to bind to 
[Eu·L3], due to the anionic charges on the peripheral arms shielding the lanthanide centre to 
some extent.  The increase in the ΔJ =2 /ΔJ = 1 ratio is approximately the same across the range 
of complexes. Complex charge appears to have little effect on this, for example, the related 
[Eu·L2]3+ and [Eu·L3] having identical increases.  It is possible that the size of the pendant arms 
exerts a limited influence, as the complexes with the sterically more bulky glutamate and 
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methylphenylalanine arms are those with slightly lower percentage increase.  The increase in 
the ΔJ = 2 emission intensity was very high in each case.   
For the only overall negatively charged complex, [Eu·L5]2-, a binding constant could not be 
obtained.  Addition of bicarbonate did not lead to the characteristic change in spectral form and 
intensity observed with the other europium complexes.  Conversely, a small decrease or 
quenching of emission intensity was observed and there was no shift in the ΔJ = 2 maxima to 616 
nm (Fig.  23).  This behaviour suggests that bicarbonate is binding only very weakly to this 
complex.  Presumably, this is due to the complexes negative charge arising from the four bulky 
carboxylate functionalities that surround the europium centre, protecting it from binding with 
the anion.  It had originally been hoped that by using this dianionic complex, it would be a 
convenient way to increase the selectivity for monoanionic bicarbonate over trianionic citrate, 
as the latter which itself has a multiple negative charge at ambient pH.  However, it appears that 
the negative charge is too big, and therefore bicarbonate binding is inhibited as well.  This 
prevented further studies from being undertaken with this complex. 
3.3.2 Binding of bicarbonate to the terbium complexes  
The bicarbonate titrations were also performed with the terbium analogues, the equivalent 
data are shown in Fig.  24.  The apparent binding affinities follow the same trend as for the 
europium analogues (Table 8).  The most striking feature is that the increases in emission 
intensities are greatly reduced.  Both the increase in the main ΔJ = -1 band, and the overall 
increase are a fraction of what they were for the europium complexes.  The general insensitivity 
of the terbium (III) emission bands to changes in coordination is highlighted here.  Whereas for 
Fig.  23:  Variation of the Eu(III) emission spectrum for [Eu·L5]2-, following addition of 
sodium bicarbonate (H2O, pH = 7.40 ± 0.05, 40 µM complex, 0 – 30 mM sodium bicarbonate, 
298 K, I = 0.1 M NaCl, λex =332 nm).   
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europium, the hypersensitive ΔJ = 2 band intensity increased much more than the overall 
luminescence increase (and hence is responsible the large change in the calculated ratio) for 
terbium there is much less difference between the bands, and consequently a smaller difference 
in the intensity ratio change.  The change in spectral form was similar for each complex 
examined upon addition of sodium bicarbonate.  The ΔJ = -2 and ΔJ = -1 bands showed a modest 
increase in emission intensity.  In each case, the ΔJ = 0 manifold at 680 nm was the only one to 
show a significant change in form.  The relative intensity of the splitting of the two bands within 
this manifold switched upon the addition of bicarbonate.  The ΔJ = +1 manifold at 620 nm was 
quite weak, and showed relatively little change. 
 
Table 8:  Affinity constants of terbium (III) complexes for bicarbonate with the corresponding increase in 
the ΔJ = -2/ΔJ = -1 ratio, increase in ΔJ = -1  luminescence and increase in overall terbium (III) 
luminescence (298 K, I = 0.1 M NaCl, pH = 7.40 ± 0.05). 
complex log K 
Ratio 
increase % 
ΔJ = -1 
increase % 
Overall 
increase % 
[Tb·L1]3+ 3.75 ± 0.10 18 14 6 
[Tb·L2]3+ 3.00 ± 0.05 12 42 34 
[Tb·L3] 2.52 ± 0.05 17 18 11 
[Tb·L4]3+ 3.15 ± 0.10 42 27 27 
 
Fig.  24:  Variation of the Tb(III) emission spectrum for [Tb·L2]3+,  following addition of 0 – 30 mM 
sodium bicarbonate (H2O, pH = 7.40 ± 0.05, 40 µM complex, 298 K, I = 0.1 M NaCl, λex =332 nm).   
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3.3.3 Circularly polarised luminescence of [Ln·L2]3+ in response to the addition of 
sodium bicarbonate 
Circularly polarised luminescence spectroscopy can be used to probe the degree of chirality 
sensed by an electronic transition.  Emission dissymmetry factors (gem) can be used to represent 
this.  Conformationally rigid chiral complexes, such as those examined in this series, will 
therefore exhibit circularly polarised luminescence and can be probed by this technique.   
 
As a representative example from the series, [Eu·L2]3+ was chosen for study.  Its CPL spectra, 
shown in red in Fig.  25 reveals a strong CPL signal, as for other complexes of this type.  The CPL 
spectra shows a high degree of similarity in form to that for [Eu·L13]3+ and [Eu·L75]3+ (Fig.  26)19 
with a (+-) signal sequence within the ΔJ = 1 band at 590 nm and a (+-) signal sequence also in 
the ΔJ = 2 band around 616 nm.  It is reasonable to suggest then, that this complex adopts the 
same configuration, namely Δ-(λλλλ).  Calculated gem values for [Eu·L2]3+ are roughly the same as 
for [Eu·L13]3+ (Table 9).  This is unsurprising as they are structurally very similar, with an amide 
linked chromophore and two coordinated amide pendant arms.  Values for [Eu·L2]3+ were 
significantly smaller than those observed for [Eu·L75]3+.  This would suggest an increased 
conformational flexibility on the experimental timescale. 
Fig.  25:  Circularly polarised luminescence spectra of [Eu·L2]3+ (red) and of [Eu·L2]3+ in the presence 
of 30 mM sodium bicarbonate (blue) (295 K, I = 0.1 M NaCl, pH = 7.40 ± 0.05), showing the large 
differences in CPL between the aqua and the bicarbonate adduct. 
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Table 9:  Emission dissymmetry factors (gem) at specified wavelengths (D2O, 295 K) 
 ΔJ = 1 ΔJ = 2 
[Eu·L2]3+ -0.020 (600 nm) 0.008 (613 nm) 
[Eu·L75]3+ -0.05 (593 nm) 0.03 (612 nm) 
[Eu·L13]3+ -0.022 (593 nm) 0.012 (616 nm) 
 
Upon addition of a limiting concentration of sodium bicarbonate (30 mM), the CPL spectra 
revealed a dramatic and significant change, particularly within the ΔJ = 1 manifold (Fig.  25).  
There is a reversal of sign sequence from (+-) to (-+) and the CPL emission intensity decreases.  
The ΔJ = 2 emission band shifts to 616 nm and accords with the change in the total 
luminescence.  The negative transition at 624 nm disappears.  The ΔJ = 4 band appears 
unchanged.  Due to the predominantly electronic dipole nature of this transition this is to be 
expected.  Emission dissymmetry factors for the bicarbonate bound adduct, and the aqua 
complex are shown in Table 10. 
 
 
 
Fig.  26:  CPL spectra of [Eu·L75]3+ (H2O, 1 mM, 295 K, λex = 255 nm) (left); total luminescence and CPL 
spectra (x18) of [Eu·L13]3+ (D2O, 0.05 mM, 295 K, λex = 275 nm) (right). 
[Eu·L75]3+ [Eu·L13]3+ 
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Table 10:  Emission dissymmetry factors at specified wavelengths (D2O, 295 K) 
λ / nm [Eu·L2]3+ [Eu·L2]3+ + 30 mM bicarbonate λ / nm 
595.5 0.050 -0.023 597 
603 -0.087 0.096 602 
624 -0.057 0.013 626.5 
657 0.271 0.078 657 
694 -0.096 -0.038 692.5 
 
 
The circularly polarised luminescence of the terbium analogue, [Tb·L2]3+, was also examined.  
The CPL spectrum of the aqua complex was recorded, and separately in the presence of limiting 
concentrations of bicarbonate (30 mM) and citrate (2 mM) (Fig.  27).  CPL emission was 
observed in the magnetic dipole allowed ΔJ = -1 and ΔJ = +1 bands for the aqua complex.  
Addition of citrate caused very little change to the form or intensity of the CPL emission in these 
bands, but did lead to a switching-on of CPL emission intensity within the ΔJ = -2 band.   
Addition of bicarbonate to a solution of [Tb·L2]3+ led to a substantial change in the CPL 
spectrum.  The form and intensity of the ΔJ = -1 transitions are particularly different, while the 
ΔJ = +1 band increased in intensity, but maintained an identical form. 
 
Fig.  27:  Circularly polarised luminescence spectra of [Tb·L2]3+ (green) and of [Tb·L2]3+ in the presence 
of 30 mM sodium bicarbonate (blue) and of [Tb·L2]3+ in the presence of 2 mM sodium citrate (orange)  
(295 K, I = 0.1 M NaCl, pH = 7.40 ± 0.05). 
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In summary, these experiments show that CPL spectroscopy can be used to signal anion 
binding, giving profiles that are characteristic of the particular ternary adduct. 
3.4 Affinity of the complexes towards other oxy-anions 
In any biological medium there exist a number of oxy-anions in addition to bicarbonate which 
could compete for binding to the lanthanide centre.  For example, extracellular fluid composes of 
approximately 120 mM chloride, 2.3 mM lactate, 0.9 mM phosphate and 0.13 mM citrate.  The 
binding of any of the latter three could potentially cause a change in spectral form or emission 
intensity competing with that observed for bicarbonate.2, 123, 124  Within the cellular environment 
where the probes are to be used, the concentrations of all these anions are constantly changing, 
and are not accurately known.  Therefore, it would be unclear which adducts the emission 
spectrum actually represents.  The probe needs to withstand binding to other oxy-anions as 
much as possible, and in the context of a competitive background, remain selective for 
bicarbonate. 
 
The complex, [Eu·L13]3+, which formed the starting point for the novel series discussed in this 
chapter suffered from this problem of competitive anion binding.2  The probe exhibited a strong 
binding to citrate as well as bicarbonate.  This meant that, in a biological context, the emission 
spectrum observed was a mixture of citrate and bicarbonate bound adducts.  As such, gaining a 
meaningful quantification of bicarbonate binding would be difficult, if not impossible.  A major 
aim of this work was to address this issue. 
 
To investigate the aspect of affinity towards other oxy-anions, spectral titrations were 
performed with individual anions, namely citrate, phosphate and lactate for the range of 
complexes.  Binding constants were calculated in each case, as well as examination of the change 
of form and intensity of the emission within the spectra. 
3.4.1 Binding affinity of the complexes towards citrate  
Citrate is perhaps likely to be the species which competes most for coordination to a 
positively charged metal centre.  The three carboxylates have pKa’s of 3.13, 4.76 and 6.40.  Thus, 
at physiological pH, citrate exists as a trianion.  This could be expected to have a strong binding 
affinity for a triply positively charged metal centre, as is found in some of these lanthanide 
complexes.  
 
Titrations of the europium complexes with citrate, as its trisodium salt, were performed at pH 
7.4, as for bicarbonate.  The spectral form upon the addition of citrate compared with that 
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observed for bicarbonate binding is strikingly different.  Emission is quenched by citrate, 
whereas an increase in emission intensity was observed for bicarbonate.  For the europium 
complexes, the change in the ΔJ = 2 / ΔJ = 1 ratio was far smaller (20 – 35% change) due to this 
quenching effect (Table 11).  For [Eu·L1]3+ and [Eu·L3], changes in the spectral form were minor.  
There was only a small change in the form of the ΔJ = 4 manifold at 700 nm for the [Eu·L2]3+ and 
[Eu·L4]3+ pair (Fig.  28).   
 
The terbium complexes behaved in a very similar way to each other, with considerable 
quenching observed in all cases (Fig.  29).  Spectral modulation was insufficient to allow any 
Fig.  29:  Variation of the Tb(III) emission spectrum for [Eu·L2]3+ following addition of sodium citrate 
(H2O, pH = 7.40 ± 0.05, 40 µM complex, 298 K, I = 0.1 M NaCl, λex = 332 nm).   
 
Fig.  28:  Variation of the Eu(III) emission spectrum for [Eu·L2]3+ following addition of sodium citrate 
(H2O, pH = 7.40 ± 0.05, 40 µM complex, 298 K, I = 0.1 M NaCl, λex = 332 nm).   
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ratiometric analysis of the bands.  It was observed that the degree of quenching was significantly 
less for [Tb·L3], the neutral complex, with an overall decrease of just 10%.  It appears that the 
negatively charged pendant arms may inhibit the binding of citrate in accord with the effect of 
Coulombic repulsion. 
 
Table 11:  Affinity constants of europium (III) and terbium (III) complexes for citrate with the 
corresponding increase in the J = -1/J = -2 ratio, increase in J = -1 luminescence and increase in overall 
terbium (III) luminescence (298 K, I = 0.1 M NaCl, pH = 7.40 ± 0.05). 
complex log K 
Ratio 
increase % 
ΔJ = 2 or ΔJ = 
-1 change % 
Overall 
change % 
[Eu·L1]3+ 4.00 ± 0.05 36 -38 -61 
[Eu·L2]3+ 4.80 ± 0.15 19 -11 -18 
[Eu·L3] 3.95 ± 0.05 26 -5 -14 
[Eu·L4]3+ 4.40 ± 0.05 19 - - 
[Tb·L1]3+ insufficient spectral 
modulation due to large 
degree of quenching 
-92 -74 
[Tb·L2]3+ -75 -52 
[Tb·L3] -13 -10 
 
3.4.2 Binding affinity of the complexes towards lactate 
Lactate is smaller in size than citrate and possesses just a single negative charge at 
physiological pH with a pKa of 3.86.  Titrations of sodium lactate with each complex were 
Fig.  30:  Variation of the Eu(III) emission spectrum for [Eu·L1]3+,  following addition of sodium lactate 
(H2O, pH = 7.40 ± 0.05, 40 µM complex, 298 K, I = 0.1 M NaCl, λex = 332 nm).   
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performed.  The pH for the lactate titrations was at 5.5, as in preliminary work, assessing the pH 
dependence of the emission in a fixed lactate background, it was shown that this is within a 
region where pH-modulation of emission was minimal.123 
 
Addition of sodium lactate produced a similar response across the series of europium 
complexes (Fig.  30).  There was an overall increase in emission intensity.  A characteristic band 
appears at 594 nm in the ΔJ = 1 manifold, and there is also the appearance of a shoulder in the ΔJ 
= 2 manifold at 621nm.  There was no change in the form of the ΔJ = 4 manifold.  The increase in 
overall emission intensity was again smallest for the neutral complex, indicating that the anionic 
periphery is inhibiting anion binding (Table 12).  Consequently, the binding constant for the 
neutral complex is once again the lowest.  
  
Differing behaviour was observed across the terbium set of complexes, in which  [Tb·L1]3+ and 
[Tb·L2]3+ showed a modest increase in intensity, but with very little change in emission form.  In 
contrast, [Tb·L3] and [Tb·L4]3+ exhibited a decrease in emission intensity upon addition of lactate 
(Fig.  31).  For [Tb·L3] there was not a sufficient change in form to allow a binding constant to be 
estimated confidently. 
 
 
 
 
 
Fig.  31:  Variation of the Tb(III) emission spectrum for [Tb·L1]3+ (left) and [Tb·L4]3+ (right) following 
addition of sodium lactate (H2O, pH = 5.50 ± 0.05, 40 µM complex, 298 K, I = 0.1 M NaCl, λex = 332 
nm).   
                                                                                                             THREE: BICARBONATE PROBES FOR THE MITOCHONDRIA 
 -91- 
Table 12:  Affinity constants of europium (III) and terbium (III) complexes for citrate with the 
corresponding increase in the calculated ratio, increase in ΔJ = 2 or ΔJ = -1 luminescence and increase in 
overall lanthanide (III) luminescence (298 K, I = 0.1 M NaCl, pH = 7.40 ± 0.05). 
complex log K 
Ratio 
increase % 
ΔJ = 2 or ΔJ = -1 
change % 
Overall 
change % 
[Eu·L1]3+ 3.30 ± 0.05 55 90 45 
[Eu·L2]3+ 3.05 ± 0.05 25 32 41 
[Eu·L3] 2.55 ± 0.05 33 38 18 
[Eu·L4]3+ 3.45 ± 0.05 29 52 32 
[Tb·L1]3+ 3.40 ± 0.05 3 26 23 
[Tb·L2]3+ 3.55 ± 0.05 6 34 32 
[Tb·L3] - - -29 -18 
[Tb·L4]3+ 2.65 ± 0.10 22 -58 -58 
 
3.4.3 Binding affinity of the complexes towards phosphate 
With addition of phosphate, each of the europium complexes behaved slightly differently.  The 
complex [Eu·L1]3+ showed a small decrease in emission intensity with little change to the 
spectral form.  For [Eu·L2]3+ there was also little change in the spectral form, but the decrease in 
intensity was approximately twice as pronounced.  The neutral complex, [Eu·L3], was more 
interesting (Fig.  32).  Across the emission spectrum a very small decrease in emission intensity 
was observed but the distinct appearance of a band at 621 nm was evident, upon the addition of 
Fig.  32:  Variation of the Eu(III) emission spectra for [Eu·L3],  following addition of sodium phosphate 
(H2O, pH = 5.50 ± 0.05, 40 µM complex, 298 K, I = 0.1 M NaCl, λex =332 nm).   
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phosphate.  This band appearing as a shoulder, was very similar to that observed with the 
lactate adducts of the europium complexes.  The contrasting behaviour of the emergence of this 
shoulder, coupled with the overall intensity decrease, meant an estimate of the ΔJ = 2 change in 
intensity became unreliable. 
 
Table 13:  Affinity constants for europium (III) and terbium (III) complexes with phosphate defining the 
corresponding increase in the calculated ratio, increase in ΔJ = 2 or ΔJ = -1  luminescence and increase in 
overall lanthanide (III) luminescence (298 K, I = 0.1 M NaCl, pH = 7.40 ±0.05). 
complex log K 
Ratio 
increase % 
ΔJ = 2 or J = -1 
decrease % 
Overall 
change % 
[Eu·L1]3+ 2.90 ± 0.05 19 -29 -25 
[Eu·L2]3+   -62 -52 
[Eu·L3] 2.00 ± 0.05 8 * 9 
[Eu·L4]3+ 3.25 ± 0.05 21 -68 -53 
[Tb·L1]3+ 3.05 ± 0.05 11 -132 -105 
[Tb·L2]3+ 1.84 ± 0.05 22 -315 -215 
[Tb·L3] 3.35 ± 0.05 5 -29 -21 
[Tb·L4]3+   -49 -32 
 
3.5 Other factors which may influence the spectral form or intensity 
3.5.1 The effect of pH upon the emission spectrum 
It is crucial that the bicarbonate responsive probes act independently of pH, and do not 
exhibit a ratiometric change in response to pH.  To assess this, a solution of [Eu·L2]3+ was taken 
in a 0.1 M sodium chloride background to maintain a constant ionic strength.  Starting at pH 9 
and decreasing the pH by approximately 0.5 units each time, a pH titration was undertaken (Fig.  
33).  
 
 An overall decrease in intensity was apparent from pH 9 to pH 3, with the spectral form 
remaining constant.  Between pH 5 and 8 there was very little change in the intensity of 
emission, and so the ratio remains constant at physiological pH.  The slight increase in intensity 
and in the ΔJ = 2/ ΔJ = 1 ratio above pH 8 may be due to bicarbonate binding, which is difficult to 
completely inhibit in basic media.  Below pH 5, the emission intensity decreases, along with the 
ΔJ = 2/ ΔJ = 1 ratio.  This could possibly be ascribed to the protonation of the azaxanthone 
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nitrogen, interfering with hydrogen bonding within the chromophore unit and pushing the 
sensitiser away from the europium centre.  This increased distance would hinder the efficiency 
of the energy transfer step, leading to a reduction in the emission intensity.  Crucially, across the 
physiologically relevant pH range there is no change in the ΔJ = 2/ ΔJ = 1, or indeed any other 
ratio. 
3.5.2 The effect of ionic strength upon the emission spectrum 
All titrations in this thesis were performed in a background of 0.1 M sodium chloride, to 
maintain a constant ionic strength that mimics the typical extracellular biological salt 
Fig.  33:  Variation of the Eu(III) emission spectra for [Eu·L2]3+,  as a function of pH (H2O, 40 µM 
complex, 298 K, I = 0.1 M NaCl, λex =332 nm).  
Fig.  34: Variation of the Eu(III) emission spectrum for [Eu·L2]3+,  following incremental addition of 
sodium chloride (H2O, 40 µM complex, 298 K, I = 0.1 M NaCl, λex =332 nm). 
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concentration.  The presence of the chloride anion does quench the intensity of lanthanide 
emission however via electron transfer quenching of the chromophore singlet excited state.  
This was investigated through a titration adding incremental amounts of sodium chloride.  A 
quenching of emission was observed that was still evident at the limit of the titration, this was 
when the chloride concentration was 0.8 M.   
 
By plotting F0/F versus [Cl-], the Stern-Volmer constant, Ksv-1, was assessed to be 100 mM (Fig.  
35).  This corresponds to the chloride concentration that reduces emission intensity to half of its 
original values. 
3.6 The competitive binding between protein and bicarbonate 
Anions are not the only class of molecule which could potentially interfere with binding to 
other lanthanide probes.  Binding of the complexes to proteins should also be considered.  There 
exist thousands of proteins within a cell, possessing negatively charged side chain groups on the 
amino acids, which are capable of competing for binding to the lanthanide metal centres.  Many 
studies have examined protein binding to lanthanide complexes and so it was necessary to 
investigate the effect protein had upon this series of complexes.2, 22  Human serum albumin 
(HSA) was chosen as a model protein, as it is the most abundant plasma protein. 
3.6.1 Binding to human serum albumin 
Initially, the binding of HSA with each complex was studied by spectral protein titrations.  
Incremental amounts of HSA were added as a solid, and the pH carefully adjusted back to 7.40 ± 
Fig.  35:  Decrease in the emission intensity of the ΔJ = 2 band of [Eu·L4]3+ upon addition of sodium 
chloride (left); Plot of F0 / F for the emission intensity of the ΔJ = 2 band of [Eu·L4]3+ upon addition of 
sodium chloride (right). 
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0.05, if necessary, after each addition.  Upon adding increased amounts of HSA, fluorescence 
originating from the tyrosine and tryptophan residues within the protein was observed.   
 
The protein fluorescence was particularly noticeable in the terbium emission spectra which 
occur at a lower wavelength (Fig.  36).  The maximum of the protein fluorescence was centred at 
around 440 nm.  Adding the protein led to quenching of the lanthanide emission.  This was 
generally more pronounced for europium complexes than for terbium analogues.  Changes in the 
form of the spectra were only really observed for the europium complex and even here they 
Fig.  37:  Variation of the Eu(III) emission spectrum for [Eu·L2]3+, following the addition of human 
serum albumin (H2O, pH = 7.40 ± 0.05, 40 µM complex, 298 K, I = 0.1 M NaCl, λex =332 nm).   
Fig.  36:  Variation of the Tb(III) emission spectrum for [Tb·L3]3+, following the addition of human 
serum albumin (H2O, pH = 7.40 ± 0.05, 40 µM complex, 298 K, I = 0.1 M NaCl, λex =332 nm).   
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were relatively minor (Fig.  37).  Most noticeable were changes in the relative intensities 
between the peaks within the hypersensitive ΔJ = 4 manifold.  The large reduction in emission 
intensity can be ascribed to quenching of the sensitiser triplet state, inducing a charge transfer 
process from electron rich residues, such as tyrosine, in the protein. 
 
Ratiometric analyses were performed examining selected bands within the spectrum, as for 
the characterisation of anion binding.  Calculated apparent affinity constants for binding to HSA 
were similar for all complexes.  Values were independent of complex charge and metal ion.  For 
two of the complexes, affinity constants could not be calculated accurately, due to an insufficient 
change in spectral form. 
 
Table 14:  Apparent affinity constants for the binding of human serum albumin to the given complexes 
(295 K, 50 µM complex, pH = 7.40 ± 0.05). 
complex log K 
[Eu·L1]3+ 3.20 ± 0.05 
[Eu·L2]3+ nd 
[Eu·L3] nd 
[Eu·L4]3+ 3.30 ± 0.05 
[Tb·L1]3+ 3.50 ± 0.05 
[Tb·L2]3+ 3.55 ± 0.05 
[Tb·L3] 3.60 ± 0.05 
[Tb·L4]3+ 3.30 ± 0.05 
 
Measurements of the complex hydration states in the free and protein-bound forms were 
made through measurement of excited state lifetimes (Table 15).  These values are consistent 
with displacement of coordinated water molecules upon protein binding.  Such effects have been 
established earlier and were ascribed to ligation of Glu or Asp side chain carboxylates.108 
 
Table 15:  Rate constants, k, (±10%) and lifetimes, (τ), observing the radiative decay of the lanthanide 
excited states at 616 nm (europium) and 545 nm (terbium) (295 K, 50 µM complex) and derived 
hydration numbers, q, (±20%) for [Ln·L2]3+, with and without the presence of HSA. 
 kH2O τH2O kD2O τD2O q 
[Eu·L2]3+ 3.85 0.26 1.73 0.58 2.0 
[Eu·L2]3+ + HSA 0.90 1.11 0.41 2.40 2.2 
[Tb·L2]3+ 2.58 0.39 1.63 0.61 0.6 
[Tb·L2]3+ + HSA 0.73 1.40 0.55 1.82 0.6 
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3.6.2 The competitive nature of protein and bicarbonate binding 
It had earlier been observed for [Eu·L13]3+ that there existed a competition between 
bicarbonate and protein for binding to the metal ion when both species were present in solution.  
A simple set of experiments was performed with [Eu·L2]3+ to examine this aspect.   
 
Firstly, in experiment A, the emission spectrum of the complex alone was recorded in solution.  
A 30 mM concentration of bicarbonate was added and the spectrum recorded again. The 
characteristic bicarbonate emission spectrum was observed.  To this solution, HSA was added to 
a concentration of 0.7 mM.  This resulted in a lowering of the emission intensity, and the 
spectrum resembled a mixture of the bicarbonate-bound and unbound complex species.  
Secondly, this experiment was performed in reverse, experiment B (Fig.  38).  After again taking 
the spectrum of the complex alone under identical conditions, HSA (0.7 mM) was added and the 
quenched protein bound species was observed, with little change in emission form.  Addition of 
Fig.  38:  Variation of the Eu(III) emission spectrum for [Eu·L2]3+, followed by the sequential addition 
of sodium bicarbonate (30 mM) and HSA (0.7 mM) (top), and followed by the sequential addition of 
HSA (0.7 mM) and sodium bicarbonate (30 mM) (bottom), (H2O, pH = 7.40 ± 0.05, 20 µM complex, 298 
K, I = 0.1 M NaCl, λex =332 nm). 
A 
B 
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30 mM bicarbonate to this solution gave an identical spectrum to that observed in experiment A.  
An identical spectrum in terms of form and intensity between the two were  observed. 
 
The fact that the same spectrum was observed via either sequence of addition suggests a 
competition between these two species. The final spectrum in each case is an averaged spectrum 
for contributions due to bicarbonate bound and protein bound species.  This is reflected by the 
averaged ΔJ = 2/ΔJ = 1 ratios observed. 
 
Table 16: ΔJ = 2/ΔJ = 1 area ratios corresponding to the data shown in Fig.  38. 
ΔJ = 2/ΔJ = 1 ratio 
1. complex 1.8 1.8 1. complex 
2. complex + 30 mM bicarb 3.4 2.2 2. complex + 0.7 mM HSA 
3. complex + 30 mM bicarb + 0.7 mM HSA 2.7 2.7 3. complex + 0.7 mM HSA + 30 mM bicarb  
 
3.6.3 Bicarbonate binding titrations in a background of protein 
The effect of a protein background upon bicarbonate binding was examined in further detail.  
A bicarbonate titration was undertaken in a fixed HSA background, at a concentration of 0.4 mM.  
Addition of incremental amounts of sodium bicarbonate to the europium complexes [Eu·L1]3+, 
[Eu·L2]3+ and [Eu·L3] caused a large increase in spectral intensity and a shift in the ΔJ = 2 maxima 
from 614 to 616 nm, consistent with the behaviour observed when protein was not present (Fig.  
Fig.  39:  Variation of the Eu(III) emission spectrum for [Eu·L2]3+, in a background of 0.7 mM HSA, 
following addition of up to 30 mM sodium bicarbonate (H2O, pH = 7.40 ± 0.05, 50 µM complex, 298 K, I 
= 0.1 M NaCl, λex = 332 nm). 
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39).  Adding 5 to 25 mM bicarbonate caused a 250% increase in emission intensity, and up to a 
25% increase in the ΔJ = 2/ ΔJ = 1 ratio.  This is consistent with partial displacement of the 
bound protein by bicarbonate. 
 
The terbium analogues showed far less change in spectral emission intensity increases upon 
addition of the same concentrations of bicarbonate (Fig.  40).  In each case, the corresponding 
intensity changes were less than 20%.  In a competitive background of protein, it appears that 
terbium is far less sensitive than europium to the addition of added bicarbonate.  This offers the 
intriguing possibility of using europium to terbium ratios to measure bicarbonate 
concentrations.  In this sense, the terbium complex with its relative insensitivity would be acting 
as a reference against the strong modulation of the europium analogue. 
3.6.4 Competition experiments 
Thus far, the effects of lactate, citrate and phosphate on lanthanide emission have been 
studied individually.  Competition experiments were also performed, examining the influence of 
addition of all these anions to a solution of the complex which contained a fixed background of 
bicarbonate and protein.  The triphosphate ATP was also included in these investigations.  This 
important anion is present at about 0.5 mM concentrations within the mitochondria, and could 
be capable of binding to the lanthanide complexes, through the terminal phosphate group. 
 
Fig.  40:  Variation of the Tb(III) emission spectrum for [Tb·L2]3+, in a background of 0.7 mM HSA, 
following addition of up to 30 mM sodium bicarbonate (H2O, pH = 7.40 ± 0.05, 50 µM complex, 298 K, I 
= 0.1 M NaCl, λex = 332 nm).   
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In each case, a fixed background of 0.4 mM human serum albumin and 20 mM bicarbonate 
was used in experiments with [Eu·L2]3+.   
 
Addition of phosphate, ATP, citrate and lactate each led to a reduction in emission intensity of 
the europium complex.  However, phosphate and lactate caused very little change, there was less 
than a 5% decrease in overall emission intensity upon adding up to 2 mM of these anions.  
Citrate led to a more pronounced decrease in emission intensity (Fig.  41).  After adding 2 mM 
citrate, the emission had decreased by 34%.  Addition of citrate continued to have a decreasing 
effect and at 20 mM citrate, overall emission was reduced by just over 60%.  However, at 
extracellular citrate concentrations of 0.13 mM the decrease was just <5%. ATP caused the most 
dramatic decrease in emission intensity at similar concentration levels.  After addition of 2 mM 
ATP, the emission had decreased by 85%, and at 0.5 mM by 60%. 
 
These experiments suggest that the binding of protein and bicarbonate to the europium 
centre is competitive and that spectral form is not significantly perturbed by concentration 
changes in phosphate, ATP, citrate or lactate. 
 
 
 
Fig.  41:  Variation of the Eu(III) emission spectrum for [Eu·L2]3+, in a background of 0.4 mM HSA and 
30 mM sodium bicarbonate, following addition of up to 20 mM sodium citrate (H2O, pH = 7.40 ± 0.05, 
50 µM complex, 298 K, I = 0.1 M NaCl, λex = 332 nm).   
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3.6.5 Binding to α-acid glycoprotein 
As mentioned at the beginning of this section, there exist numerous plasma protein, serum 
albumin being just one representative example.  Another plasma protein, α-acid glycoprotein 
was therefore also studied in relation to its binding with lanthanide complexes.  This protein is 
typically present in serum at concentrations of around 40 µM, although this concentration is 
known to rise during inflammation.  A titration was carried out using α-AGP with [Eu·L2]3+, other 
experimental conditions being identical to that of the analogous titration with HSA.  α-AGP was 
added as very small quantities of a concentrated stock solution rather than as a solid as for HSA, 
as the concentrations used were far less than for HSA. 
 
A clear reduction in lanthanide emission intensity can be observed.  Fluorescence from the 
protein is much weaker here, as the concentration of α-AGP was only 60 µM at the end-point.  
Spectral form was not modulated sufficiently to allow an accurate binding constant to be 
calculated. 
 
In summary, the complexes do not show a specific binding to either HSA or α-AGP, both 
exhibit a decrease in spectral intensity, consistent with quenching of the sensitised triplet state 
by a charge transfer process. 
 
Fig.  42:  Variation of the Eu(III) emission spectrum for [Eu·L2]3+, following addition of α-acid 
glycoprotein (H2O, pH = 7.40 ± 0.05, 50 µM complex, 298 K, I = 0.1 M NaCl, λex = 332 nm).   
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3.7 Tandem probe methodology using a red : green ratiometric 
analysis, and time-gated analysis 
It is possible that one may think, given the lack of response from the terbium analogue 
towards bicarbonate binding in a protein background, that the terbium probe offers little in 
terms of use as a ratiometric probe.  However, it is possible that its limited response to great use, 
by using it in conjunction with the europium probe.  Using both probes together, allows the 
terbium probe to be used an internal calibrant.  So, instead of taking a ratio of the ΔJ = 2/ΔJ = 1 
for europium, or ΔJ = -1/ΔJ = -2, for terbium, it is possible to use a pair of europium/terbium 
emission bands, or a red/green ratio.  This is particularly promising for use in cellular 
applications, where optical microscopy will be used.  It allows the use of a wider spectral 
window maximising the intensity of the emission signal collected and reducing the signal-to-
noise ratio.  The resolution available on confocal microscopy equipment is also much less than 
for fluorescence, and so an accurate ΔJ = 2/ΔJ = 1 ratio becomes rather difficult to measure.  The 
next stage, therefore, was to assess whether a mixture of europium and terbium complexes of a 
common ligand could be used to monitor bicarbonate concentrations. 
 
Background media in biological systems contain a huge number of species at varying 
concentrations.  Therefore, the next logical step was to examine the binding of bicarbonate, in a 
mixed competing background.  The anions which were investigated earlier were used at their 
typical extracellular concentrations, and HSA also at its typical average extracellular 
concentration of 0.4 mM.  The anion ATP is another biological species which is present within 
the mitochondria, and potentially interfere with bicarbonate binding.  It was therefore also 
included in this background mixture. 
 
Thus, an 80 µM total complex concentration was added to a background solution containing 
0.4 mM HSA, 0.13 mM citrate, 1.3 mM lactate, 0.7 mM phosphate and 1 mM ATP.  The ratio of the 
europium to terbium complex concentration used was 3:2.  A higher proportion of europium to 
terbium was required, as terbium has a higher quantum yield, and it is desirable to start at a 
point where the emission intensity is approximately 1:1.  Incremental additions, from a 
concentrated stock solution of bicarbonate, were made up to a limit of 60 mM.  The presence of 
the competing background lowers the affinity for bicarbonate.  Notably, changes to the spectrum 
occurred over an extended concentration range relative to that for the standard bicarbonate 
titrations. 
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An increase in emission intensity for both the europium and terbium band was observed upon 
addition of sodium bicarbonate (Fig.  43).  Observing the maxima for each of the observed bands, 
the increase was much more substantial for europium than for terbium.  It can be seen that the 
maximum intensity at the start was approximately the same for both europium and terbium, and 
reached a ratio of about 4:1 at the end of the titration.   
 
Also apparent from the spectral titration is fluorescence emission from the protein at 430 nm, 
creating the trailing baseline that stretches over the terbium emission spectrum and into the 
beginning of the europium spectral window.  This needs to be mathematically subtracted to 
allow an accurate europium to terbium ratio to be calculated.  However, this can be avoided by 
taking advantage of the long-lived nature of lanthanide emission and using time-gated data 
acquisition. 
 
Fig.  43:  Variation of the total Ln(III) emission spectrum for [Tb·L2]3+: [Eu·L2]3+, 3:2, following addition 
of up to 60 mM sodium bicarbonate (H2O, pH = 7.40 ± 0.05, 80 µM total complex, 298 K, I = 0.1 M NaCl, 
λex =332 nm).  
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With appropriate instrumentation, time-gated data acquisition is possible.  By waiting for a 
period of 10 µs after the excitation pulse any short-lived fluorescence from protein, the ligand or 
other species will have decayed to zero.  As a consequence, emission solely from the lanthanide 
ion can be acquired.  This removes the trailing baseline which is otherwise observed whenever a 
spectrum is taken when protein is present within the background medium; it is then easier to 
take an accurate measurement of the red to green emission intensity ratio. 
 
Thus, an integrated ratio of the ΔJ = 2 europium band centred at 616 nm to the ΔJ = -1 terbium 
band centred at 545 nm was taken and plotted as a function of added bicarbonate.  It is pleasing 
to observe that over the relevant biological range of 10 – 30 mM, a near-linear variation was 
found.  Additionally, the change in the ratio over this range is >40%; suggesting that the use of 
europium and terbium probes in tandem offers a convenient way of measuring bicarbonate 
concentrations. 
 
Fig.  44:  Time-gated data showing the variation of the Ln(III) emission spectra for [Tb·L2]3+/[Eu·L2]3+, 
following addition of sodium bicarbonate (H2O, pH = 7.40 ± 0.05, 80 µM total complex, 298 K, I = 0.1 M 
NaCl, λex =365 nm).  The inset shows the variation of the red:green ratio, comparingthe integrated 
emission intensity from 605 – 630 nm (red) against that at 535 – 555 nm (green). 
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In subsequent microscopy experiments, pCO2 will be varied between 3% and 5%.  The 
concentration of bicarbonate in solution at 3%, 4% and 5% CO2 atmospheric concentrations at 
pH 7.4 can be calculated using the Henderson-Hasselbach equation, [Eq. 8]. 
 
pH = pK’ + log[HCO3-]/spCO2  [Eq. 8] 
 
The dissolved bicarbonate concentration can be calculated at equilibrium; i.e. at 298 K, 760 
mm Hg, pH 7.4.  This estimation requires a value of 6.1 to be assumed for the practical 
coefficient, pK’, associated with ionisation of carbonic acid.125  The calculated values of 
bicarbonate for 3, 4 and 5% CO2 are 13.6, 18.1 and 22.7 mM, assuming that the solubility 
coefficient, s, of CO2 gas in the medium is 0.0307 mM per mm Hg pCO2, and the atmospheric 
pressure is 760 mm Hg.  Between 13.6 and 22.7 mM bicarbonate, the europium / terbium 
emission intensity ratio increased by 45% and 42% respectively for [Ln·L1]3+ and [Ln·L2]3+ 
respectively.  This provides sufficient change to be accurately measured. 
 
3.8 Intracellular localisation 
A clear, well defined localisation profile is essential for a truly useful cellular probe.  Ideally, 
the probe will localise to just a single cellular compartment, rapidly and efficiently.  For the 
bicarbonate probes discussed here, it is the mitochondria that are the target organelle of 
interest.  The Krebs cycle and glycolysis both produce mitochondrial CO2 which is converted into 
bicarbonate for transport.  Matching the selective targeting of a probe with its desired analyte 
function remains a key challenge in general probe design.20, 68 
 
To assess the localisation, a number of cell-lines (CHO, NIH-3T3, HeLa, MCF-7, A459) were 
investigated.  These were grown on glass coverslips and the complexes incubated at varying 
concentrations (10 - 100 µM) and time-points (30 min – 24 h).  After the incubation period, the 
coverslip was removed, washed in phosphate-buffered saline (PBS) and mounted on a glass slide 
before sealing with nail varnish and visualised using a confocal microscope.  Excitation of the 
azaxanthone chromophore was achieved using a 355 nm UV laser.  When examining emission 
from the complexes alone, a red channel operating over 570 nm – 720 nm was used for 
europium, and a green channel operating over 450 – 650 nm for terbium. 
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Localisation was confirmed by co-localising with commercially available cellular stains (Fig.  
45). Green emissive probes were used for europium complexes and red emissive probes were 
used for terbium complexes.  At time-points of between 1 and 6 hours, the lanthanide complexes 
showed a clear co-localisation with the MitoTrackerTM probes, confirming a localisation within 
the mitochondrial region.  At time points of around 8 h, the localisation was less distinct, and 
was probably a combination of localisation within both the mitochondria, and the lysosomes.  At 
further time points (up to 24 h), emission closely matched that of the LysoTracker probes, 
consistent with dominant lysosomal staining. 
 
It has been hypothesised that it is the nature of the heterocyclic sensitising unit that is 
responsible for directing complexes to a particular region within a cell.22  The complexes in this 
series correlate well with these observations in that an amide linked azaxanthone unit will lead 
to a mitochondrial localisation with subsequent shuttling to the lysosomes. 
 
An important point to note is that when examining the terbium complexes and co-localising 
with MitoTracker red, care needs to be taken to ensure that cross-excitation does not take place.  
Excitation of MitoTracker red occurs at 579 nm, which happens to lie directly under the ΔJ = 0 
emission band of terbium.  Excitation of the terbium complex may therefore subsequently cause 
excitation of MitoTracker red.  This aspect meant that when observing terbium emission, whilst 
MitoTracker red is present, emission could not be collected over the range in which MitoTracker 
red emits, which is from 560 – 700 nm.  In practice, this meant that terbium emission was 
selected over the range 450 – 555 nm conveniently covering the two main emissive bands. 
 
 
Fig.  45:  Microscopy images for [Eu·L2]3+, 50 µM complex, 4 h incubation, MCF-7 cells, co-staining with 
MitoTracker GreenTM: (left) Eu(III) complex (570 – 720 nm); (centre) MitoTracker GreenTM; (right) 
overlayed image. 
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3.9 Cytotoxicity studies 
It is imperative when designing cellular probes for reporting upon physiological conditions, 
that the probe be non-toxic towards the cell.  It needs to be shown that the presence of the probe 
does not induce a toxic effect, or induce stress to the cell perturbing its homeostasis.  The 
concentration used of the probe is an important factor, as it is the toxicity of the probe at the 
applied concentration which is crucial.  Virtually all compounds will be toxic to some degree, if 
administered at a sufficiently high concentration. 
 
The cytotoxicity of a complex refers to its ability to be toxic to and kill cells, resulting in a 
number of cellular fates.  They may undergo necrosis where they lose membrane integrity and 
die rapidly.  Alternatively, they can undergo a decrease in viability where they stop growing and 
dividing, or they can activate apoptosis; this is programmed cell death. 
 
Cell viability can be readily assessed by measuring membrane integrity, as this is often 
compromised by compounds exhibiting cytotoxic effects.  Trypan blue is a commonly used dye 
for this purpose.37  Normally, it is excluded from the interior of healthy cells, but it can freely 
cross into the cell and intracellular compartments if the external membrane is compromised, 
thus providing a qualitative rather than quantitative assessment of cytotoxicity. 
 
An alternative method involves the MTT assay.67  This was used for the attainment of 
quantitative cytotoxicity data for the complexes studied in this thesis.  The MTT assay measures 
the reducing potential of a cell using a colorimetric reaction.  Mitochondrial reductase enzymes 
of viable cells reduce MTT into an insoluble purple formazan product.  This can be solubilised 
and its concentration quantified spectrophotometrically.  The amount of formazan produced is 
proportional to the number of viable cells. 
 
Cells were grown overnight to allow them to adhere to the surface in 96-well plates, with 
approximately 10,000 cells per well initially.  Varying concentrations of the complex were then 
administered in triplicate or quadruplicate, spanning a two-log range typically up to 200 µM, and 
incubated for a period of 24 h.  For the final 4 h, MTT was added to the medium.  After this time, 
the complex medium and MTT were removed, and DMSO added to solubilise the formazan 
product.  The absorbance of this product at 540 nm could then be recorded using a plate reader.  
Mouse skin fibroblasts (NIH-3T3 cells) were used in the assay as in previous studies they had 
been shown to possess the best adherence to the base of the wells.126  This is of importance as 
the process of removing the medium at the end of the incubation period sometimes can dislodge 
poorly adhered cells.   
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To process the results, the percentage viability of a well was calculated from the relative 
absorbance of the well, compared to a well containing untreated cells.  It was found that viability 
decreased exponentially with increasing concentration of the probe.  Conversion to a logarithmic 
scale allowed for a linear relationship with complex concentration to be observed.  This 
procedure allowed an IC50 value to be calculated.  This is the concentration of the complex 
required to inhibit viability by 50%. 
 
In all cases, the IC50 values at 24 h for all complexes examined in the series were above 200 
µM, which was the upper limit incubated in these studies.  Considering that typical dosages are 
well below these values, typically around 20 – 50 µM and involve time periods of around 2 - 4 
hours, it can be assumed that the complexes will not exert a significant cytotoxic effect in the 
experiments performed. 
3.10 Variable CO2 Microscopy Experiments 
Preliminary work utilising [Eu·L1]3+ had previously shown that the emission intensity 
decreased as the level of atmospheric CO2, and consequently mitochondrial bicarbonate 
Fig.  46:  Confocal microscopy images for [Eu·L1]3+ 50 µM complex, 2-3.5 h 
incubation, λex = 360 nm) in HeLa cells at 3% (left image), 4%(centre image) and 
5% (right image) atmospheric CO2 (scale bar 20 microns).  The graph shows a plot 
of the relative intensities of complex emission as a function of pCO2. 
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concentration was reduced (Fig.  46). When the incubation was performed at a constant 
atmospheric CO2 of 5% over the same time period, no significant modulation of intensity was 
observed.  This initial result suggested that the series of probes could find use in relaying spatial 
concentrations of bicarbonate over the time scale of imaging experiments. 
 
To build upon these initial observations, a number of points needed to be investigated.  
Firstly, the reversibility of the above process should be examined.  When reducing the 
atmospheric CO2 concentration and observing the decrease in emission intensity it is necessary 
to show that when the CO2 concentration is subsequently increased back to the starting value, 
that the emission intensity also increases back to its original value.  Secondly, an investigation of 
whether this process can be inhibited in some way is of interest.  This may involve either 
blocking or enhancing bicarbonate production within the mitochondria, and observing any 
changes in emission which occur.  Lastly, investigations with the terbium analogues were to be 
performed.  Given the observed lack of spectral intensity change in vitro, if this behaviour is 
maintained, then it may be expected that it will remain insensitive to changes in atmospheric 
CO2 concentrations in cellulo. 
 
3.10.1 Reversibility studies and quantification using the europium analogues 
Initially, it was established that the observed result could be repeated and that the effect was 
fully reversible.  After repeating the initial experiment where the percentage CO2 was decreased 
from 5% to 3%, the CO2 concentration was then increased stepwise back up to 5%.  Emission 
spectral intensity increased back to the original values.  The variation of europium emission 
intensity from a repeated experiment of this type is shown in Fig.  47.  It can be seen to be in 
good agreement with the original data discussed in the previous section.  When examining the 
percentage increases in emission intensity, the two data sets accorded very well with each other.  
The ΔJ = 2 band intensity increased by 110% in each case from 3% to 5%, whilst the ΔJ = 2 / ΔJ = 
1 intensity ratio increased by 14% and 16% respectively.   
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3.10.2 Variable pCO2 using the terbium analogues as a control 
In vitro experiments examining the terbium complexes had revealed that they showed little 
response to addition of bicarbonate in competitive backgrounds, and could therefore be used as 
a standard to calibrate the europium emission.  It was necessary to check whether this 
behaviour was also observed in cells.  The europium complexes had been shown to exhibit a 
significant change when the atmospheric concentration of CO2 was varied between 3% and 5%, 
and so this experiment was repeated for incubations of the terbium analogues. 
  
The complex [Tb·L2]3+ was incubated for 2 h at a concentration of 50 µM.  Upon cycling 
between 3% and 5% CO2 no significant modulation of the emission intensity or spectral form 
was observed (Fig.  48).  In independent repeated experiments, the change in emission intensity 
over this range of 3 - 5% CO2 was always less than 10%. 
 
Fig.  47:  Confocal microscopy images for [Eu·L1]3+ 50 µM complex, 2-3.5 h incubation, 
λex = 360 nm) in HeLa cells at 3% (bottom image), 4% (middle image) and 5% (top 
image) atmospheric CO2 (scale bar 20 microns).  The graph shows a plot of the relative 
intensities of complex emission as a function of pCO2. 
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The lack of response observed with the terbium analogues in cellulo suggested that if used in 
tandem with the europium probes, that by using a red : green ratiometric analysis, changes in 
bicarbonate concentrations can be monitored and quantified, as found with the in vitro 
calibration. 
3.10.3 pCO2 calibration using both europium and terbium analogues 
A further experiment was performed where both the europium and terbium analogues were 
incubated with the cells at the same time.  Initial experiments indicated that a higher ratio of 
europium to terbium complex was required than with the in vitro studies which used a 3:2 ratio, 
to gain enough signal from the europium component.  Thus, a 3:1 ratio of europium to terbium 
complex of [Ln·L2]3+ was used.  This was incubated with NIH-3T3 cells for one hour at 5% CO2 to 
allow complex uptake within the mitochondria.  At this point, spectral data were obtained 
examining two emission channels.  The green terbium channel was set from 450 to 570 nm 
observing emission arising from only the terbium component.  The red europium channel 
collected emission from 600 to 720 nm.  Subsequently, the percentage CO2 within the live cell 
imaging chamber was adjusted, and a period of 25 minutes allowed to elapse to allow 
equilibration, before taking the reading at that concentration.  This was repeated for integer 
concentrations of CO2 between 2 and 7%.  The range was extended from the previous 
experiments of this type which had looked between 3 and 5%, as another aspect we wished to 
address was the range over which this effect worked.  The values of 3 and 5% CO2 correspond to 
bicarbonate concentrations of just 13.6 and 22.7 mM bicarbonate, so extending the range is 
logical. 
Fig.  48:  Confocal microscopy images for [Tb·L1]3+ 50 µM complex, 2-3.5 h incubation, λex = 360 nm) 
in HeLa cells at 3 (left image) & and 5% (right image) atmospheric CO2 (scale bar 20 microns).  The 
graph shows a plot of the relative intensities of complex emission as a function of pCO2. 
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To extract an intensity value for each image, three small (about 500 pixels) areas representing 
a mitochondrial part of the cell were taken.  The maximum values observed in each case were 
averaged, giving the lanthanide intensity for that image.  An intensity ratio was then calculated 
using the europium and terbium images to give the red/green ratio.  The data from Fig.  49 is 
plotted in Table 17.  Whilst the range of 3-5% is approximately linear, the data fits to a sigmoidal 
curve over the fuller range of 2-7% CO2, suggesting that these are the limits which can be probed 
in cellulo. 
 
This experiment shows that a mix of europium and terbium complexes can be used in tandem 
to monitor changes in bicarbonate concentrations within the mitochondrial region of cells.  This 
is unprecedented. 
 
Table 17:  Eu(III) and Tb(III) emission intensities, and the calculated red/green ratio for a range of pCO2 
after incubation in NIH-3T3 cells. 
% 
CO2 
Eu(III) 
intensity 
Tb(III) 
intensity 
Red/green 
ratio 
2 56 96 0.58 
3 78 128 0.61 
4 93 133 0.70 
5 118 140 0.84 
6 160 147 1.09 
7 160 138 1.16 
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Fig.  49:  Plot of Eu(III)/Tb(III) emission intensities as a 
function of pCO2. observed in the mitochondria of NIH-3T3 
cells. 
                                                                                                             THREE: BICARBONATE PROBES FOR THE MITOCHONDRIA 
 -113- 
3.10.4 Using acetazolamide to inhibit modulation of the spectral form 
Acetazolamide, 76, is a broad spectrum carbonic anhydrase inhibitor.  It suppresses the 
activity of carbonic anhydrases which are a family of zinc-containing enzymes that rapidly 
interconvert carbon dioxide and water to bicarbonate anions and protons.  Carbonic anhydrases 
were the first enzymes discovered to contain zinc, and are now known to be among the most 
efficient enzymes in biology.  As well as maintaining an acid-base balance in the blood, this 
process helps to transport carbon dioxide out of tissues.89  This is the case in the mitochondria, 
where vast quantities of CO2, produced through glycolysis and the Krebs cycle, need to be 
removed and transported away.  
 
The experiment in which the atmospheric carbon dioxide concentrations were controlled and 
varied during incubation with the europium complex was performed again, but in the presence 
of acetazolamide.  Acetazolamide concentrations of both 1 and 10 µM were used, for an 
incubation period of 1 h.  Acetazolamide is not toxic, at these concentrations, in the cell lines 
used, as determined by an independent MTT assay. 
 
Using the same time incubation periods, concentration of complex and experimental 
conditions as in the previous experiments, no significant modulation in the emission intensity 
upon adjusting the pCO2 between 3% and 5% was observed in the presence of acetazolamide 
(Fig.  50).  Furthermore when acetazolamide was present, the spectral intensity was lowered.  
Fig.  50:  Confocal microscopy images for [Eu·L1]3+ 50 µM complex, 2-3.5 h incubation, λex = 360 nm) in 
HeLa cells at 3% (left image), 4% (centre left image) and 5% (centre right image) atmospheric CO2 (scale 
bar 20 microns).  Transmission (right image).  
76 
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Taken together, it appears that acetazolamide is inhibiting the conversion of CO2 to bicarbonate, 
and this is being reflected in the emission of the europium probe.  It has been shown that the 
bicarbonate bound complex is more emissive than a protein-bound europium complex.  So, in 
the presence of acetazolamide, bicarbonate concentrations decrease and there is a higher 
proportion of protein-bound complex that quenches emission. 
3.11 Measuring fluctuations of bicarbonate concentrations within 
marine algae 
Certain species of marine algae, called coccolithophores, are unique amongst marine species 
in that they extrude intricate calcium carbonate shells termed coccoliths on their exterior 
surface.  Coccolithophores are single-celled spherical algae, and are found in vast quantities in 
the upper layers of the oceans.  Coccolithophores are of scientific interest, as they may play a 
large part in global climate change.91, 92 
 
The exact purpose of the calcium carbonate liths remains unknown.  The mechanism through 
which they are formed, and extruded is only partially understood.  Current understanding comes 
largely from studies looking at sections of coccolithophores at various stages of growth, and 
isolated incompletely formed coccoliths.95  Coccolith growth initiates with nucleation of an 
elliptical ring of calcium carbonate crystals and then simultaneously progresses in a number of 
well-constrained directions. It is hoped that if fluctuations of bicarbonate levels could be 
monitored within the algae in real time, then further details of this mechanism may be revealed. 
 
Organic pH-responsive fluorescent probes have been observed to be taken up within 
coccolithophores.96  However, it appears this is a very inefficient process, as long incubation 
times were used (2 days).  In some cases, it appeared necessary to remove the calcium carbonate 
shells via incubation in mild acid, in order to allow the probes to enter. 
 
Responsive lanthanide probes of the type discussed in this chapter had previously only been 
used in applications with mammalian cells.   Although the mechanisms of uptake, localisation 
and fate in such mammalian cell-lines is now fairly well understood, at the outset of this work it 
was unclear how algae or plant cells would respond to incubations of the lanthanide complexes.   
 
Initially, the same procedure found to be successful with mammalian cells was examined.  
However, no internal localisation was observed after incubation of the complexes for up to 12 
hours at concentrations of 50 µM.  Concentrations were increased to 200 µM, and time periods 
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were studied at up to 3 days, but no convincing evidence was found to show that the probes had 
entered the cells.  
 
An alternative method involved removal of the calcium carbonate shells, in the hope that this 
would enable uptake of the probes.  To achieve this, the algae were briefly suspended in mild 
hydrochloric acid (pH 5) for one minute to remove the shells, and then the pH of the seawater 
solution was restored to its original value of 8.2.  The probe was incubated at this stage, and 
aliquots taken periodically over the next two days and observed by microscopy.  Again, no clear 
definitive uptake of the probe was observed.  It was seen by microscopy that acid treatment 
successfully removed the calcium carbonate shells.  After 24 hours they were seen to have 
partially grown back, and after 48 hours appeared to be fully grown.  This suggests that acid 
treatment is not particularly harmful to the algae, and they continue to grow normally after the 
event. 
 
As an alternative method for checking whether the probe had localised, emission spectra of 
the algae were recorded on a fluorimeter.  After the time periods above, suspensions of the algae 
in the complex incubated seawater were taken.  An emission spectrum was taken of the 
suspension at this point, and lanthanide emission could be observed, along with emission from 
the chloroplasts.  Lanthanide emission did appear to be fairly significantly quenched.  The algae 
were then centrifuged, and resuspended in fresh seawater a number of times, in order to remove 
any complex adhered to the surfaces and present within the seawater incubation.  By the third 
wash, only chlorophyll emission was visible in suspensions of the algae, with the lanthanide 
emission found only in the seawater washings.  This suggests that uptake of the complexes had 
not occurred. 
 
Arguably, it is possible that the probe does localise within the algae, but is being quenched to 
such an extent that no lanthanide emission is observable.  The intracellular composition of the 
algae is unknown.127  Also, if the probe is localising to the mitochondria within the algae, and the 
algae contain only one mitochondrion then this may not be providing sufficient signal to be 
observed.  Experimental methods should perhaps be extended to include ICP-MS, as this should 
provide evidence of any quantity of europium present.  If detected, this can only come from the 
probes, so it could be concluded that it is quenching rather than non-uptake of the probes 
responsible for the lack of observable signal. 
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3.12 Measurement of bicarbonate levels in serum samples 
The probes, [Ln·L1-4], were primarily designed with intracellular purposes in mind but need 
not necessarily be limited to such applications.  Whilst they have been carefully designed to 
selectively measure concentrations of bicarbonate anions, crucially they function whilst 
withstanding competing biological backgrounds of other anionic species and proteins.  
Therefore, they could potentially perform equally well when applied to in vitro testing of 
biological fluids, which also contain such species. 
 
Serum (blood plasma in which the blood cells have been removed) is one possible medium 
that could be tested.  The rapid measurement of bicarbonate levels within serum is crucial in 
emergency medicine in determining acidosis.128  There is a need for a new rapid, reliable test for 
measuring this parameter.  Emission spectra can be acquired within a few minutes and so a 
ratiometric lanthanide based probe may offer a convenient way of achieving this. 
 
The tandem europium/terbium emission method was selected for this application, as it had 
been highly successful for the in vitro calibration discussed previously.  A bicarbonate titration 
was undertaken, using human serum as the background medium.  To start, 1 ml of human serum 
was taken and any bicarbonate naturally present removed by lowering the pH to 5 and bubbling 
argon gas through for 10 minutes with gentle agitation.  The pH was increased back to 7.4, 
immediately prior to the start of the titration.  Sequential additions of a bicarbonate stock 
solution were added up to a final concentration of 40 mM.  It was found that the observed 
intensity increase upon bicarbonate addition was greatly reduced when undertaken in a 
background of serum.  There was also a reduction in the signal to noise ratio.  This may be due in 
part to the increased turbidity of the serum compared to water, in addition to the higher degree 
of quenching.  However, using a europium/terbium mix, similar to the microscopy experiments, 
allows a larger spectral window to be used (Fig.  51).  Indeed, by calculating a red : green 
intensity ratio plotted as a function of added bicarbonate, a binding curve was obtained that 
could be used as a calibration curve thereby allowing values of bicarbonate concentration to be 
estimated for other serum samples. 
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Fig.  51  Variation of the Ln(III) emission spectrum for [Tb·L2]3+: [Eu·L2]3+, following addition of sodium 
bicarbonate (H2O, pH = 7.40 ± 0.05, 75 µM total complex, 298 K, I = 0.1 M NaCl, λex =332 nm).  Inset is a 
plot of the integrated intensity ratio (605 - 630 nm/535 – 555 nm) with [bicarbonate]. 
3.13 Conclusions 
A novel series of lanthanide-based probes has been synthesised.  They exhibit a selective 
binding to bicarbonate anions, as reported through changes in their emission profiles.  The 
complexes are non-toxic to cells, and localise within the cellular mitochondria.  Their responsive 
behaviour is maintained within the mitochondrial region, and has been used to measure the 
response to variations in external pCO2. 
 
The synthesis of the probes was undertaken via a route that has a number of common 
intermediates.  This allows structurally analogous series to be created relatively easily.  Reaction 
yields for key steps were optimised where appropriate, and this proved crucial, given the long 
linear sequence needed for the final complexes. 
 
Sensitisation of the coordinated lanthanide ion occurs via an azaxanthone chromophore, 
which is linked to the macrocycle by an amide linkage.  This sensitising moiety appears to be 
responsible for directing the complex to the mitochondria, behaviour that is consistent with 
earlier work where this moiety was previously incorporated into related complex structures.  
Modifications to the pair of trans amide arms allow variation of overall complex charge and 
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steric bulk.  In this manner, a range of five ligands with an overall complex charge between +3 
and -2 was synthesised. 
 
Apparent binding affinities towards a range of anions were calculated.  The change in spectral 
from was most significant following addition of bicarbonate.  Binding of protein and bicarbonate 
to the europium complex was competitive at physiological values.  As the coordination of 
bicarbonate increases europium emission intensity, whilst protein association leads to an 
overall quenching of emission, the increase in bicarbonate concentration in the presence of 
protein is signalled by an increase in overall europium emission intensity.  The selective binding 
towards bicarbonate was maintained in a competitive background of other anions and protein.  
Particularly when a background of protein was present, the europium analogues exhibited a far 
greater spectral change than the analogous terbium complexes.  This allows a tandem probe 
methodology to be created, where a mixture of both europium and terbium complexes of a 
common ligand are used at the same time.  This has been used earlier with systems that report 
urate concentration changes in urine or serum, based on the differential quenching sensitivity of 
Tb and Eu analogues.27  
 
The complexes have been used to monitor changes in the steady-state bicarbonate 
concentrations within the mitochondrial region of living cells.  Upon cycling the  pCO2 between 
3% and 5%, the emission spectral intensity of the europium complexes varied proportionally.  
With the corresponding terbium analogue, the change observed was <10%. Acetazolamide was 
shown to inhibit the spectral response of the europium probes.  By using a mixture of europium 
and terbium complexes, it is possible to calibrate a red/green ratio, from which changes in 
bicarbonate concentrations can be monitored. 
3.14 Future Work 
The behaviour of the complexes within mammalian cells is highly promising.  Now that the 
use of a tandem probe methodology using europium and terbium analogues together has been 
established, its potential could be further explored.  For example, processes known to occur 
within the mitochondria could be inhibited or stimulated whilst the probes are incubated, and 
the spectral response measured. 
 
Another experiment could be performed, similar to the inhibition of carbonic anhydrase 
activity by acetazolamide but using antimycin A.  This is a compound which blocks complex III of 
the electron transport chain,129 thus bicarbonate production should be halted.  Alternatively, 
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carbonyl cyanide m-chlorophenyl hydrazine (CCCP) could also be used to block oxidative 
phosphorylation, which would also be expected to stop formation of mitochondrial CO2.130 
 
Further studies could be performed using the carbonic anhydrase inhibitor, acetazolamide.  
This was shown to lead to a reduction in the signal of europium emission, as it greatly slows 
down the conversion of mitochondrial CO2 to bicarbonate.  Eventually, given a long enough time 
period however, the signal may return to original values.   
 
Conversely, the mitochondria could be stimulated such that an increase in production of 
bicarbonate occurs.  This could potentially be achieved on whole cells by starving them in a 
medium deficient in pyruvate, and then feed them pyruvate back.  If the cells contain a 
bicarbonate-responsive lanthanide probe, this may be accompanied by an increase in emission 
of the europium analogue relative to that of terbium. 
 
Whilst the novel series of probes described in this chapter fulfill all the criteria set out in the 
introduction section, an improved set of probes could be created, based on the knowledge 
gained through this work.  The area in which an improvement would be most useful is the 
quantum yield of the complexes.  By requiring a more highly emissive probe to be made that also 
resists photobleaching.  Such work is currently being undertaken, investigating alternative 
sensitising systems.  It is hoped that these complexes will exhibit higher quantum yields and 
extinction coefficients.  Key challenges remain however, as any new probe still needs to retain 
the ideal localisation profile, non-toxicity and selectivity profile for bicarbonate. 
 
The bicarbonate responsive probes described were shown to be insensitive to fluctuations in 
pH over the range of 5 - 8.  The pH changes within the mitochondria are also of interest, 
however.  It would be interesting, and useful, to have a pH responsive probe that localises to the 
mitochondria and use this to monitor mitochondrial pH.  Using these probes, it would be of 
interest to repeat the experiments described for the bicarbonate-responsive probes, such as 
examining the variation in response to pCO2, with the pH-responsive probes and observe 
changes, if any, in pH during the time-course of the experiment.  Together, the two sets of probes 
would give an increased understanding of the processes occurring. 
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4     pH Probes For The Lysosomes 
4.1 Introduction 
Chapter three began with a brief discussion of the importance of matching probe function 
with probe localisation, and this is an equally important issue here.  Within the lysosomal 
compartments of cells, it is arguably the pH which is the most important parameter to measure.  
The lysosomes are the waste disposal compartments of cells, containing many different species.  
Measurement of individual anions is perhaps less important.  Indeed, a bicarbonate probe for 
the lysosomes would be useless as the pH is typically around 4.5 meaning that virtually no 
bicarbonate would be present at this pH.  Although the normal pH of a lysosome is around 4.5 to 
6.5, abnormal pH is associated with a number of diseases, and the pH changes through the life-
cycle of a lysosome.131  Therefore, measurement of these values by a pH-dependent probe would 
be highly useful in assessing mechanisms involved in these diseases.  Organic, fluorescent pH-
dependent probes that localise to acidic compartments in cells,78 such as the lysosomes, are 
available but as discussed in detail in the introductory chapter they are known to have 
significant drawbacks and are considered to be unreliable.80, 84   There is a requirement for more 
efficient, improved pH-responsive probes for the lysosomes. 
 
This chapter details the development of lanthanide-based pH-responsive probes.  A number of 
designs are considered, in relation to meeting the combined aims of lysosomal distribution and a 
pH-responsive output over the relevant pH range of 4-6.  The behaviour of promising candidates 
is discussed in terms of pH titrations, examining the influence of competing species such as 
anions and protein, and preliminary cell-based experiments. 
4.2 The design of pH-dependent probes with an appropriate pH-
dependent range 
The final class of pH responsive lysosomal probes, which are described in detail at the end of 
this chapter, were only reached after examining a number of different types of complexes.  These 
consisted of various chromophores and pH-dependent moieties.  Their synthesis, along with a 
brief rationale explaining their design was given in chapter two.  Although they are of limited 
use as pH probes for the lysosomal region of cells, lessons can be learnt about probe design from 
their results.  It is also possible that they could find use in other applications. 
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4.2.1 The importance of the capping ligand 
 The complex, [Eu·L9]3+, was the first complex to be examined during this work.  The 
structurally related complex, [Eu·L77]3+, has been shown to exhibit a lysosomal distribution.26  It 
was hoped that exchange of one of the amide pendant arms for a pH dependent sulfonamide 
moiety, would not alter this localisation profile.  Instead, it was postulated that this would lead 
to a modulation in the europium spectral form, associated with pH-dependent sulfonamide 
nitrogen ligation. 
 
The complex was synthesised as outlined in chapter two.  The initial europium emission 
spectra taken at high and low pH appeared to show little change in the form of emission.  To 
investigate this further, a full pH titration was undertaken over the range pH 3 – 9.  Outside of 
these limits, decomplexation of the lanthanide ion may be possible, and it adequately covers the 
biological range which we are interested in.  The titration was performed in a 0.1 M sodium 
chloride background, to maintain a constant ionic strength when adding small quantities of 
concentrated hydrochloric acid or sodium hydroxide to change the pH.  The pH titration began at 
pH 9, and decreased by intervals of approximately 0.33 down to pH 3.  The pH titrations were 
performed by acidification as this procedure minimises the risk of bicarbonate formation which 
may contaminate stock solutions of sodium hydroxide. 
 
The pH titration of [Eu·L9]3+ showed no modulation of spectral form across the entire pH 
range (Fig.  52).  There was a quenching of emission intensity as the pH was increased.  
Examination of any pair of bands or individual wavelengths gave rise to no change in their 
intensity ratios.   
 
[Eu·L9]3+ 
[Eu·L77]3+ 
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It was expected that upon deprotonation of the sulfonamide nitrogen, it would bind to the 
metal centre causing a change in the spectral form.  So, either the sulfonamide is not binding at 
all, or there is binding, but just not in a manner that causes a change in spectral form.  
Examination of the lifetimes of the excited states in H2O and D2O gave values for the number of 
coordinated water molecules at the limits of the titration (Section 2.4.2).  At pH 3, the hydration 
state of the europium was 1.9, and at pH 9 this was 0.7.  This indicates that upon moving from 
pH 3 to pH 9, a water molecule is displaced from the coordination sphere, suggesting that 
binding of the sulfonamide nitrogen is occurring.   
 
It appears that binding of the sulfonamide may be occurring but without a change in spectral 
form.  This is most likely because the sulfonamide is not binding at the capping axial position in 
the square antiprismatic coordination environment.  As described in previous chapters, it is this 
feature which is the overriding influence upon spectral form for this class of complexes.  In the 
related complex, [Eu·L77]3+, it is the pyridyl nitrogen from the chromophore which occupies this 
site and so this is presumably also true for [Eu·L9]3+.  Binding of the sulfonamide presumably 
occurs in the plane of the amide oxygen donors, displacing a water molecule and causing no 
change to the spectral form.  The decrease in luminescence intensity upon sulfonamide binding 
may be associated with the steric bulk of the sulfonamide or a π-π interaction between the dpqC 
chromophore and the phenyl group on the sulfonamide partly quenching the intermediate dpqC 
excited state. 
 
Fig.  52:  Variation of the Eu(III) emission spectrum for [Eu·L9]3+ as a function of pH, from pH 4 (red) to 
9 (blue).  (H2O, 50 µM complex, 298 K, I = 0.1 M NaCl, λex = 340 nm). 
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As no ratiometric output was gained from this probe, it offers no use as an intracellular probe.  
It does however serve to highlight the importance of this geometric aspect in probe design.  
Evidently, there is a need to ensure that the reversibly bound donor site occupies an axial 
position, in this class of complexes. 
4.2.2 The importance of relatively simple changes to the emission spectra and 
ratiometric analysis 
The complex [Eu·L10]+ has a vacant site free in the axial position, so binding of the methyl 
sulfonamide is possible at this important position in this case.  The anionic arms derived from 
alanine were incorporated, as they had previously been shown to inhibit interference from 
anion binding in pH-responsive probes.69 
 
A pH titration of [Eu·L10]+ was carried out over the pH range of 9 to 3, in a 0.1 M sodium 
chloride background (Fig.  53).  For simplification, the ΔJ = 2 band is shown separately in Fig.  54, 
as it can be seen that the spectra overlap each other.  Upon moving from pH 3 to pH 5 there is an 
Fig.  53:  Variation of the Eu(III) emission spectrum for [Eu·L10]+ as a function of pH (H2O, 40 µM 
complex, 298 K, I = 0.1 M NaCl, λex = 340 nm).   
[Eu·L10]+ 
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increase in emission intensity, whilst the form of the spectra remains largely constant across this 
pH range (left, Fig.  50).  At pH 5, the form of the spectra changes drastically, and following this 
point,  the emission intensity decreases.  The most obvious differences between the two limiting 
spectral forms are an increased splitting within the bands at low pH.  The main band within the 
ΔJ = 2 manifold centered at 615 nm is split into two, and there is also another band emerging at 
622 nm at low pH.  This slightly unusual behaviour suggests there may be two processes 
contributing to the change in spectral form and intensity. 
 
Examination of the excited state lifetimes in H2O and D2O revealed that the number of 
coordinated water molecules switched from 1.4 to 0.5 upon moving from pH 3 to pH 9, 
presumably as sulfonamide ligation takes place.  This is consistent with displacement of a 
coordinated water molecule upon binding of the sulfonamide nitrogen.  This complex is an 
improvement on the dpqC-based probe, [Eu·L9]3+, in the previous section in that sulfonamide 
binding causes a change in the spectral form.  However, the nature of the increase and then 
decrease in intensity limits the applicability of the probe through ratiometric analysis, however.  
A plot of the ΔJ = 2 / ΔJ = 1 ratio highlights this (Fig.  55, left).  For a calculated ratio, there are 
two possible pH values which this could correspond to centered around pH 5.  Close 
examination of the spectral form does allow each case to be distinguished, when this 
information is available.   
Fig.  54:  Variation of the Eu(III) emission spectrum for [Eu·L10]+ as a function of pH, (H2O, 40 µM 
complex, 298 K, I = 0.1 M NaCl, λex = 340 nm).  (left) shows the pH range from pH 3 (red) to pH 5.5 
(green), (right) shows the pH range from pH 5.5 (green) to pH 9 (blue), 
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The large change in the spectral form makes it likely that binding of the sulfonamide is 
occurring as required at the axial position.  As higher pH values are approached, the sulfonamide 
binds and effectively locks the pendent arms into a more rigid conformation, leading to a 
reduced splitting within the spectra at this point.  The subsequent decrease in emission intensity 
could occur because binding of the sulfonamide has an increased steric demand at the metal 
centre, and might weaken the azaxanthone-lanthanide interaction.  If the azaxanthone nitrogen 
is no longer directly bound, the distance dependent energy transfer step will be less efficient, 
accounting for the weaker emission observed.  Displacement of a coordinated azaxanthone 
moiety has been reported recently, when HSA bound to a bis-azaxanthone europium complex.132  
 
The use of integrated area ratios was shown to be ineffective at constructing pH curves.  
Taking the emission at a wavelength of 591 nm to that at 617.5 nm does lead to a curve for 
which a good fit of the data can be found (Fig.  55, right).  Differentiation of the curve can 
abstract a pKa value for this, which was calculated to be 6.5.  This value is perhaps too high for 
measurement of lysosomal pH which is usually 1 – 2 units lower.  It is likely that in competing 
backgrounds, this pKa would alter, and so therefore required investigation. 
 
The spectral response of [Eu·L10]3+ to pH is unaffected by the presence of protein.  Performing 
the pH titration in a background of 0.4 mM HSA, led to a very similar spectral output, in terms of 
intensity changes and spectral form.  The insensitivity of the observed spectra to the presence of 
protein is a promising attribute, as it suggests that the system may be applicable for biological 
samples.  The effect of added anions was also investigated.   Addition of a mixed anion 
background containing, 30 mM bicarbonate, 2.3 mM lactate, 1.3 mM phosphate, 0.13 mM citrate 
Fig.  55:  Plots of ratios as a function of pH for [Eu·L10]+. (left) the ΔJ = 2 / ΔJ = 1 ratio and (right) the 
617.5 / 591 nm ratio  
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and 100 mM chloride caused a very different response to pH in terms of the spectral output (Fig.  
56).  At low pH values the form is very similar to that in a 0.1 M sodium chloride background, 
although increasing pH leads to a very slight decrease in intensity as opposed to a large increase 
in intensity.  Above pH 6, there is a very large increase in emission intensity across the spectral 
window, but particularly within the ΔJ = 2 manifold.  A plot of the integrated ratio of the ΔJ = 2 
band vs. ΔJ = 1 band shows negligible change below pH 6, and a sharp increase in the ratio up to 
pH 8 at which point it levels out (Fig.  57).  The apparent pKa defining this behaviour is 7.00 (± 
0.05) which can be ascribed to bicarbonate binding.  
 
 A pH titration in a fixed background of 30 mM sodium bicarbonate confirmed this behaviour 
(Fig.  59), as the large increase in spectral intensity at high pH was also observed in this case 
Fig.  56:  Variation of the Eu(III) emission spectrum for [Eu·L10]3+ as a function of pH in a background 
of protein and 30 mM sodium bicarbonate, 2.3 mM sodium lactate, 1.3 mM sodium phosphate, 0.13 mM 
sodium citrate and 0.1 M sodium chloride. (H2O, 40 µM complex, 298 K, I = 0.1 M NaCl, λex = 340 nm).  
Inset shows the ΔJ = 2 region highlighted for (left) pH 3 to 5, and (right) pH 5 to 9. 
Fig.  57:  Plot of the ΔJ = 2 / ΔJ = 1 ratio as a 
function of pH for [Eu·L10]3+ in a background of 
mixed anions and protein.  pKa = 7.0 ± 0.05. 
Fig.  58:  Plot of the ΔJ = 2 / ΔJ = 1 ratio as a function 
of pH for [Eu·L10]3+ in a background of 30 mM 
sodium bicarbonate. 
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both in terms of changes in form and relative intensity (compare Fig.  56 and Fig.  59). 
   
Finally, the response to pH was studied by following changes in the circularly polarised 
luminescence of this complex.  Circularly polarised emission spectra were recorded at the two 
pH limits and also at pH 5.6 which is approximately where the cross-over point is between the 
two forms (Fig.  60).  A background of 0.1 M NaCl was used.  Changes in the CPL spectrum were 
evident between the two pH limits.  The ΔJ = 1 manifold changes from a (-+) signal sequence at 
pH 3 to a (++-) sequence at pH 9 whilst the ΔJ = 2 manifold changes from a (++-) sequence to a (-
-) sequence.  This shows that it is possible to follow the binding of the sulfonamide by changes in 
the circularly polarised luminescence and that binding of the sulfonamide changes the chirality 
at the metal centre.  This is the first example of signalling a pH change using lanthanide based 
CPL. 
 
Due to this signigicant change in form of the CPL emission, it may also be possible to use 
ratiometric analysis to analyse pairs of bands and gain information that is otherwise hidden 
within the total emission spectra.  For example, the ratio of the ΔJ = 2 / ΔJ = 1 bands is 
approximately 2.0 at both pH 3 and pH 9.  If a ratio is taken using data from the corresponding  
CPL spectra, then the values are substantially different.  Thus, by taking a ratio of the ΔJ = 2 / ΔJ 
= 1 bands a value of +0.2 is found at pH 3 and -8.3 at pH 9, allowing the different pH values to be 
distinguished clearly.   
Fig.  59:  Variation of the Eu(III) emission spectra for [Eu·L10]3+ as a function of pH in a background of 
30 mM sodium bicarbonate. (H2O, 40 µM complex, 298 K, I = 0.1 M NaCl, λex = 340 nm).   
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4.2.3 The importance of pKa and withstanding a competitive biological 
background 
The europium azathioxanthone complex [Eu·L11]3- contains a non-coordinating chromophore.  
This should mean that the distance between this sensitiser and the europium should remain 
approximately constant during any reversible binding event.  Thus, the decrease in emission 
intensity associated with binding by the pH-dependent donor group should not be observed . 
 
The emission spectra at both low and high pH were shown in the previous chapter and a large 
amount of ligand fluorescence was observed, relative to the intensity of the lanthanide emission.  
Fig.  60:  Circularly polarised luminescence spectra (red) and total emission spectra (blue) of [Eu·L10]3+ 
at pH 3 (top), pH 5.6 (middle) and pH 9 (bottom). (295 K, I = 0.1 M NaCl) 
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A pH titration was first undertaken in a background of 0.1 M sodium chloride.  The lanthanide 
emission intensity decreased in response to lowering the pH.  The fluorescence from the ligand 
also decreased.  The relative form of the lanthanide spectrum showed little change, and as such 
it was not possible to extract any information from the usual ΔJ = 2 / ΔJ = 1 ratio analysis.  
Plotting the ratio of the ΔJ = 2 band to ligand fluorescence did however yield some information.  
There was a gradual increase in this ratio from 3 to 6, possibly associated with binding of the 
terminal carboxylate which will occur over this region.115  Between pH 6 and 8 there was no 
change in this ratio, and then a very small increase from pH 8 to 9, possibly due to the 
competitive binding of bicarbonate.   
 
The titration of [Eu·L11]3- was then undertaken in a mixed anion background (Fig.  61), in a 
background of protein (Fig.  62), and with both mixed anions and protein present (Fig.  63).  In a 
background of mixed anions containing chloride, lactate, phosphate, citrate and bicarbonate 
there was an overall increase in emission intensity (Fig.  61).  Ligand fluorescence increased by a 
Fig.  61:  Variation of the Eu(III) emission spectrum for [Eu·L11]3- as a function of pH in a background 
of 30 mM sodium bicarbonate, 2.3 mM sodium lactate, 0.13 mM sodium citrate and 0.9 mM sodium 
phosphate (H2O, 40 µM complex, 298 K, I = 0.1 M NaCl, λex = 380 nm).   
[Eu·L11]3- 
                                                                                                                                         FOUR: pH PROBES FOR THE LYSOSOMES 
 -130- 
very small amount as the pH increased.  Europium emission intensity increased steadily from pH 
3 to pH 4.5.  It then remained constant until 7, and there was a strong increase up to pH 9.  This 
second increase was accompanied by a change in spectral form, and is probably due to 
bicarbonate binding in this pH régime.  A plot of the pH dependence of the ΔJ = 2 / ΔJ = 1 ratio 
for this system is shown in the insert in Fig.  57. 
 
In the presence of protein, the titration of [Eu·L11]3-, with respect to pH showed an increase in 
europium emission from pH 3 to around pH 5.8, and then from pH 5.8 till 9 there was a very 
small decrease in emission intensity (Fig.  62).  The ΔJ = 2 / ΔJ = 1 ratio also defined variation of 
this change . 
 
When performing the titration in a background containing both the mix of anions and protein 
that the potential difficulties of using [Eu·L11]3- in a biological context were really highlighted.  
The response of the complex to pH in this background was a large increase in emission intensity 
from pH 3 to 6, but then a very large substantial decrease from pH 6 to 9 (Fig.  63).  Ratiometric 
analysis using pairs of bands revealed the complexity of the system.  Given the vastly different 
response of the probe to pH in different backgrounds, this particular complex is unlikely to be 
useful as a probe of pH. 
 
Fig.  62:  Variation of the Eu(III) emission spectrum for [Eu·L11]3+ as a function of pH in a background 
of protein (H2O, 40 µM complex, 298 K, I = 0.1 M NaCl, λex = 380 nm).   
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4.3 A series of probes for assessing lysosomal pH based upon 
sulfonamide ligation 
The probes described in the previous section suffered from various problems, including a pKa 
lying outside the lysosomal pH range, sensitivity to interference from anions and protein, and an 
unsuitability for simple ratiometric analysis.  It had been observed that the bicarbonate series of 
probes, discussed throughout chapter three, exhibited a lysosomal distribution at extended 
time-points approaching 24 h.  They had been shown to withstand competing backgrounds and 
were highly successful in providing ratiometric outputs.  They also contained a free cyclen NH 
and so it was postulated that incorporating a pH sensitive moiety onto this position would 
enable the complexes to be used as pH sensors.  This does, of course, assume that lysosomal 
localisation would still exist and the complexes would remain non-toxic.  It was hoped that the 
Fig.  63:  Variation of the Eu(III) emission spectrum for [Eu·L11]3- as a function of pH in a background of 
mixed anions and protein (H2O, 40 µM complex, 298 K, I = 0.1 M NaCl, λex = 380 nm).   
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complex would no longer exhibit such a high response to the presence of bicarbonate, as the 
sulfonamide substituent would increase the steric demand at the metal centre, and binding of 
bidentate ligands such as bicarbonate would then be disfavoured. 
 
The synthesis of such probes was described in chapter two.  The initial work to assess their 
performance involved a series of spectral titrations, examining the changes in emission intensity 
and spectral form in response to pH in various background media. 
 
Fig.  64:  Variation of the Ln(III) (Ln = Eu, Tb) emission spectrum as a function of pH (H2O, 40 µM complex, 
298 K, I = 0.1 M NaCl, λex = 332 nm).  (top left) [Eu·L6]3+, (top right) [Eu·L7]3+,(bottom left) [Tb·L6]3+ and 
(bottom right) [Tb·L7]3+. 
 [Eu·L6]3+  [Eu·L7]3+ 
 [Tb·L6]3+  [Tb·L7]3+ 
[Eu·L6]3+ 
 
[Eu·L7]3+ 
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Firstly, the spectra were recorded in aqueous salt solution (0.1 M sodium chloride, 
maintaining a constant ionic strength) (Fig.  64).  The complexes [Eu·L6]3+ and [Eu·L7]3+ behaved 
quite similarly to one another.  Each showed a very large increase in emission intensity across 
the spectral window, as the pH was decreased from 9 to 3.  There was no obvious change to the 
form of the emission, which appeared very similar for each complex.  For [Eu·L7]3+, ratiometric 
analysis comparing the ΔJ = 2 / ΔJ = 1 ratio gave a pKa for sulfonamide binding of 5.4 ± 0.1.  The 
small deviation and increase observable approaching pH 9 is possibly due to the influence of 
dissolved bicarbonate.   
 
For [Eu·L6]3+, ratiometric analysis of the bands could not yield an appropriate binding curve.  
Examination of the wavelengths at 616 nm versus 680 nm, where there appeared to be an 
apparent isoemissive point, did yield an appropriate sigmoidal curve.  The pKa for this complex 
was slightly lower, at 5.1 ± 0.1. 
 
In contrast, the terbium emission spectra of the same two ligands behaved quite differently to 
one another.  There are some similarities.  Both showed a large change in the form of the 
emission, between low and high pH.  At pH 3, the form of the emission was rather featureless, 
and consisted of four broad bands, corresponding to each of the main emissive transitions.  At 
pH 9, each of the first three bands became quite clearly resolved into two.  They differed in that 
whilst [Tb·L6]3+ exhibited a decrease in emission upon moving from pH 9 to pH 3, [Tb·L7]3+ 
increased its emission intensity.  The increase in the emission intensity behaviour of [Tb·L7]3+ 
matched that of the europium analogues which also increased, and by approximately the same 
amount.   
 
It is [Tb·L6]3+ which appears to be the anomaly in this mini-series, although the change in 
emission is less than that for the others.  Using the ΔJ = 2 / ΔJ = 1 ratio to analyse the data for 
[Tb·L7]3+, a pKa of 4.6 ± 0.1 was obtained.  For [Tb·L6]3+ individual wavelengths were required, 
and a plot of 546 nm / 542 nm gave a pKa for sulfonamide binding of 4.7 ± 0.1 with this complex. 
 
A larger emission intensity decrease for the complexes of L7 realtive to L6 was observed, this 
may be due to intramolecular charge transfer processes quenching emission to a greater degree 
between the para-methoxy sulfonamide and the azaxanthone, when the sulfonamide is bound to 
the metal centre and brought into close proximity at high pH.   
 
Comparing the pKa values of the complexes, each terbium analogue had lower pKa values than 
the europium complexes, about 0.5 units lower.  Whilst the values for the two terbium 
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complexes are roughly similar to one another, [Eu·L7]3+ has a slightly higher value than [Eu·L6]3+.  
Terbium (III) is more charge dense, so the Tb-sulfonamide interaction is stronger than the Eu-
sulfonamide interaction.  Thus, it is harder to protonate the nitrogen in the terbium analogues, 
leading to the lower pKa observed with terbium compared to europium.   
 
[Tb·L6]3+ is the anomaly in the series in that it is the only complex where an increase in 
emission intensity occurs as pH rises.  This is tentatively ascribed to the dominating effect of 
disruption to the intramolecular hydrogen bonding within the chromophore unit.  Pertubation 
to hydrogen bonding at low pH causes modulation of the sensitiser to lanthanide distance, and 
effects the efficicency of energy transfer leading to a decrease in emission intensity at low pH, 
observed for the [Tb·L6]3+ analogue.  With [Tb·L7]3+, the previously mentioned effect of 
intramolecular charge transfer from the aryl sulfonamide dominates, and so it instead at high pH 
that a large decrease in emission intensity is observed. 
 
As throughout this thesis, the next stage was to examine the effect of added protein or anions.  
All four pH titrations were repeated in a fixed salt background containing 0.4 mM human serum 
[Tb·L7]3+ [Tb·L6]3+ 
[Eu·L6]3+ [Eu·L7]3+ 
Fig.  65: Variation of the Ln(III) (Ln = Eu, Tb) emission spectrum as a function of pH in a fixed background 
of 0.4 mM human serum albumin (H2O, 40 µM complex, 298 K, I = 0.1 M NaCl, λex = 332 nm).  (top left) 
[Eu·L6]3+, (top right) [Eu·L7]3+,(bottom left) [Tb·L6]3+ and (bottom right) [Tb·L7]3+. 
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albumin (Fig.  65).  The relative form and intensity changes with respect to the changes in pH 
were very similar to those observed without the background of protein.  [Tb·L6]3+ still exhibited 
the opposite behaviour to the other three.  It is promising that the spectral response appear 
unaffected by the presence of protein, and suggests that the complex may be useful in biological 
situations. 
 
Working systematically through these titrations, the final set were performed in a background 
of both the mixed anions and protein.  Changes were more clearly defined for the [Ln·L7]3+ duo 
of probes.  Ratiometric analysis, examining the integrated area ratios of the two main bands in 
the spectra gave a pKa of 5.9 ± 0.05 for both the europium and terbium analogue.  For [Ln·L6]3+ it 
was not possible to use area ratios to plot accurate pH curves.  It was, however,  possible to find 
individual wavelengths which provided this information.  The 620 nm / 615.5 nm ratio from the 
europium spectra yielded a pKa of 6.8, whilst the 545.5 nm / 542.5 nm ratio from the terbium 
spectra gave a slightly lower pKa of 6.5. 
 
Fig.  66:  Variation of the Ln(III) (Ln = Eu, Tb) emission spectrum as a function of pH in a fixed background 
of 2.3 mM lactate, 0.9 mM phosphate, 0.13 mM citrate and 30 mM bicarbonate (H2O, 40 µM complex, 298 K, 
I = 0.1 M NaCl, λex = 332 nm).  (top left) [Eu·L6]3+, (top right) [Eu·L7]3+,(bottom left) [Tb·L6]3+ and (bottom 
right) [Tb·L7]3+. 
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4.4 Using a red : green ratiometric analysis 
In chapter three, fluctuations in bicarbonate concentrations were measured, both in vitro and 
in cellulo, using a ratio of the europium to terbium emission intensity.  This worked particularly 
successfully when applied to the microscopy experiments and it was hoped to extend this 
method to the lysosomal pH probes. 
A mixture of the europium and terbium complexes of L6 were taken together and subjected to 
a pH titration over the range of pH 3 to 9.  A ratio of the ΔJ = 2 at 605 – 630 nm band of the 
europium spectrum was taken versus the ΔJ = -1 band of terbium at 534 – 550 nm (Fig.  67).  At 
the two extremes of the titration, the data tails off in opposite directions.  Over the relevant pH 
range of interest the usual sigmoidal curve is apparent.  This yields a pKa value of 5.8.  This value 
is higher than that observed when calculating the pKa using changes within one of the 
lanthanides only which were 5.4 and 4.7.  If greater signal intensity is required, then using 
europium to terbium intensity ratios in this manner may offer the most simple option.  
Alternatively, it offers a way of tuning the pKa of the system.  Using the same ligand, L6, can lead 
to pKa’s of 4.7, 5.4 or 5.8 depending on whether the lanthanide used is terbium, europium or a 
mixture of the two, respectively.  The difference observed between europium and terbium 
analogues of a common ligand is again likely to be due to the stronger charge density of terbium 
making the sulfonamide nitrogen harder to protonate. 
4.5 Analysis of the complexes using changes in the circularly 
polarised luminescence 
The complexes are amenable to analysis examining their circularly polarised luminescence.  It 
had been shown for the structurally related bicarbonate series of probes, that binding of anions 
Fig.  67:  Ratio of the europium emission versus 
terbium emission with respect to pH for [Ln·L6]3+ 
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induced a change in the chirality at the metal centre.  It is likely that binding of the sulfonamide 
arm may also cause this, in the case of this series of probes. 
 
[Tb·L6]3+ had been shown to be the only complex in the series to demonstrate an increase in 
emission intensity upon increasing pH.  The CPL spectrum of this complex was taken at both low 
and high pH (Fig.  68).  Circularly polarised emission was observed in each case.  The most 
intense emission arose from the ΔJ = -1 band at 545 nm, and this was accompanied by a 
significant change in the circularly polarised emission depending on pH.  This behaviour is 
consistent with a distortion of the complex geometry (ie. the CPL is at a maximum when the 
twist angle about the principal axis defining the ring N4 and oxygen donors is 22.5°) (Section 
1.1.4) upon binding by the methyl sulfonamide.  Emission dissymmetry values are considerably 
higher for the complex when taken at pH 9, which corresponds to when the sulfonamide 
nitrogen is bound (Table 18). 
 
Table 18:  Emission dissymmetry factors (gem) at pH 3 and pH 9 for the maxima/minima of the transitions 
within the ΔJ = -1 manifold for [Tb·L6]3+. 
pH 3 pH 9 
(548 nm) +0.051 
(551 nm) -0.022 
(548 nm) +0.125 
(553 nm) +0.057 
(560 nm) -0.213 
 
Fig.  68:  Total emission spectra (green) and circularly polarised luminescence spectra (red = pH 3, blue = 
pH 9) of [Tb·L6]3+ at pH 3 (left) and pH 9 (right). (295 K, I = 0.1 M NaCl). 
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Given the change in CPL spectra observed upon changing pH, it should be possible to follow a 
pH titration in terms of the variation of the emission dissymmetry factor.  This is shown in Fig.  
69 for [Eu·L7]3+, in which the emission dissymmetry factor, calculated at 632 nm, is examined as 
a function of pH.  Fitting a curve to the data yields a pKa of 5.5 ± 0.1.  This is in good agreement 
with data calculated using the ΔJ = 2 / ΔJ = 1 ratio of the total emission, which estimated the pKa 
to be 5.4 ± 0.1.  This is the first time that CPL has been used to assess the pKa of an emissive 
lanthanide complex. 
4.6 Cellular localisation behaviour 
The cellular localisation of the probes needed to be established before further microscopy 
experiments could be performed.  The complexes in this series closely resembled the 
bicarbonate probes in the previous chapter which showed a mitochondrial distribution, before 
shuttling to the lysosomes.  All previous analogous complexes, in which an azaxanthone 
sensitiser was linked to the cyclen framework via an amide linkage, had shown this distribution 
pattern.2 
 
The localisation experiments were performed in a similar manner to that described in chapter 
3.  Mouse skin fibroblast cells (NIH-3T3) were incubated with each complex (50 µM) for several 
different time periods.  For the final 5 minutes of incubation, the commercially available 
LysoTrackerTM probes were added, in order to assess when the lysosomal localisation was 
reached.  Each of the complexes in this series behaved in a similar fashion to one another. 
 
Fig.  69:  Variation in the emission dissymmetry 
factor (632 nm) as a function of pH for [Eu·L7]3+ 
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The localisation of [Tb·L7]3+ is shown in Fig.  70, along with the emission from LysoTracker 
Red.  Overlaying of the two image channels shows a very high degree of co-localisation, and 
indicates that the complexes are localising to the lysosomes, at time periods of between one and 
four hours.  This is in contrast to other complexes containing an amide coordinating 
azaxanthone, which exhibited a mitochondrial distributions at these time periods, and only 
showing a lysosomal distribution at much longer time-points.   
 
The inclusion of a sulfonamide arm has altered the localisation profile.  This is however, highly 
useful for the application in which the probe is intended.  It is no longer necessary to wait for at 
least 10 h for a lysosomal distribution; and instead, the results are achieved within one hour.   
4.7 Cytotoxicity studies 
The pH-responsive complexes [Ln·L6-8]3+ were assessed for their cytotoxicity.  The MTT assay, 
described in chapter three was performed, looking at incubations of up to 200 µM for 24 hours 
using mouse skin fibroblast (NIH-3T3) cells.  As found for the related bicarbonate probe series, 
Fig.  70:  Confocal microscopy images for [Tb·L7]3+ (top), 50 µM complex, (left) 1h incubation, (middle) 2h 
incubation, (right) 4h incubation.  Lower three images show the corresponding LysoTracker Red 
emission. 
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no significant toxicity was observed under these conditions.  Calculated IC50 values were found 
to be greater than 200 µM in each case. 
4.8 Conclusions 
Modification to the structure of the bicarbonate probes described in chapter three by 
incorporating a variety of sulfonamides into the macrocyclic ligand has led to a series of pH-
responsive complexes.  Tuning of the pH-responsive range of the complex, or the pKa of 
sulfonamide binding was achieved by variation of the sulfonamide.   
 
The pH-response of sulfonamide binding was not prevented in competing backgrounds, 
examining the influence of added anions and protein.  Differing backgrounds did adjust the pKa 
of binding, however, with the pKa shifting to slightly higher values if protein or anions were 
present.  This is likely to mean that a system monitoring pH with these probes may need to be 
calibrated independently for each individual system. 
 
Changes within the circularly polarised luminescence emission spectra could be monitored as 
a function of pH.  Binding of the sulfonamide causes a change in the local helicity at the metal 
centre, and this is reflected in changes in the CPL emission.  The largest changes to the CPL 
spectrum occurred with the terbium analogues.  Nevertheless, it was still possible to analyse 
data for each europium analogue, monitoring the pH dependence of the emission dissymmetry 
factor.  The pKa value calculated using this method, matched that found by examining data from 
changes in the total emission spectrum. 
 
The complexes described were non-toxic to cells, and localised preferentially to the lysosomes 
within one hour.  This localisation profile remained constant for a number of hours, which 
should allow experiments examining pH changes in the lysosomes within this time period. 
 
The work described is promising, as it suggests the probes potential to be used in cellulo to 
monitor changes in pH within the lysosomes.   
4.9 Future Work 
There is plenty of scope to extend the work presented in this chapter.  Most of it focuses on 
the application of the probes in cell-based work, and then examination by confocal microscopy. 
 
There are one or two minor structural changes which could be made to the probes, however.  
To address the issues associated with the small effects of a change in pKa upon background 
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composition, it may be beneficial to use complexes with a lower overall charge.  The work in 
chapter three showed that by using neutral or anionic complexes, affinities for anions was 
reduced.  Thus, using the neutral analogues of the complexes in this chapter, anion interference 
may be suppressed further. 
 
The immediate cellular work in this area to be undertaken involves establishment of a reliable 
calibration.  This involves incubating the cells in high potassium salt buffered solutions of 
differing pH, together with the ionophores monensin and nigericin.133  A tandem probe approach 
would be used, and the ratio of europium/terbium emission calculated at each pH.  This should 
allow a calibration curve to be constructed for that system.  The selection of buffers needs 
careful thought as a citrate or phosphate buffer is likely to quench the emission of the 
complexes. 
 
Further cell work should also focus on ways of deliberately perturbing the system, and 
monitoring any spectral changes that occur.  Administration of chloroquine is known to cause an 
elevation of pH within the lysosomes.  A series of experiments could be devised to observe these 
changes via variation in the europium/terbium ratio.  The effect of chloroquine concentration on 
intralysosomal pH could be examined as a function of time. 
 
One last option for further work is to combine the ideas presented and discussed throughout 
this thesis and create pH probes for the mitochondria.  Addition of the pH-responsive 
sulfonamide altered the localisation away from the mitochondria. It remains a challenge to 
incorporate a pH responsive moiety whilst retaining a mitochondrial localisation.   
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5 Experimental 
5.1 General Procedures 
5.1.1 Reagents and Solvents 
All commercially available reagents were used as received from their respective suppliers. 
Water and H2O refer to high purity water obtained from the “PuriteSTILL Plus” purification 
system, with conductivity of <0.04 µS cm-1.  Reactions requiring anhydrous conditions were 
carried out using Schlenk-line techniques, under an atmosphere of dry argon.  All solvents used 
were laboratory grade, and where required were dried using an appropriate drying agent. 
 
5.1.2 Chromatography 
Thin-layer chromatography was performed using silica plates (Merck 5554) or neutral 
aluminium oxide plates (Merck 5550), each visualised using UV irradiation or by staining with 
iodine or Dragendorff’s reagent, as appropriate.  
 
Preparative column chromatography was carried out using silica (Merck Silica Gel 60, 230-
400 mesh) or neutral aluminium oxide (Merck Aluminium Oxide 90, 70-230 mesh), pre-soaked 
in ethyl acetate. 
 
5.1.3 Exchange of complex counter-anions 
Exchange of complex counter-anions was performed using ‘DOWEX® 1x2-200’ ion exchange 
resin (Sigma-Aldrich).  Typically, the resin (1 g) was prepared by boiling in MeOH (50 ml) 
overnight followed by washing with H2O (500 ml).  The resin was then loaded into a pipette and 
HCl(aq) passed through (1 M, 25 ml), this was then washed with H2O until the washings were pH 
7. 
 
5.1.4 Spectroscopy 
1H and 13C-NMR spectra were recorded on a Varian Mercury-400 (1H at 399.96 MHz), Bruker 
Avance-400 (1H at 400.13 MHz, 13C at 100.61 MHz), Varian Inova-500 (1H at 499.78 MHz, 13C at 
125.67 MHz), or a Varian VNMRS-700 (1H at 699.73 MHz, 13C at 175.95 MHz) spectrometer.  All 
spectra were internally referenced to the solvent residual proton signals.  All chemical shifts are 
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given in ppm, with coupling constants in Hz. Splitting patterns are described as singlet (s), 
doublet (d), triplet (t), quartet (q) or multiplet (m). 
 
5.1.5 Optical Spectroscopy 
UV/Vis absorbance spectra were recored on a Perkin Elmer Lambda 900 UV/Vis/NIR 
spectrometer using FL Winlab software).  Emission spectra were recorded on a ISA Joblin-Yvon 
Spex Fluorolog-3 luminescent spectrometer using DataMax v2.20 software).  Lifetimes were 
measured on a Perkin Elmer LS55 luminescence spectrometer using FL Winlab Molecular 
Spectroscopy Version 4.00.02 software.  Each sample was contained in quartz cuvettes with a 
pathlength of 1cm.  Measurements were recorded at 298 K.  Generally, an integration time of 0.5 
seconds, increment of 0.5 nm and excitation and emission slits of 2.5 and 1.5 nm respectively 
were used.  Circularly polarized luminescence measurements were made using a home-built CPL 
spectrophotometer, based on a Spex Fluoromax-2-spectrofluorimeter at the University of 
Glasgow with the assistance of Dr R. D. Peacock.  Measurements were undertaken in D2O using 
indirect excitation at 332 nm.  Absorbance measurements of 96-well plates were made on an 
Analytik Jena FLASHScan 530 using WinFLASH version 1.5 software. 
 
5.1.6 pH measurements 
pH measurements were undertaken using a Jenway 3020 or a Jenway 3320 pH meter attached 
to an Aldrich Chemical Company micro-pH combination electrode.  Calibration of the pH meter 
was conducted daily using a three point calibration: pH =4.00, pH = 7.00 and pH = 7.00 buffer 
solutions (Aldrich).  For measurements in D2O, the pD was calculated using the actual pH meter 
reading and [Eq. 9]. 
 
pD = pH (meter reading) + 0.41  [Eq. 9] 
 
5.1.7 Luminescent titrations 
Luminescent titrations were carried out, examining the effect of a number of different anions 
and protein upon the emission spectra of the complexes.  Protein was added as a solid, and pH 
adjustments were made, if necessary, after each addition.  Anions were added as a small volume 
from a concentrated stock solution.  Volume additions at each point were typically only 0.1% of 
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the original solution.  A correction for this small dilution effect was nevertheless made for each 
Ln(III) spectrum. 
 
5.1.8 Determination of binding constants 
The apparent binding constants were calculated from the data obtained following these 
luminescent titrations.  [Eq. 10] was fitted to the data, using a non-linear least squares fitting 
algorithm in Microsoft Excel 2010, using the solver add-in. 
2[ ]* [ ]*
[ ]
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And [X] is the concentration of the anion or selected added species in solution 
 K is the binding constant 
 F is the ratio or intensity of the selected peak 
 F0 is the ratio or intensity of the selected peak at the beginning of the titration 
 F1 is the final ratio or intensity of the selected peak 
[Ln·L] is the total concentration of the Ln(III) complex in solution 
 
5.1.9 Lifetime measurements 
Lifetimes of Eu(III) and Tb(III) complexes were measured by excitation (332 nm) of the 
sample using a short pulse of light followed by monitoring the integrated intensity of light (616 
nm for Eu(III), 545 nm for Tb(III)) emitted during a fixed gate time, tg, after a delay time, td.  At 
least 20 delay times were used covering at least 3 lifetimes. A gate time of 0.1 ms was used, and 
the excitation and emission slits were set to 10 nm and 5 nm band-pass respectively. The 
obtained exponential decay curves were plotted in Microsoft Excel and [Eq. 11] fitted to the 
data: 
I = A0 + A1e-kt  [Eq. 11] 
 
where: I is the intensity at time t after the flash 
A0 is the intensity after the decay has finished 
A1 is the pre-exponential factor 
k is the rate constant for the decay of the excited state 
The excited state lifetime, τ, is the inverse of the rate constant, k. 
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5.1.10 Inner Sphere Hydration Number (q’) Determination 
The rate constant for the depopulation of the lanthanide excited state in water may be 
represented as the sum of a number of different contributing factors.  In [Eq. 5.2], these are the 
natural radiative rate constant (kr), the global rate constant for non-radiative quenching 
mechanisms (knr) and the rate constant associated with energy transfer to nearby XH matched 
oscillators, respectively. 
 
2H O r nr XH
k k k k     [Eq. 12] 
 
It is assumed that in D2O, all exchangeable XH oscillators have zero contribution to the 
quenching, so the equation simplifies to: 
 
2D O r nr
k k k 
    [Eq. 13] 
 
The difference between the rate constants is therefore given by the sum of the rate constants 
for the non-radiatve decay to nearby XH oscillators. 
 
2 2H O D O XH
k k k k      [Eq. 14] 
 
Assuming that OH oscillators are the major contributor to the ΣkXH term, then this equation 
can be modified to relate the number of inner sphere water bound molecules to the difference in 
the rate of quenching between H2O and D2O. 
 
 'q A k x y   
   [Eq. 15] 
 
A is a proportionality constant, representing the sensitivity of a particular lanthanide ion to 
vibronic quenching by XH oscillators.  It takes a value of 1.2 ms-1 for europium and 5 ms-1 for 
terbium.  x is a correction factor, allowing for the effect of closely diffusing OH oscillators.  x 
takes a value of 0.25 ms-1 for europium and 0.06 ms-1 for terbium complexes.  The final 
correction needed, y, relates to the particular case of close proximity amide NH oscillators, such 
as the carbonyl bound amide groups common in most of the complexes presented in this thesis.  
This takes a value of 0.075n ms-1 for europium complexes and 0.01n ms-1 for terbium complexes, 
where n is the number of such bound amides. 
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 ' 1.2 0.25 0.075Euq k n     [Eq. 16] 
 ' 5 0.06 0.01Tbq k n      [Eq. 17] 
 
5.1.11 Mammalian Cell Culture 
Three cell lines were selected for cellular studies: CHO (Chinese Hamster Ovary), NIH-3T3 
(mouse skin fibroblast) and HeLa (human endothelial carcinoma cells). Cells were maintained in 
exponential growth as monolayers in F-12 (Ham) medium for CHO cells or DMEM (Dulbecco’s 
Modified Eagle Medium) for NIH and HeLa cell lines. For each cell line, the medium was 
supplemented with 10% foetal bovine serum (FBS) and 1% penicillin and streptomycin. Cells 
were incubated at 37 °C, 20% average humidity and 5% (v/v) CO2. 
5.1.12 Marine Cell Culture 
Six algeal cell lines were selected for study: three coccolithophores; Geophyrocapsa oceanica, 
Calcidiscus leptoporus and Emiliania huxleyi and three diatoms; Ditylum brightwelli, Rhizoselenia 
setigera and Stephanodiscus hantzschii. 
5.1.13 Cytotoxicity measurements 
IC50 values were determined using the MTT assay.  Approximately 1 x 104 NIH 3T3 cells in 100 
µl DMEM were seeded into each well of flat-bottomed 96-well plates and allowed to attach 
overnight.  Complex solutions were added to triplicate wells to give final concentrations over a 
2-log range.  After 20 h incubation, MTT (1.0 mM) was added to each well and the plated 
incubated for a further 4 h.  The culture medium was removed, and DMSO (150 µl) was added.  
The plate was shaken for 20 seconds and the absorbance measured at 520 - 560 nm in a 
microplate reader against a blank of DMSO. 
 
5.1.14  Fluorescence Microscopy 
Epifluorescence images were taken on a Zeiss Axiovert 200M epifluorescence microscope 
equipped with an Axiocam CCD camera and 63x/1.40 oil DIC and 40x/1.40 oil DIC objectives.  
G365 filters (Zeiss) were used for excitation of the complexes, with 546±12 and 570LP filters 
used for emission of Tb and Eu respectively. 
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5.1.15 HPLC Analysis 
Reverse phase HPLC traces were recorded at 298 K using a Perkin Elmer system using a 4.6 x 
150 mm 4μm Phenomenex Synergi Fusion RP 80Å analytical column. A gradient elution with a 
solvent system composed of H2O + 0.1% HCOOH/ MeCN + 0.1% HCOOH was used for a total run 
time of 22.4 min.  In each case, a single major product was observed in >95% purity using a 
diode array UV-Vis detector operating at 332 nm.  A fluorescence detector was also connected, 
monitoring eluent from the column at 545 or 616 nm, emission was seen for each of the peaks 
observed before suggesting that each peak corresponds to a lanthanide bound chromophore. 
 
Time (min) Solvent A (%) Solvent B (%) Curvature 
0 95 5 0 
2.4 95 5 0 
15.4 0 100 1 
17.4 0 100 0 
19.4 95 5 1 
22.4 95 5 0 
 
5.1.16 Confocal Microscopy 
Confocal microscopy images were taken using a Leica SP5 II equipped with a 355 nm coherent 
CW UV laser and HeNe and Argon lasers operating at 458, 476, 488, 514 and 633 nm, running 
LAS AF software. 
The detection system could be altered between 400 – 800 nm using a PMT-based tri-imaging 
system, also equipped with a GaAr HiD dectotor system operating in bright red mode.  Scanning 
speed could be adjusted between 10 – 8000 Hz (using a resonance galvonemetric scanner). The 
pinhole was calculated automatically using the Airy disc size and the lowest wavelength number. 
The microscope has an environmental chamber attached for temperature and CO2 enrichment 
(Life Imaging Services Brick, Life Imagining Services Cube), standard operating conditions were 
37 °C and 5% CO2, humidity was controlled by a bubble humidifier. 
 
 
5.1.17 Flow Cytometry 
Flow cytometric analysis and sorting was conducted using a DakoCytomation Inc. MoFlo 
multi-laser flow cytometer (Fort Collins, CO, USA) operating at 60 psi with a 70 µM nozzle. 
Samples were interrogated with a 100mW 488 nm solid state laser.  Fluorescence signals were 
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detected through interference filters (FL1 530/40, FL2 670/30 nm) and were collected in the 
logarithmic mode. Data were analysed using Summit v4.3 software (Dakocytomation). 
For flow cytometry, cells were grown to confluence in 6-well plates. Medium was replaced and 
cells were treated with complex. Cells were detached from the plastic surface with 0.25% (v/v) 
trypsin solution for five minutes at 37 °C. The resulting cell suspension was pelleted by 
centrifugation. Immediately prior to flow cytometric analysis, cell suspensions were filtered 
through a 40 µm filter. 
 
5.2 Synthesis 
5.2.1 Azaxanthone Chromophore 
2-[4-(Methoxycarbonyl)phenoxy]-6-methylnicotinic acid2 
 
Sodium metal (0.94 g, 40.8 mmol) was carefully added to dry methanol (15 ml) under argon.  
Methyl-4-hydroxybenzoate (12.6 g, 82.8 mmol) was then added, forming a viscous light yellow 
solution.  Solvent was removed from the solution under reduced pressure to leave a glassy pale 
yellow solid.  2-Chloro-6-methylnicotinic acid (2.50 g, 14.6 mmol) was added and the mixture 
heated at 155 C for 15 hours with stirring under argon.  The mixture was cooled to room 
temperature and 100 ml of cold water added.  The resulting suspension was extracted with 
diethyl ether (5 x 50 ml) and the aqueous phase acidified with glacial acetic acid to pH 4, yielding 
a white precipitate.  This was collected by Buchner filtration, washed thoroughly with water and 
dried under vacuum (3.73 g, 12.9 mmol, 88%). 
RF = 0.31 (DCM : 5% MeOH); m.p. 121 – 123 °C (Lit. 118 – 120 °C);  1H-NMR (CDCl3, 700 MHz) δ 
8.41 (1H, d, J = 8.0, H4), 8.12 (2H, d, J = 9.0, H8), 7.24 (2H, d, J = 9.0, H7), 7.06 (1H, d, J = 8.0, H3), 
3.94 (3H, s, H11), 2.42 (3H, s, H12); 13C-NMR (CDCl3, 175 MHz) δ 166.5 (C5), 166.5 (C10), 163.4 (C2), 
160.0 (C1’), 156.4 (C6), 143.8 (C4), 131.5 (C8), 127.5 (C9), 121.6 (C7), 119.9 (C3), 110.6 (C4’), 52.7 
(C11), 24.3 (C12); HRMS (ES-) (m/z): [M - H]- calculated for C15H12NO5 286.0715, found 286.0710. 
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7-Methoxycarbonyl-2-methyl-1-azaxanthone2 
 
Polyphosphoric acid (70 g) and 2-[4-(methoxycarbonyl)phenoxy]-6-methylnicotinic acid (3.43 g, 
12.0 mmol) were heated together for 18 h, at 120 ˚C under argon.  The resulting brown solution 
was cooled to 0 ˚C and methanol (100 ml) was added with vigorous stirring.  Conc. KOH(aq) was 
added at 0 ˚C, until pH 7 was reached.  The mixture was extracted with DCM (4 x 100 ml) and 
solvent removed to yield the desired product as a yellow solid (1.44 g, 5.34 mmol, 45%). 
RF = 0.26 (hexane : EtOAc, 50 : 50); m.p. 197 – 199 °C (Lit. 194 – 196 °C); 1H-NMR (CDCl3, 400 
MHz) δ 8.98 (1H d, J = 2.5, H6), 8.59 (1H, d, J = 8.0, H4), 8.40 (1H, dd, J = 8.0, 2.5, H8), 7.64 (1H, d, J 
= 8.0, H9), 7.33 (1H, d, J = 8.0, H3), 3.98 (3H, s, H11), 2.72 (3H, s, H12);  13C-NMR (CDCl3, 101 MHz) δ 
176.8 (C5), 165.7 (C10), 165.6 (C2), 159.3 (C1’), 158.2 (C9’), 137.5 (C4), 135.9 (C8), 129.1 (C6), 126.8 
(C7), 121.7 (C3), 121.4 (C5’), 118.9 (C9), 114.3 (C4’), 52.5 (C11), 25.1 (C12); MS (ES+) m/z 291.9 [M + 
Na]+; HRMS (ES+) (m/z): [M + H]+ calculated for C15H12NO4 270.0766, found 270.0767. 
 
7-Methoxycarbonyl-2-dibromomethyl-1-azaxanthone 
 
7-Methoxycarbonyl-2-methyl-1-azaxanthone (564 mg, 2.09 mmol) was dissolved in CCl4 (15 ml) 
and stirred under argon, under irradiation using a 100 W tungsten filament lamp.  After 5 
minutes, NBS (820 mg, 4.65 mmol) and dibenzoyl peroxide (25 mg) was added.  After 18 h the 
solution was hot filtered and the solvent removed under reduced pressure.  The residue was 
dissolved in DCM (50 ml), washed with water (3 x 50 ml) and the organic phase dried over 
MgSO4.  The solvent was removed under reduced pressure and the product used directly in the 
next step without further purification (794 mg, 1.86 mmol, 89%). 
RF = 0.38 (hexane : EtOAc, 50 : 50);  1H-NMR (CDCl3, 400 MHz) δ 9.00 (1H, d, J = 2.5, H6), 8.81 
(1H, d, J = 8.0, H4), 8.44 (1H, dd, J = 8.0, 2.5, H8), 7.93 (1H, d, J = 8.0, H3), 7.68 (1H, d, J = 8.0, H9), 
6.68 (1H, s, H12), 3.99 (3H, s, H11).   
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7-Methoxycarbonyl-2-bromomethyl-1-azaxanthone 
 
Diethylphosphite (1.19 ml, 9.25 mmol) and diisopropylamine (1.51 ml, 10.8 mmol) were added 
at 0 C to a stirred solution of 7-methoxycarbonyl-2-dibromomethyl-1-azaxanthone (0.835 g, 
1.96 mmol) in dry THF (30 ml) under argon.  After ten minutes the reaction was halted and 
poured onto iced water (50 ml), then extracted with CHCl3 (3 x 50 ml).  This was backwashed 
with sat. NaHCO3(aq) (50 ml) followed by water (50 ml).  The organic phase was dried over 
MgSO4, and the solvent removed under reduced pressure.  The desired product was purified by 
column chromatography (silica, DCM   3% MeOH) as a fine white powder (0.532 g, 1.53 mmol, 
78%). 
RF = 0.42 (hexane :  EtOAc, 50 : 50); m.p. 166 – 168 ˚C (Lit. 156 – 158 ˚C);  1H-NMR (CDCl3, 700 
MHz) δ 9.00 (1H, d, J = 2.0,  H6), 8.73 (1H, d, J = 8.0, H4), 8.44 (1H, dd, J = 9.0, 2.0, H8), 7.67 (1H, d, J 
= 9.0, H9), 7.62 (1H, d, J = 8.0, H3), 4.62 (2H, s, H12), 3.99 (3H, s, H11);  13C-NMR (CDCl3, 176 MHz) δ 
176.6 (C5), 165.7 (C10), 162.6 (C2), 159.8 (C1’), 158.4 (C9’), 139.0 (C4), 136.5 (C8), 129.4 (C6), 127.2 
(C7), 121.5 (C3), 121.5 (C5’), 119.1 (C9), 116.1 (C4’), 52.7 (C11), 32.1 (C12); MS (ES+) m/z 371.2 [M + 
Na]+.  
 
7-Methoxycarbonyl-2-pththalimidomethyl-1-azaxanthone2 
 
7-Methoxycarbonyl-2-bromomethyl-1-azaxanthone (0.216 g, 0.598 mmol) and potassium 
pththalimide (0.443 g, 2.39 mmol) were stirred in DMF (12 ml), under argon for 1 h at room 
temperature.  Solvent was then removed under reduced pressure and the desired product 
purified by column chromatography (silica, DCM   5% MeOH) to yield the product as a bright 
yellow powder (0.155 g, 0.374 mmol, 63%). 
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m.p. >250 ˚C (Lit. >250 ˚C);  1H-NMR (CDCl3, 700 MHz) δ 8.97 (1H, s, H6), 8.68 (1H, d, J = 8.0, H4), 
8.39 (1H, dd, J = 9.0, 2.0, H8), 7.93 (2H, dd, J = 5.5, 3.0, H15), 7.79 (2H, dd, J = 5.5, 3.0, H16), 7.60 
(1H, d, J = 9.0, H9), 7.41 (1H, d, J = 8.0, H3), 5.14 (2H, s, H12), 3.70 (3H, s, H11); 13C-NMR (CDCl3, 176 
MHz) δ 177.0 (C5), 168.2 (C13), 165.6 (C10), 162.2 (C2), 160.0 (C1’), 158. 7 (C9’), 138.6 (C4), 136.4 
(C8), 134.5 (C16), 132.5 (C14), 129.8(C6), 127.4 (C7), 124.0 (C15), 121.4 (C5’), 119.5 (C3), 119.3 (C9), 
116.0 (C4’), 52.8 (C11), 43.1 (C12); MS (ES+) m/z 437.3 [M + H]+. 
 
7-Methoxycarbonyl-2-aminomethyl-1-azaxanthone2 
 
7-Methoxycarbonyl-2-phthtalimidomethyl-1-azaxanthone (0.128 g, 0.308 mmol) was dissolved 
in DCM : MeOH (50 : 50, 10 ml) and stirred under argon at room temperature.  H2NNH2.H2O (30 
µl, 0.620 mmol) was added and the temperature increased to 50 °C.  After 4 h the reaction was 
halted, allowed to cool to room temperature and the pH adjusted to 2 by the addition of conc. 
HCl.  The resulting mixture was heated at 50 °C for 1 h.  The reaction was then cooled in a fridge 
for 2 h and the product obtained as its hydrochloride salt by centrifugation (55 mg, 0.193 mmol, 
63%). 
m.p. >250 ˚C (Lit. >250 ˚C); 1H-NMR (CDCl3, 400 MHz) δ 8.74 (1H, s, H6), 8.66 (1H, d, J = 8.0, H4), 
8.38 (1H, d, J = 8.5, H8), 7.70 (1H, d, J = 8.5, H9), 7.58 (1H, d, J = 8.0, H3), 4.70 (2H, s, H12), 3.92 (3H, 
s, H11); 13C-NMR (CDCl3, 101 MHz) δ 177.3 (C5), 169.4 (C2), 165.7 (C10), 160.1 (C1’), 158.7 (C9’), 
138.4 (C4), 136.3 (C8), 129.5 (C6), 126.8 (C7), 121.5 (C5’), 119.3 (C3), 118.9 (C9), 115.5 (C4’), 52.5 
(C11), 44.8 (C12); MS (ES+) m/z 285.1 [M + H]+. 
 
2,5-Dioxopyrrolidin-1-yl-2-chloroacetate33 
 
Chloroacetic acid (4.00 g, 42.6 mmol), EDC (8.10 g, 42.3 mmol) and N-hydroxysuccinimide (4.86 
g, 42.3 mmol) were stirred in dry DCM (200 ml) for 18 h under argon.  The solvents were 
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removed under reduced pressure and the remaining residue redissolved in DCM (50 ml).  The 
organic phase was washed with water (75 ml), dried over MgSO4 and the solvent removed under 
reduced pressure to yield the product as a white solid (4.61 g, 24.1 mmol, 57%). 
RF = 0.51 (silica, EtOAc); m.p. 102 – 104 °C; 1H-NMR (CDCl3, 400 MHz) δ 4.39 (2H, s, H1), 2.89 
(4H, s, H4); 13C-NMR (CDCl3, 101 MHz) δ  168.5 (C3), 163.6 (C2), 38.2 (C1), 25.9 (C4). 
 
7-Methoxycarbonyl-2-chloromethylcarbonylaminomethyl-1-azaxanthone 
 
7-Methoxycarbonyl-2-aminomethyl-1-azaxanthone (147 mg, 0.459 mmol), 2,5-dioxopyrrolidin-
1-yl-2-chloroacetate (175 mg, 0.917 mmol) and triethylamine (160 µl, 1.15 mmol) were stirred 
in dry THF (20 ml) under argon for 18 h at room temperature.  DCM (20 ml) was added and the 
mixture was washed repeatedly with H2O (5 x 20 ml).  The solvent was removed under reduced 
pressure to leave the desired product as a light yellow powder (101 mg, 0.282 mmol, 61%). 
1H-NMR (CDCl3, 700 MHz) δ 8.99 (1H, d, J = 2.0, H6), 8.70 (1H, d, J = 8.0, H4), 8.43 (1H, dd, J = 8.5, 
2.0, H8), 7.67 (1H, d, J = 8.5, H9), 7.66 (1H, br s, H13), 7.45 (1H, d, J = 8.0, H3), 4.76 (2H, d, J = 5.5, 
H12), 4.17 (2H, s, H15), 3.98 (3H, s, H11); 13C-NMR (CDCl3, 176 MHz) δ 176.7 (C5), 166.5 (C14), 165.7 
(C10), 162.4 (C2), 160.0 (C1’), 158.3 (C9’), 138.6 (C4), 136.4 (C8), 129.3 (C6), 127.2 (C7), 121.5 (C5’), 
119.9 (C3), 119.1 (C9), 115.8 (C4’), 52.7 (C11), 45.0 (C12), 42.7 (C15); MS (ES+) m/z 361.1 [M + H]+; 
HRMS (ES+) (m/z): [M + Na]+ calculated for C17H13ClNaN2O5 383.0419, found 383.0411. 
 
5.2.2 Pendant arms 
(S)-Alanine ethyl ester hydrochloride 
 
(S)-Alanine (1.00 g, 11.2 mmol) was suspended in dry ethanol (40 ml).  Dry HCl (produced by 
dropping conc. H2SO4 onto NaCl and passing through conc. H2SO4) was bubbled through the 
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solution for 3 h, while refluxing under argon.  The mixture was boiled under reflux for a further 
12 h, and the solvent removed under reduced pressure to yield a white solid (1.71 g, 11.2 mmol, 
>99 %). 
m.p. 82 – 83˚C;  1H-NMR (CD3OD, 400 MHz) δ 4.27 (q, 2H, J = 7.0, H2), 4.02 (1H, q, J = 7.0, H4), 1.53 
(d, 3H, J = 7.0, H5), 1.29 (t, 3H, J = 7.0, H1); 13C-NMR (CDCl3, 175 MHz) δ 170.0 (C3), 62.4 (C2), 49.3 
(C4), 16.1 (C5), 14.0 (C1); HRMS (ES+) (m/z): [M + H]+ calculated for C5H12O2N 118.0863, found 
118.0863. 
 
N-Bromoacetyl-(S)-alanine ethyl ester 
 
(S)-Alanine ethyl ester hydrochloride (1.71 g, 11.2 mmol) was stirred under argon at -20 ˚C in 
dry CHCl3 (10 ml).  Triethylamine (2.3 ml, 32.0 mmol) and bromoacetyl bromide (1.6 ml, 17.9 
mmol) were added and the mixture stirred at -20 ˚C for 2 h before being allowed to gradually 
warm to room temperature and stirred for a further 12 h.  The reaction was then halted and 
washed with HCl(aq) (6 M, 30 ml) and then H2O (4 x 25 ml).  The organic phase was dried and the 
product recrystallised from DCM / pet. ether as white crystals (1.88 g, 7.95 mmol, 71 %). 
m.p. 33 – 34 ˚C;  1H-NMR (CDCl3, 400 MHz) δ 7.03 (1H, br s, H6), 4.45-4.65 (1H, m, H4), 4.23 (1H, 
q, J = 7.0, H2), 3.88 (2H, s, H8), 1.45 (3H, d,  J = 7.0, H5), 1.28 (3H, t, J = 7.0, H1); 13C-NMR (CDCl3, 
125 MHz) δ 172.5 (C7), 165.6 (C3), 62.1 (C2), 48.8 (C4), 42.3 (C8), 18.0 (C5), 14.0 (C1); MS (ES+) 
m/z 260.1 [M + Na]+; HRMS (ES+) (m/z): [M + Na]+ calculated for C7H12NO3BrNa 259.9893, found 
259.9895. 
 
N-Bromoacetyl-(S)-glutamic acid diethyl ester 
 
(S)-Glutamic acid diethyl ester hydrochloride (2.40 g, 10.0 mmol) was stirred under argon at -20 
˚C in dry CHCl3 (10 ml).  Triethylamine (3.0 ml, 20.0 mmol) and bromoacetylbromide (1.13 ml, 
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12.5 mmol) were added and the mixture stirred at -20 ˚C for 2 h before being allowed to warm to 
room temperature and stirred for a further 12 h.  The reaction was then halted and washed with 
HCl(aq) (6 M, 30 ml) and then H2O (4 x 20 ml).  The organic phase was dried and the solvent 
removed under reduced pressure to yield the product (2.08 g, 6.38 mmol, 64%). 
1H-NMR (CDCl3, 400 MHz) δ 7.16 (1H, br s, H10), 4.48-4.66 (1H, br m, H4), 4.20 (2H, q, J = 7.0, H2), 
4.12 (2H, q, J = 7.0, H8), 3.86 (2H, s, H12), 2.32-2.42 (2H, m, H6), 2.22 (1H, m5-2.29, H5), 2.00-2.10 
(1H, m, H5’), 1.28 (3H, t, J = 7.0, H9), 1.24 (3H, t, J = 7.0, H1); 13C-NMR (CDCl3, 101 MHz) δ 172.7 
(C11), 171.2 (C7), 165.8 (C3), 62.0 (C2), 60.9 (C8), 52.3 (C12), 30.1 (C4), 28.5 (C6), 26.0 (C5), 14.1 
(C1), 14.0 (C9); MS (ES+) m/z 346.1 and 348.1 [M + Na]+. HRMS (ES+) (m/z): [M + Na]+ calculated 
for C11H19NO53Br 323.0368, found 323.0358. 
 
(S)-2-Bromopentanedioic acid 5-benzyl ester 1-tert-butyl ester 
 
A solution of (S)-2-bromo-pentanedioic acid-5-benzyl ester (1.00g, 3.43 mmol) in tert-butyl 
acetate (15 ml) and HClO4 in H2O (70%, 0.20 mmol) was stirred at rt.  After 16 h, H2O was added 
to the reaction mixture, and the organic phase separated.  The organic phase was washed 
successively with H2O (2 x 25 ml) and 5% aq. Na2CO3 solution (2 x 25 ml) The solvent was 
removed under reduced pressure to yield a pale yellow oil (0.923 g, 2.58 mmol, 81%). 
1H-NMR (CDCl3, 400 MHz) δ  7.30-7.41 (5H, m, H7), 5.11 (2H, s, H6), 4.30 (1H, dd, J = 6.0, 2.0, H2), 
2.56-2.64 (2H, m, H4), 2.33-2.41 (1H, m, H3), 1.47 (9H, s, H9);  13C-NMR (CDCl3, 126 MHz) δ 173.1 
(C5), 169.5 (C1), 136.2 (C7(q)), 128.9 (C7), 128.8 (C7), 128.3 (C7), 82.8 (C8), 66.9 (C6), 47.1 (C2), 31.8 
(C4), 30.0 (C3), 27.8 (C9); HRMS (ES+) m/z: [M + H]+ calculated for C21H16BrO4 379.0334, found 
379.0345. 
(S)-2-Bromopentanedioic dimethyl ester 
 
Sodium nitrite (5.50 g, 80.1 mmol) dissolved in H2O (50 ml) was added dropwise to a stirred 
solution of sodium bromide (16.0 g, 156 mmol) and S-glutaric acid 5 methyl ester (6.41 g, 39.8 
mmol) in 1M HBr (250 ml), cooled at -5 ˚C.  After 20 h, conc. H2SO4 (1 ml) was added dropwise to 
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the reaction mixture, which was subsequently extracted with diethyl ether (2 x 250 ml).  The 
combined organic extracts were washed with brine (2 x 200 ml), dried over MgSO4, filtered and 
the solvent removed under reduced pressure.  The crude material was dissolved in anhydrous 
MeOH (50 ml) and conc. H2SO4 (0.5 ml) was added.  The solution was stirred at 50 ˚C under 
argon for 4 h.  After cooling, the solvent was removed under reduced pressure and the crude 
material purified by column chromatography (silica, 100% toluene  25% DCM) to yield a 
colourless oil (6.19 g, 25.9 mmol, 65%). 
1H-NMR (CDCl3, 400 MHz) δ 4.35 (1H, t, J = 8.0, H2), 3.76 (3H, s, H7), 3.66 (3H, s, H6), 2.41.2.49 
(2H, m, H4), 2.28-2.44 (1H,  m, H3), 2.19-2.31 (1H, m, H3’); 13C-NMR (CDCl3, 101 MHz) δ 172.5 
(C5), 169.8 (C1), 53.1 (C7), 51.9 (C6), 44.6 (C2), 31.3 (C4), 29.8 (C3); HRMS (ES+) m/z [M + H]+ 
calcualted for C7H11O4Na79Br 260.9738, found 260.9740. 
 
5.2.3 [Ln·L1]3+ 
1,7-Bis(benzyloxycarbonyl)-1,4,7,10-tetraazacyclododecane119 
 
Disodium hydrogen phosphate (14.0 g, 98.6 mmol) was added to a solution of 1,4,7,10-
tetraazacyclododecane (5.00 g, 29.0 mmol) in purite water : dioxane (5 : 2, 70 ml).  The pH was 
adjusted to 2.5 by the addition of conc. HCl.  Benzyl chloroformate (10.0 ml, 70.1 mmol) was 
dissolved in dioxane (20 ml) and added dropwise to the mixture over 2 h at room temperature, 
followed by stirring for a further 18 h.  A colourless solution was formed containing a white 
precipitate.  Solvent was removed under reduced pressure leaving a viscous white residue.  This 
was extracted with diethyl ether (3 x 50 ml), removing side products.  The aqueous phase was 
further extracted with DCM (3 x 50 ml).  The organic phase was dried under reduced pressure to 
yield a colourless viscous oil.  The oil was redissolved in DCM (5 ml) followed by precipitation 
via the addition of diethyl ether (60 ml) and sonication.  The product was obtained by filtration 
as a coarse white powder (9.68 g, 22.0 mmol, 76%). 
 1H-NMR (CDCl3, 400 MHz) δ 7.32 – 7.39 (10H, m, H3), 5.17 (4H, s, H2), 2.85 – 3.90 (16H, br, H4), 
1.66 (2H, br, s, H5); 13C-NMR (CDCl3, 100 MHz) 156.3 (C1), 136.0 (C3q), 128.9 (C3q), 129.0 (C3), 
1289 (C3),  128.7 (C3), 128.6 (C3), 128.4(C3), 128.3(C3), 68.0(C4), 67.9(C4), 50.8(C4), 50.6(C4), 
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50.4(C4), 50.0(C4), 49.8(C4), 49.3(C4), 49.2(C4);  HRMS (ES+) (m/z): [M + H]+ calculated for 
C24H33N4O4 441.2502, found 441.2504. 
 
4,10-Bis-[((S)-1-phenyl-ethylcarbamoyl)-methyl]-1,4,7,10-tetraazacyclododecane-1,7-
dicarboxylic acid dibenzyl ester134 
 
1,7-Bis(benzyloxycarbonyl)-1,4,7,10-tetraazacyclododecane (1.82 g, 4.14 mmol) was dissolved 
in dry MeCN (30 ml) and 2-chloro-N-[(S)-1phenylethyl]ethanamide (2.39 g, 12.1 mmol) added.  
Cs2CO3 (2.17 g, 6.66 mmol) was added and the mixture stirred at 70 ˚C under argon for 24 h.  The 
reaction was allowed to cool to room temperature and the solvent removed under reduced 
pressure.  DCM (25 ml) was added and the mixture washed with water (3 x 25 ml).  The solvent 
was again removed under reduced pressure.  The residue was sonicated in diethyl ether (2 x 25 
ml) and the resulting solution centrifuged.  The precipitated solid was isolated by column 
chromatography on silica gel (DCM  6% MeOH), as a brown glassy oil (2.40 g, 3.14 mmol, 
71%). 
1H-NMR (CDCl3, 400 MHz) δ 7.65 (2H, s br, H6), 7.15 - 7.40 (20H, m, H3,10), 4.99-5.19 (2H, m, H7), 
4.97 (4H, s br, H2), 3.28 – 3.61 (8H, br m, H11), 3.08 (4H, s, H4), 2.56 – 2.71 (8H, br m, H11), 1.35-
1.45 (6H, m, H8); 13C-NMR (CDCl3, 101 MHz) δ 170.0 (C5), 156.7 (C1), 143.5 (C9q), 136.5 (C3q), 
128.7(C3,10), 128.3(C3,10), 128.3(C3,10), 127.4(C3,10), 127.3(C3,10), 126.2 (C3,10), 67.4 (C2), 59.1 (C4), 
54.4 - 56.3 (C11), 48.7 (C7), 47.7 - 48.9 (C11), 22.0 (C8); MS (ES+) m/z 763.6 [M + H]+; HRMS (ES+) 
(m/z): [M + Na]+ calculated for C44H54O6N6Na 785.4003, found 785.3975. 
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N-((S)-1-Phenyl-ethyl)-2-(7-[((S)-1-phenyl-ethylcarbamoyl)-methyl]-1,4,7,10-tetraaza-
cyclododec-1-yl)-acetamide134 
 
4,10-Bis-[((S)-1-phenyl-ethylcarbamoyl)-methyl]-1,4,7,10-tetraazacyclododecane-1,7-
dicarboxylic acid dibenzyl ester (2.35 g, 3.08 mmol) was dissolved in EtOH (40 ml) and Pd/C  
(50 mg) and ammonium formate (1.20 g, 19.0 mmol) were added.  The mixture was heated 
under reflux for 18 h and then allowed to cool to room temperature.  Solvent was removed 
under reduced pressure and the residue dissolved in DCM (100 ml).  This was washed 
repeatedly with water, dried over MgSO4 and the solvent removed under educed pressure to 
leave a glassy white solid (1.15 g, 2.32 mmol, 75%). 
1H-NMR (CD3OD, 500 MHz) δ 7.20 - 7.36 (10H, m, H7), 4.99-5.11 (2H, m, H4), 3.38-3.46 (4H, br m, 
H1), 2.83 - 3.22 (16H, br, H8), 1.46 (6H, d, J = 7.0, H5); 13C-NMR (CD3OD, 126 MHz) δ 172.5 (C2), 
145.7 (C7), 130.7(C7), 128.9(C7), 127.9 (C7), 57.0 (C1), 52.4 (C4), 51.0 (C8),  50.6 (C8),  45.0 (C8), 
23.5 (C5); MS (ES+) m/z 495.3 [M + H]+; HRMS (+m/z): [M + H]+ calculated for C28H43O2N6 
495.3442, found 495.3449. 
 
4,10-Bis[((S)-1-phenyl-ethylcarbamoyl)-methyl]-1,4,7,10-tetraazacyclododecane-1-
carboxylic acid tert-butyl ester134 
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N-((S)-1-Phenyl-ethyl)-2-(7-[((S)-1-phenyl-ethylcarbamoyl)-methyl]-1,4,7,10-tetraaza-
cyclododec-1-yl)-acetomide (0.812 g, 1.67 mmol) and di-tert-butyl dicarbonate (0.363 mg, 1.67 
mmol) were stirred, under argon, in CHCl3 at 30 °C for 18 h.  Solvent was then removed under 
reduced pressure and the product purified by column chromatography on silica gel (DCM  3% 
MeOH) to yield a viscous oil (239 mg, 0.407 mmol, 24%). 
1H-NMR (CDCl3, 500 MHz) δ 7.81 (1H, br s, H12), 7.15 - 7.35 (10H, m, H7), 5.01-5.15 (2H, m, H4), 
2.91-2.13 (4H, m, H1), 2.50 - 3.40 (16H, br m, H11), 1.57 (6H, d, J = 7.0, H5), 1.38-1.41 (9H, m, H10); 
13C-NMR (CDCl3, 126 MHz) δ 170.4 (C2), 156.6 (C8), 143.7 (C7q), 128.8 (C7), 127.4 (C7), 126.6 (C7), 
80.3 (C10), 59.4 (C1), 49.0 – 54.1 (C11), 48.8 (C4), 28.6 (C10), 21.9 (C5); MS (ES+) +m/z 595.4 [M + 
H]+; HRMS (ES+) (m/z): [M + H]+ calculated for C33H51O4N6 595.3966, found 595.3962. 
 
2-[(2-(7-tert-Butoxycarbonyl-4,10-bis-[((S)-1-phenyl-ethylcarbamoyl)-methyl]-1,4,7,10-
tetraaza-cyclododec-1-yl)-acetylamino)-methyl]-10-oxo-10H-9-oxa-1-aza-anthracene-6-
carboxylic acid methyl ester2 
 
4,10-Bis[((S)-1-phenyl-ethylcarbamoyl)-methyl]-1,4,7,10-tetraazacyclododecane-1-carboxylic 
acid tert-butyl ester (90 mg, 0.150 mmol) was combined with 7-methoxycarbonyl-2-
chloromethylcarbonylaminomethyl-1-azaxanthone (54 mg, 0.150 mmol) and DIPEA (53 μl, 
0.300 mmol) in dry MeCN (10 ml) under argon.  The mixture was stirred at 60 ˚C for 24 h.  A 
further addition of DIPEA (25 μl, 0.150 mmol) was made at this time-point and the mixture 
stirred for a further 18 h.  Solvent was removed under reduced pressure and the residue purified 
by column chromatography (silica, DCM  5% MeOH) to yield a glassy orange solid (91 mg, 99 
µmol, 66%). 
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1H-NMR (CDCl3, 500 MHz) δ 8.95 (1H, d, J = 2.5, H6), 8.62 (1H, d, J = 8.0, H4), 8.41 (1H, dd, J = 8.5, 
2.0, H8), 8.23 (1H, br s, H13), 7.58 (1H, d, J = 8.5, H9), 7.39 (1H, d, J = 8.0, H3 ), 7.18 - 7.27 (10H, m, 
H22), 5.03-5.15 (2H, m, H19), 4.54 (2H, d, J = 5.0, H12), 3.97 (3H, s, H11), 2.40 - 3.16 (22H, br m, 
H15,16,26), 1.41 (6H, d, J = 6.5, H20), 1.39 (9H, s, H25); 13C-NMR (CDCl3, 126 MHz,) δ 176.8 (C5), 171.3 
(C14), 170.4 (C17), 165.8 (C10), 163.9 (C2), 160.0 (C1’), 158.3 (C9’), 156.3 (C23), 143.6, 143.1 (C21), 
138.2 (C4), 136.4 (C8), 129.3 (C6), 126.4 – 129.0 (C22), 127.2 (C7), 121.6 (C5’), 120.0 (C3), 119.0 
(C9), 115.5 (C4’), 80.1 (C24), 60.0 (C26), 59.3 (C26), 54.4 (C26), 53.3 (C26), 52.8 (C11), 48.6 (C19), 47.7 
(C15,16), 44.7 (C12), 28.6 (C4), 21.6 (C25), 21.4 (C20); MS(ES+) m/z 919.7 [M + H]+; HRMS (ES+) m/z: 
[M + H]+ found 919.4720 C50H63O9N8 requires 919.4713. 
 
2-[(2-(4,10-Bis-[((S)-1-phenyl-ethylcarbamoyl)-methyl]-1,4,7,10-tetraazacyclododec-1-
yl)acetylamino)-methyl]-10-oxo-10H-9-oxa-1-aza-anthracene-6-carboxylic acid methyl 
ester, (L1)2 
 
2-[(2-(7-tert-Butoxycarbonyl-4,10-bis-[((S)-1-phenyl-ethylcarbamoyl)-methyl]-1,4,7,10-
tetraaza-cyclododec-1-yl)-acetylamino)-methyl]-10-oxo-10H-9-oxa-1-aza-anthracene-6-
carboxylic acid methyl ester (85.0 mg,) in DCM : TFA (50 : 50, 2 ml) was stirred in a sealed flask 
for 12 h yielding a yellow solution. Solvent was then removed under reduced pressure to yield 
the a glassy yellow solid in quantitative yield which was used immediately in the next step, 
having confirmed removal of the Boc-protecting group by mass spectrometry and 1H-NMR 
spectroscopy. 
1H-NMR (CDCl3, 400 MHz) δ 9.31 (1H, s, H13), 8.91 (1H, d, J = 1.5, H6), 8.58 (1H, d, J = 8.0, H4), 8.39 
(1H, dd, J = 8.5, 1.5, H8), 8.10 (2H, br s, H18), 7.57 (1H, d, J = 8.5, H9), 7.38 (1H, d, J = 8.0, H3), 7.15 - 
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7.23 (10H, m, H22), 4.90 (2H, br m, H19), 4.55 (2H, br m, H12), 3.96 (3H, s, H11), 2.85 - 3.65 (22H, br 
m, C16,26), 1.40 (6H, s, J = 6.5 H20); MS (ES+) m/z 819 .5 [M + H]+. 
 
[Eu·L1]Cl3 
 
2-[(2-(4,10-Bis-[((S)-1-phenyl-ethylcarbamoyl)-methyl]-1,4,7,10-tetraazacyclododec-1-
yl)acetylamino)-methyl]-10-oxo-10H-9-oxa-1-aza-anthracene-6-carboxylic acid methyl ester 
(20.1 mg, 22.6 μmol) was added to Eu(OTf)3 (16.5 mg, 27.8 μmol) and dissolved in MeCN (1 ml).  
The reaction stirred for 48 h at 75 ˚C.  The reaction was cooled to room temperature and the 
solvents removed under reduced pressure. The remaining residue was dissolved in dry MeCN 
(0.1 ml) and the mixture dropped onto anhydrous Et2O (5 ml) which resulted in the 
precipitation of the title compound as a triflate salt. The precipitate was centrifuged and 
dissolved in aqueous MeOH : H2O (50 : 50, 3 ml).  The pH was then adjusted carefully to 10 by 
addition of conc. NaOH solution to remove the excess Eu as Eu(OH)3 resulting in a white 
precipitate, which was removed by centrifugation.  The pH was adjusted back to neutral and the 
mixture lyophlised to give a bright yellow solid which was loaded onto a DOWEX 1-X8(Cl) anion 
exchange resin.  The column was eluted with water  10% NH4OH.  The fractions were 
combined and lyophilized to yield the Eu-complex as its chloride salt as a light yellow glassy 
solid (10.8 mg, 11.1 μmol, 49%). 
λabs(H2O): 332 nm; HRMS (ES+) m/z: [M + 2Na]+ found 1017.3122 C45H55151EuN8O7Na2 requires 
1017.3107.; tR = 10.0 min; τH2O = 0.26  ms, τD2O = 0.64 ms, q =2.2 . 
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[Tb·L1]Cl3 
The complex was prepared using an analogous method as for [Eu·L1]Cl3 using L1 (20.1 mg, 22.6 
µmol) and Tb(OTf)3 (16.9 mg, 27.8 µmol) to yield the terbium complex as its chloride salt (16.6 
mg, 17.0 μmol, 75%). 
λabs(H2O): 332 nm; HRMS (ES+) m/z: [M + 2Na]+ found 1023.3179 C45H55TbN8O7Na2 requires 
1023.3164.; tR = 10.0 min; τH2O = 1.15  ms, τD2O = 2.50 ms, q =2.1 . 
 
5.2.4 [Ln·L2]3+ and [Ln·L3]  
 (SS)-1,7-Bis(benzyloxycarbonyl)-4,10-bis(ethyl-N-acetyl-S-alanine)-1,4,7,10-
tetraazacyclododecane 
 
1,7-Bis(benzyloxycarbonyl)-1,4,7,10-tetraazacyclododecane (1.82 g, 4.13 mmol) was dissolved 
in dry MeCN (20 ml) and bromoacetyl-(S)-alanine ethyl ester (2.07 g, 8.69 mmol) was added.  
K2CO3 (1.4 g, 10.2 mmol) was added and the mixture stirred at 60 ˚C under argon for 2 days.  The 
reaction was allowed to cool to room temperature and filtered.  Solvent was removed under 
reduced pressure.  The product was isolated by column chromatography (silica, DCM  4% 
MeOH), as a light orange glassy oil (2.92 g, 3.87 mmol, 94%). 
1H-NMR (CDCl3, 700 MHz) δ 7.50 – 7.61 (2H, br s, H6), 7.27 7.37 (10H, br m, H3), 5.05 (4H, s, H2), 
4.31-4.52 (2H, br m, H7), 4.09 (4H, q, J = 7.0, H10), 2.76 – 3.47 (16H, br, H4,12), 1.21-1.41 (3H, br m, 
H8), 1.21 ( 6H, t, J = 7.0, H11); 13C-NMR (CDCl3, 176 MHz) δ 173.9 (C9), 170.9 (C5), 157.0 (C1), 
136.7 (C3), 128.8 (C3), 128.4 (C3), 67.6 (C10), 61.5 (C4), 55.9 (C12), 54.9 (C12), 48.1 (C7), 18.1 (C8), 
14.4 (C10); MS (ES+) m/z 755.4 [M + H]+; HRMS (ES+) (m/z): [M + H]+ calculated for C38H55N6O10 
755.3980, found 755.3967. 
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 (SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-1,4,7,10-tetraazacyclododecane  
 
(SS)-1,7-Bis(benzyloxycarbonyl)-4,10-bis(ethyl-N-acetyl-S-alanine)-1,4,7,10-
tetraazacyclododecane (0.973 g, 1.35 mmol) was dissolved in MeOH (20 ml) and Pd(OH)2/C (Pd 
content 10%) (75 mg) added.  The mixture was shaken in a Parr hydrogenator flask at 40 psi H2 
for 3 days.  The resulting mixture was filtered through celite leaving a clear solution which was 
dried under reduced pressure to yield a yellow viscous oil (0.400 g, 0.823 mmol, 61%). 
1H-NMR (CDCl3, 400 MHz) δ 7.61-7.80 (2H, br m, H10), 7.44.7.60 (2H, br m, H3), 4.50-4.58 (2H, m, 
H4), 4.11-4.22 (4H, m, H7), 3.13-3.33 (4H, m, H1), 2.60 - 2.85 (16H, br, H9), 1.35-1.39 (6H, m, H8), 
1.21-1.30 (6H, m, H5); 13C-NMR (CDCl3, 101 MHz) δ 173.1 (C6), 171.0 (C2), 62.1 (C7), 61.4 (C1), 
53.4 (C9), 52.5 (C9), 48.2 (C4), 18.5 (C6), 14.4 (C8); MS (ES+) m/z 487.4 [M + H]+; HRMS (ES+) 
(m/z): [M + H]+ calculated for C22H43O6N6 487.3239, found 487.3248. 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-4-carboxylic acid-tert-butyl-ester-1,4,7,10-
tetraazacyclododecane 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-1,4,7,10-tetraazacyclododecane (0.812 g, 1.67 mmol) and 
di-tert-butyl dicarbonate (0.363 mg, 1.67 mmol) were stirred, under argon, in CHCl3 at 30 °C for 
18 h.  Solvent was then removed under reduced pressure and the product purified by column 
chromatography (alumina, DCM  3% MeOH) to yield a light yellow glassy oil (239 mg, 0.407 
mmol, 24%). 
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RF = 0.23 (alumina, DCM : 8% MeOH); 1H-NMR (CDCl3, 700 MHz) δ 7.47 (2H, br s, H3), 4.58 (2H,  
q, J = 7.5, H4), 4.16 (4H, q, J = 7.5, H7), 3.16-3.39 (4H, m, H1), 2.80 - 3.40 (16H, br, H12), 1.42 (9H, s, 
H11), 1.40 (6H, t, J = 7.5, H5), 1.24 (6H, t, J = 7.5, H8); 13C-NMR (CDCl3, 126 MHz) δ 173.2 (C6), 
170.5 (C2), 156.5 (C9), 80.4 (C10), 61.9 (C7), 59.7 (C1), 55.3 (C12), 48.2 (C12), 48.0 (C4), 28.9 (C11), 
18.3 (C5), 14.5 (C8); MS (ES+) m/z 587.5 [M + H]+; HRMS (ES+) (m/z): [M + H]+ calculated for 
C27H51N6O8 587.3758, found 587.3768. 
Tert-butyl 4,10-bis( [(2S)-1-ethoxy-1-oxopropan-2-yl]carbamoyl)methyl)-7-[( [7-
(methoxycarbonyl)-5-oxo-5H-chromeno[2,3-b]pyridin-2-yl]methyl)carbamoyl)methyl]-
1,4,7,10-tetraazacyclododecane-1-carboxylate 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-4-carboxylic acid tert-butyl ester-1,4,7,10-
tetraazacyclododecane (98.7 mg, 0.168 mmol) was combined with 7-methoxycarbonyl-2-
chloromethylcarbonylaminomethyl-1-azaxanthone (16.8 mg, 46.6 μmol) and DIPEA (40 μl, 
0.230 mmol) in dry MeCN under argon.  The mixture was stirred at 60 ˚C for 24 h.  A further 
addition of 7-methoxycarbonyl-2-chloromethylcarbonylaminomethyl-1-azaxanthone (19.0 mg, 
52.7 μmol) and DIPEA (50 μl, 0.287 mmol) was made at this time-point and the mixture stirred 
for a further 18 h.  Solvent was then removed under reduced pressure and the residue purified 
by column chromatography (silica, DCM  7% MeOH) to yield a glassy orange solid (63.9 mg, 
70.2 μmol, 71%). 
1H-NMR (CDCl3, 500 MHz) δ  11.21 (2H, br s, H18), 8.96 (1H, d, J = 2.5, H6), 8.64 (1H, d, J = 8.0, H4), 
8.41 (1H, dd, J = 9.0, 2.5, H8), 7.60 (1H, d, J = 9.0, H9), 7.43 (1H, d, J = 8.0, H3), 4.71 (2H, d, J = 5.0, 
H12), 4.50 (2H, p, J = 7.0, H19), 4.12 (4H, q, J = 7.0, H22), 3.96 (3H, s, H11), 3.55 - 2.60 (22H, br. m, 
H15,16,27), 1.53 (6H, t, J = 7.5, H20), 1.39 (9H, s, H26), 1.37 (6H, t, J = 7.0, H23); 13C-NMR (CDCl3, 126 
MHz) δ 176.8 (C5), 173.1 (C14), 165.7 (C17), 160.0 (C1’), 158.2 (C9’), 155.8 (C24), 138.2 (C4), 136.3 
(C8), 129.3 (C6), 127.0 (C7), 121.5 (C5’), 119.7 (C3), 118.9 (C9), 115.4 (C4’), 61.6 (C22), 53.7 (C27), 
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52.7 (C11), 47.4 (C16), 46.7 (C27), 44.8 (C12), 42.0 (C19), 28.6 (C25), 18.8 (C26), 14.3 (C23), 12.2 (C20); 
HRMS (ES+) (m/z): [M + H]+ calculated for C44H63N8O13 911.4515, found 911.4518. 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-4-[7-methoxycarbonyl-2-
chloromethylcarbonylmethyl-1-azaxanthone]-1,4,7,10-tetraazacyclododecane, (L2) 
 
Tert-butyl 4,10-bis([(2S)-1-ethoxy-1-oxopropan-2-yl]carbamoyl}methyl)-7-[([7-
(methoxycarbonyl)-5-oxo-5H-chromeno[2,3-b]pyridin-2-yl]methyl}carbamoyl)methyl]-
1,4,7,10-tetraazacyclododecane-1-carboxylate (98.7 mg, 0.168 mmol) in DCM : TFA (50 : 50, 2 
ml) was stirred in a sealed flask for 12 h yielding a yellow solution. Solvent was then removed 
under reduced pressure to yield a glassy yellow solid which was used immediately in the next 
step, after verifying removal of the Boc-protecting group by mass spectrometry. MS (ES+) m/z 
811.4 [M + H]+.  
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[Eu·L2]Cl3, 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-4-[7-methoxycarbonyl-2-chloromethylcarbonylmethyl-1-
azaxanthone]-1,4,7,10-tetraazacyclododecane (22.4 mg, 23.3 μmol) was added to Eu(OTf)3 (19 
mg, 31.9 μmol) and dissolved in MeCN (1 ml).  The reaction was stirred for 48 h at 75 ˚C.  The 
reaction was cooled to room temperature and the solvents removed under reduced pressure. 
The remaining residue was dissolved in dry MeCN (0.1 ml) and the mixture dropped onto 
anhydrous Et2O (5 ml) which resulted in the precipitation of the triflate salt. The precipitate was 
centrifuged and dissolved in aqueous MeOH : H2O (50 : 50, 3 ml).  The pH was then adjusted 
carefully to 10 by addition of conc. NaOH solution to remove any excess Eu as Eu(OH)3, resulting 
in a white precipitate which was removed by centrifugation.  The pH was adjusted back to 
neutral and the mixture lyophilised to give a bright yellow solid which was loaded onto a 
DOWEX 1-X8(Cl) anion exchange resin.  The column was eluted with water   10% NH4OH.  The 
fractions were combined and lyophilized to yield the chloride salt as a light yellow glassy solid 
(14.0 mg, 14.5 μmol, 62%). 
HRMS (ES+) (m/z): [M + HCO2-]2+ calculated for C40H57153EuN8O13 504.1550 found 504.1538; tR = 
9.4 min; τH2O = 0.26 ms, τD2O = 0.58 ms; q = 2.0. 
 
[Tb·L2]Cl3, 
The complex was prepared by an analogous method as for [Eu.L2]Cl3, using L2 (11.2 mg, 11.7 
μmol) and Tb(OTf)3 (8.3 mg, 14.0 μmol) to yield the Tb-complex as its chloride salt (9.0 mg, 9.3 
μmol, 79%). 
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HRMS (ES+) (m/z): [M + 2Na]2+ calculated for C40H57TbNa2N8O13 507.1571 found, 507.1540; tR = 
9.5 min; τH2O = 1.11 ms, τD2O = 2.44 ms; q = 2.2. 
 
2- [[2-(4- [(1-Carboxyethyl)carbamoyl]methyl]-10[[(carboxymethyl)carbamoyl]methyl]-
1,4,7,10-tetraazacyclododecan-1-yl)acetamido]methyl}-5-oxo-5H-chromeno[2,3-
b]pyridine-7-carboxylic acid, (H3L3) 
 
Aqueous KOD solution (1 ml, 0.1 M) was added to (SS)-1,7-bis(ethyl-N-acetyl-S-alanine)-4-[7-
methoxycarbonyl-2-chloromethylcarbonylmethyl-1-azaxanthone]-1,4,7,10-
tetraazacyclododecane (30 mg, 40.0 µmol).  The reaction mixture was stirred under argon at 
room temperature and progress monitored by 1H-NMR, observing the formation of ethanol and 
methanol solvent peaks, with the corresponding elimination of the methyl- and ethyl-ester 
peaks.  After 3 h, the pH of the mixture was decreased to pH 6.5 with conc. HCl(aq) and the 
solution loaded onto a DOWEX 50X4-100 strong cation exchange resin.  The column was eluted 
with 10% NH4OH and the fractions containing product lyophilized to yield the title compound as 
a orange glassy solid which was immediately used in the complexation reactions (16.1 mg, 21.6 
µmol, 54%). 
1H-NMR (D2O, 400 MHz) δ [signals all quite broad], 8.71-8.94 (1H, br m, H6), 8.48-8.64 (1H, br d, 
H4), 8.28-8.41 (1H, br m, H8), 7.55-7.85 (1H,br  m, H9), 7.32-7.45 (1H,br  m, H3), 4.50-4.70 (2H, br 
m, H12), 4.32-4.44 (2H, br m, H19), 3.55 - 2.60 (22H, br m, H15,16,24), 1.53 (6H, br t, J = 7.5, H20). 
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[Eu·L3] 
 
 
2- [[2-(4- [(1-Carboxyethyl)carbamoyl]methyl]-10[[(carboxymethyl)carbamoyl]methyl]-
1,4,7,10-tetraazacyclododecan-1-yl)acetamido]methyl)-5-oxo-5H-chromeno[2,3-b]pyridine-7-
carboxylic acid (12.1 mg, 16.0 µmol) was added to Eu(OAc)3 (1.2 eq, 19.2 µmol) and dissolved in 
3 ml H2O : MeOH (7 : 1).  The pH was carefully adjusted to 5 by the addition of acetic acid and the 
reaction stirred for 48 h at 75 ˚C.  The reaction was cooled to room temperature and the pH 
carefully adjusted to 10 by the addition of  conc. NaOH solution, to precipitate excess europium 
as Eu(OH)3 which was removed by centrifugation. The pH was adjusted back to 6.5 with acetic 
acid and the sample lyophilized to yield the product (2.5 mg, 2.8 μmol, 18%). 
HRMS (ES+) (m/z): [M + H]+ calculated for C34H42151EuN8O11 891.2185 found, 891.2205; tR = 8.8 
min; τH2O = 0.26 ms, τD2O = 0.67 ms; q = 2.3. 
 
 [Tb.L3] 
The complex was prepared using an analogous method as for [Eu.L3]Cl3 using L3 (4.0 mg, 5.4 
µmol) and Tb(OAc)3 (2.3 mg, 6.5 µmol) to yield the Tb-complex as its chloride salt (1.0 mg, 1.1 
μmol, 20%) 
HRMS (ES+) (m/z): [M + H]+ calculated for C34H42TbN8O11 896.2227, found 896.2270; tR = 8.8 
min; τH2O = 1.11 ms, τD2O = 2.55 ms; q = 2.3. 
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5.2.5 [Ln·L4]3+ and [Ln·L4]- 
(SS)-1,7-Bis(benzyloxycarbonyl)-4,10-bis(diethyl-N-acetyl-S-glutamate)-1,4,7,10-
tetraazacyclododecane 
 
1,7-Bis(benzyloxycarbonyl)-1,4,7,10-tetraazacyclododecane (1.35 g, 3.00 mmol) was dissolved 
in dry MeCN (50 ml) and N-bromoacetyl-(S)-glutamic acid diethyl ester (2.08 g, 6.38 mmol) was 
added.  K2CO3 (2.50 g, 18.0 mmol) was added and the mixture stirred at 60 ˚C under argon for 3 
days.  The reaction was allowed to cool to room temperature and filtered.  Solvent was removed 
under reduced pressure.  The desired product was isolated by column chromatography (silica, 
DCM  3% MeOH) as a glassy orange solid (1.08 g, 1.55 mmol, 81%). 
1H-NMR (CDCl3, 400 MHz) δ 7.63 (2H, br s, H3), 7.27 – 7.36 (10H, m, H15), 5.10 (4H, q, J = 7.0, H14), 
4.53 (2H,  br s, H4), 4.15 (4H, q, J = 7.0, H6), 4.09 (4H, q, J = 7.0, H11), 3.30 – 3.56 (8H, br, H16), 2.73 
– 3.29 (4H, br, H1), 2.72 – 2.96 (8H, br, H16), 2.40 (4H, br, H9), 2.19 (2H, br, H8), 2.03 (2H, br, H8’), 
1.25 (6H, t, J = 7.0, H12), 1.22 (6H, t, J = 7.0, H7); 13C-NMR (CDCl3, 101 MHz) δ 172.9 (C10), 172.8 
(C5), 172.0 (C2), 157.0 (C13), 136.7 (C15q), 128.7 (C15), 128.3 (C15), 128.3 (C15), 67.5 (C14) 61.7 (C6), 
60.8 (C11), 55.1 (C16), 55.2 (C1), 51.7 (C4), 47.9 (C16), 30.7 (C9), 27.3 (C8), 14.3 (C7), 14.3 (C11); MS 
(ES+) m/z 927.9 [M + H]+; HRMS (ES+) (m/z): [M + H]+ calculated for C46H67N6O14 927.4715, 
found 927.4710. 
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(SS)-1,7-Bis(diethyl-N-acetyl-S-glutamate)-1,4,7,10-tetraazacyclododecane 
 
(SS)-1,7-Bis(benzyloxycarbonyl)-4,10-bis(ethyl-N-acetyl-S-glutamate)-1,4,7,10-
tetraazacyclododecane (1.72 g, 1.92 mmol) was dissolved in MeOH (20 ml) and Pd(OH)2/C (Pd 
content 10%) (75 mg) added.  The mixture was shaken in a Parr hydrogenator flask at 40 psi H2 
for 3 days.  The resulting mixture was filtered through celite leaving a clear solution which was 
dried under reduced pressure to a light yellow oil (1.08 g, 1.55 mmol, 81%). 
1H-NMR (CDCl3, 500 MHz) δ 8.65 (2H, br s, H14), 7.88 (2H, br d, H3), 4.57 (2H,  m, H4), 4.15 (4H, 
m, H6), 4.09 (4H, q, J = 7.0, H11), 3.34 (2H, d, J = 16.0 H1), 3.26 (2H, d, J = 16.0 H1’), 2.70 - 3.00 
(16H, br m, H13), 2.40 (4H, m, H9), 2.19 (2H, m, H8), 1.99 (2H, m, H8’), 1.24 (6H, t, J = 7.5, H12), 1.22 
(6H, t, J = 7.5, H7); 13C-NMR (CDCl3, 126 MHz) δ  172.9 (C10), 172.2 (C5), 171.7 (C2), 61.7 (C6), 60.5 
(C11), 58.3 (C1), 51.2 – 53.4 (C13), 52.0 (C4), 30.5 (C9), 26.9 (C8), 14.1 (C7), 14.0 (C12); HRMS (ES+) 
(m/z): [M + H]+ calculated for C30H55N6O10 659.3980, found 659.3984. 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-glutamate)-4-carboxylic acid-tert-butyl-ester-1,4,7,10-
tetraazacyclododecane 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-glutamate)-1,4,7,10-tetraazacyclododecane (0.483 g, 0.694 mmol) 
and di-tert-butyl dicarbonate (0.150 mg, 0.687 mmol) were stirred, under argon, in CHCl3 at 30 
°C for 18 h.  Solvent was removed under reduced pressure and the product purified by column 
chromatography (alumina, DCM  1% MeOH) to yield a glassy orange solid. (224 mg, 0.295 
mmol, 43%). 
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RF = 0.28 (alumina, DCM : 3% MeOH); 1H-NMR (CDCl3, 500 MHz) δ 7.75 (1H, br s, H17), 7.63 (2H, 
br d, H3), 4.58 (2H,  m, H4), 4.17 (4H, m, H6), 4.12 (4H, q, J = 7.0, H11), 3.51 (2H, d, J = 15.5 H1), 
3.28 (2H, d, J = 15.5 H1’), 2.80 - 3.40 (16H, br m, H16), 2.45 (4H, t, J = 7.5, H9), 2.22 (2H, m, H8), 
2.01 (2H, m, H8’), 1.46 (9H, s, H15), 1.27 (6H, t, J = 7.5, H7), 1.25 (6H, t, J = 7.5, H12); 13C-NMR 
(CDCl3, 126 MHz) δ  173.3 (C10), 172.2 (C5), 171.0 (C2), 155.0 (C13), 80.7 (C14), 61.9 (C6), 60.8 
(C11), 58.6 (C1), 55.4 (C16), 52.9 (C16), 52.0 (C4), 51.2 (C16), 30.9 (C9), 28.7 (C15), 26.9 (C8), 14.4 
(C7), 14.3 (C11); HRMS (ES+) m/z: [M + H]+ calculated for C35H63N6O12 759.4504, found 759.4517. 
 
Tert-butyl 4,10-bis( [(2S)-1-ethoxy-1-oxopropan-2-yl]carbamoyl}methyl)-7-[( [7-
(methoxycarbonyl)-5-oxo-5H-chromeno[2,3-b]pyridin-2-yl]methyl)carbamoyl)methyl]-
1,4,7,10-tetraazacyclododecane-1-carboxylate, (38) 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-glutamate)-4-carboxylic acid tert-butyl ester-1,4,7,10-
tetraazacyclododecane (38.0 mg, 50.0 µmol) was combined with 7-methoxycarbonyl-2-
chloromethylcarbonylaminomethyl-1-azaxanthone (18.0 mg, 49.9 μmol) and DIPEA (40 μl, 
0.230 mmol) in dry MeCN under argon.  The mixture was stirred at 60 ˚C for 24 h.  Solvent was 
removed under reduced pressure and the residue purified by column chromatography (silica, 
DCM  7 % MeOH) to yield a glassy orange solid (63.9 mg, 70.2 μmol, 71%).  
1H-NMR (CDCl3, 500 MHz) δ  11.21 (2H, br s, H13), 9.08 (1H, br s, H13), 8.96 (1H, d, J = 2.5, H6), 
8.64 (1H, d, J = 8.0, H4), 8.41 (1H, dd, J = 9.0, 2.5, H8), 7.60 (1H, d, J = 9.0, H9), 7.43 (1H, d, J = 8.0, 
H3), 4.71 (2H, d, J = 5.0, H12), 4.50 (2H, p, J = 7.0, H19), 4.17 (4H, m, H21), 4.12 (4H, q, J = 7.0, H26), 
3.96 (3H, s, H11), 3.55 - 2.60 (22H, br. m, H15,16,31), 2.41 (4H, t, J = 7.0, H24), 2.21 (2H, m, H23), 2.04 
(2H, m, H23), 1.39 (9H, s, H30), 1.29 (6H, t, J = 7.0, H22), 1.27 (6H, t, J = 7.0, H27); 13C-NMR (CDCl3, 
126 MHz) δ 176.8 (C5), 173.1 (C25), 172.4 (C14), 170.8 (C17), 160.0 (C1’), 158.3 (C9’), 156.0 (C28), 
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138.2 (C4), 136.3 (C8), 129.3 (C6), 127.1 (C7), 121.6 (C5’), 119.9 (C5’), 119.0 (C9), 115.5 (C4’), 80.5 
(C25), 61.8 (C22), 60.7 (C26), 60.3 (C31), 59.5 (C31), 54.4 (C31), 53.1 (C31), 52.8 (C11), 52.0 (C19), 47.6 
(C16), 44.8 (C12), 30.7 (C24), 28.6 (C29), 26.9 (C23), 20.5 (C30), 14.1 (C27); MS (ES+) m/z 1083.5 [M + 
H]+; HRMS (ES+) (m/z): [M + H]+ calculated for C52H75N8O17 1083.5250, found 1083.5261. 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-glutamate)-4-[7-methoxycarbonyl-2-
chloromethylcarbonylmethyl-1-azaxanthone]-1,4,7,10-tetraazacyclododecane, (L4) 
 
Tert-butyl 4,10-bis( [(2S)-1-ethoxy-1-oxopropan-2-yl]carbamoyl}methyl)-7-[( [7-
(methoxycarbonyl)-5-oxo-5H-chromeno[2,3-b]pyridin-2-yl]methyl}carbamoyl)methyl]-
1,4,7,10-tetraazacyclododecane-1-carboxylate (52.0 mg, 0.048 mmol) in DCM : TFA (50 : 50, 2 
ml) was stirred in a sealed flask for 12 h yielding a yellow solution. Solvent was removed under 
reduced pressure to yield a glassy yellow solid in quantitative yield. 
1H-NMR (CDCl3, 700 MHz) δ 8.65 (1H, d, J = 7.5, H4), 8.47 (1H, s, br, H11), 8.30 (1H, d, J = 8.0, H6), 
7.85 (2H, s, br, H16), 7.78 (1H, t, J = 8.0, H7), 7.59 (1H, d, J = 8.0, H9), 7.48 (1H, d, J = 7.5, H3), 7.43 
(1H, t, J = 8.0, H8), 4.71 (2H, d, J = 5.5, H12), 4.49 (2H, q, J = 7.0, H19), 4.13 (4H, q, J = 7.0, H21), 4.07 
(4H, q, J = 7.0, H26), 2.40 (4H, t, J = 7.0, H24), 2.20 (2H, m, H23), 2.08 (2H, m, H23’), 1.24 (6H, t, J = 
7.0, H25), 1.21 (6H, t, J = 7.0, H22).  13C-NMR (CDCl3), 176 MHz) δ 177.4 (C5), 163.7 (C2), 160.2 (C4’), 
155.8 (C9’), 138.2 (C4), 135.9 (C7), 127.0 (C6), 125.0 (C8), 121.9 (C5’), 119.4 (C3), 118.6 (C9), 115.6 
(C1’), 61.9 (C24), 60.9 (C21), 52.2 (C17), 45.0 (C10), 30.9 (C19), 26.7 (C18), 14.4 (C25), 14.3 (C22); MS 
(ES+) m/z 984.0; HRMS (ES+) (m/z): [M + H]+ calculated for C47H67N8O15 983.4726, found 
983.4716. 
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[Eu·L4]Cl3 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-glutamate)-4-[7-methoxycarbonyl-2-chloromethylcarbonylmethyl-
1-azaxanthone]-1,4,7,10-tetraazacyclododecane (23.4 mg, 23.8 μmol) was added to Eu(OTf)3 
(15.6 mg, 26.2 μmol) and dissolved in MeCN (1 ml).  The reaction was stirred for 72 h at 60 ˚C.  
The reaction was then cooled to room temperature and the solvents removed under reduced 
pressure. The remaining residue was dissolved in dry MeCN (0.1 ml) and the mixture dropped 
onto anhydrous Et2O (5 ml) which resulted in the precipitation of the title compound as a triflate 
salt. The precipitate was centrifuged and dissolved in aqueous MeOH : H2O (50 : 50, 3 ml).  The 
pH was then adjusted carefully to 10 by addition of conc. NaOH solution to remove the excess Eu 
as Eu(OH)3 resulting in a white precipitate which was removed by centrifugation.  The pH was 
adjusted back to neutral and the mixture lyophlised to give a bright yellow solid which was 
loaded onto a DOWEX 1-X8(Cl) anion exchange resin.  The column was eluted with water   
10% NH4OH.  The fractions were combined and lyophilized to yield the Eu-complex as its 
chloride salt as a light yellow glassy solid (12.0 mg, 10.2 μmol, 43%). 
HRMS (ES+) (m/z): [M]3+ calculated for C47H66151EuN8O15 378.4615 found, 378.4612; tR = 10.3 
min; τH2O = 0.48 ms, τD2O = 1.14 ms; q = 0.9. 
 
 [Tb·L4]Cl3 
The complex was prepared by an analogous method as for [Eu.L4]Cl3 using L4 (23.4 mg, 23.8 
μmol) and Tb(OTf)3 (15.9 mg, 26.2 μmol) to yield the Tb-complex as its chloride salt (26.3 mg, 
22.2 μmol, 93%).  
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HRMS (ES+) (m/z): [M]3+ calculated for C47H66TbN8O15 380.4628 found, 380.4634; tR = 10.4 min; 
τH2O = 1.24 ms, τD2O = 1.96 ms; q = 10.4 
 
(2S)-2-[2-(4-([((7-Carboxy-5-oxo-5H-chromeno[2,3-b]pyridin-2-
yl)methyl)carbamoyl]methyl)-7-(([(1S)-1,3-dicarboxypropyl]carbamoyl)methyl)1,4,7,10-
tetraazacyclododecan-1-yl)acetamido]pentane dioic acid, (L5) 
 
Aqueous KOD solution (1 ml, 0.1 M) was added to (SS)-1,7-Bis(ethyl-N-acetyl-S-glutamate)-4-[7-
methoxycarbonyl-2-chloromethylcarbonylmethyl-1-azaxanthone]-1,4,7,10-
tetraazacyclododecane (39.8 mg, 40.5 µmol).  The reaction mixture was stirred under argon at 
room temperature and progress monitored by 1H-NMR spectroscopy, observing the formation of 
ethanol and methanol solvent peaks, with the corresponding elimination of the methyl- and 
ethyl-ester peaks.  After 3 h the pH of the mixture was decreased to pH 6.5 with conc. HCl(aq) and 
the solution loaded onto a DOWEX 50X4-100 strong cation exchange resin.  The column was 
eluted with 10% NH4OH and the fractions containing the desired product lyophilized to yield a 
orange glassy solid which was immediately used in the complexation reactions. 
1H-NMR (CDCl3, 400 MHz) [all signals quite broad] δ 8.85 (1H, br m, H6), 8.54 (1H, br d, H4), 8.36 
(1H, br m, H8), 7.65 (1H, br m, H9), 7.39 (1H, br m, H3), 4.62 (2H, br m, H12), 4.39 (2H, br m, H19), 
2.37 -3.54 (22H, br m, H15,16), 2.39 (4H, br m, H34), 2.10 (4H, br m, H23). 
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Na2[Eu·L5] 
 
2- [[2-(4- [(1-Carboxyethyl)carbamoyl]methyl]-10[[(carboxymethyl)carbamoyl]methyl]-
1,4,7,10-tetraazacyclododecan-1-yl)acetamido]methyl}-5-oxo-5H-chromeno[2,3-b]pyridine-7-
carboxylic acid (14.2 mg, 16.7 µmol) was added to Eu(OAc)3 (6.5 mg, 18.4 µmol) and dissolved in 
3 ml H2O : MeOH (7 : 1).  The pH was carefully adjusted to 5 by the addition of acetic acid and the 
reaction stirred for 48 h at 75 ˚C.  The reaction was cooled to room temperature and the pH 
carefully adjusted to 10 by the addition of  conc. NaOH solution, to precipitate excess europium 
as Eu(OH)3 which was removed by centrifugation. The pH was adjusted back to 6.5 with acetic 
acid and the sample lyophilized to yield a colourless solid (3.2 mg).  
HRMS (ES-) (m/z): [M]2- calculated for C38H45151EuN8O15 502.1035 found, 502.1042; tR = 8.6 min; 
τH2O = 0.37 ms, τD2O = 0.75 ms; q = 1.1. 
 
Na2[Tb·L5] 
The complex was prepared by an analogous method as for Na2[Eu.L5] using L5 (14.2 mg, 16.7 
µmol) and Tb(OAc)3 (6.6 mg, 18.4 µmol) to yield the Tb-complex as its chloride salt (5.8 mg)  
HRMS (ES-) (m/z): [M]2- calculated for C38H45TbN8O15 505.1056 found, 505.1046; tR = 9.4 min; 
τH2O = 1.21 ms, τD2O = 2.39 ms; q = 1.5. 
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5.2.6 Ligands and complexes of L6-9 
(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-4-[7-methoxycarbonyl-2-
chloromethylcarbonylmethyl-1-azaxanthone]-10-[2’-(methylsulfonylamino)ethyl]-
1,4,7,10-tetraazacyclododecane, (L6) 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-4-[7-methoxycarbonyl-2-chloromethylcarbonylmethyl-1-
azaxanthone]-1,4,7,10-tetraazacyclododecane (100mg, 123 µmol), methylsulfonate-N-
methanesulfonylethylamine (28 mg, 129 µmol) and K2CO3 (18 mg, 129 µmol) were stirred in 
MeCN (3 ml), under argon, at 65 °C for 24 h.  Solvent was removed under reduced pressure and 
the residue dissolved in DCM (5 ml) allowing the insoluble salts to be removed by centrifugation.  
Solvent was again removed under reduced pressure before purification by column 
chromatography on silica gel (DCM  10% MeOH) yielded an orange glassy solid (76 mg, 74.0 
µmol, 60%). 
1H-NMR (CDCl3, 700 MHz) δ 8.93 (1H, d, J = 1.5, H6), 8.65 (1H, d, J = 8.0, H4), 8.36 (1H, dd, J = 9.0, 
1.5, H8), 7.62 (1H, d, J = 9.0, H9), 7.59 (1H, d, J = 8.0, H3), 4.63-4.71 (2H, m, H12), 4.41-4.49 (1H, m, 
H19), 4.38-4.44 (1H, m, H19), 4.12-4.18 (4H, m, H22), 4.03.4.11 (2H, m, H25), 3.97 (3H, s, H11), 3.85 
(3H, s, H31), 1.85–3.45 (24H, br, H15,16,24,32), 1.40-1.49 (6H, m, H20), 1.14 (6H, t, J = 7.0, H23); 13C-
NMR (CDCl3, 126 MHz) δ 176.8 (C5), 173.2 (C14), 172.4 (C21), 171.1 (Cx), 165.8 (C10), 165.2 (C17), 
163.0 (C2), 159.7 (C1’), 158.3 (C9’), 138.3 (C4), 136.0 (C8), 129.4 (C29), 129.2 (C6), 126.8 (C7), 121.5 
(C5’), 120.3 (C3), 118.9 (C9), 115.3 (C4’), 114.4 (C28), 61.7 (C22), 61.5 (C22), 57.5 (C24), 55.8 (C31), 
55.4 (C11), 52.6 (C11), 49.9 (C16), 48.8 (C19), 48.5 (C15), 45.1 (C12), 41.8 (C27), 40.4 (C19), 17.7 (C20), 
14.3 (C23), 14.2 (C23); HRMS (ES+) (m/z): [M+H]+ calculated for C42H62N9O13S 933.4188 found, 
933.4181. 
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(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-4-[7-methoxycarbonyl-2-
chloromethylcarbonylmethyl-1-azaxanthone]-10-[2’-(4-
Methoxyphenylsulfonylamino)ethyl]-1,4,7,10-tetraazacyclododecane, (L7) 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-4-[7-methoxycarbonyl-2-chloromethylcarbonylmethyl-1-
azaxanthone]-1,4,7,10-tetraazacyclododecane (100 mg, 123 µmol), 2-
paramethoxyphenylsulfonate-N-methanesulfonylethylamine (50 mg, 125 µmol) and K2CO3 (18 
mg, 129 µmol) were stirred in MeCN (3 ml), under argon, at 65 °C for 24 h.  Solvent was removed 
under reduced pressure and the residue dissolved in DCM (5 ml) allowing the insoluble salts to 
be removed by centrifugation.  Solvent was again removed under reduced pressure before 
purification by column chromatography on silica gel (DCM  10% MeOH) to yield an orange 
glassy solid (40 mg, 39 µmol, 31%). 
1H-NMR (CDCl3, 700 MHz) δ 8.93 (1H, d, J = 1.5, H6), 8.65 (1H, d, J = 8.0, H4), 8.36 (1H, dd, J = 9.0, 
1.5, H8), 7.75 (2H, d, J = 9.0, H29), 7.62 (1H, d, J = 9.0, H9), 7.59 (1H, d, J = 8.0, H3), 6.95 (2H, d, J = 
9.0, H28), 4.63-4.72 (2H, m, H12), 4.42-4.50 (1H, m, H19), 4.37-4.43 (1H, m, H19), 4.02-4.11 (2H, m, 
H25), 3.97 (3H, s, H11), 3.85 (3H, s, H31), 1.85 – 3.45 (24H, br, H15,16,24,32), 1.38-1.42 (3H, m, H20), 
1.33-1.37 (3H, m, H20), 1.14 (3H, t, J = 7.0, H23), 1.12 (3H, t, J = 7.0, H23); 13C-NMR (CDCl3, 126 
MHz) δ 176.8 (C5), 173.2 (C14), 172.4 (C21), 165.8 (C10), 165.2 (C17), 163.0 (C2), 159.7 (C1’), 158.3 
(C9’), 138.3 (C4), 136.0 (C8), 129.4 (C29), 129.2 (C6), 126.8 (C7), 121.5 (C5’), 120.3 (C3), 118.9 (C9), 
115.3 (C4’), 114.4 (C28), 61.7 (C22), 61.5 (C22), 57.5 (C24), 55.8 (C31), 55.4 (C11), 52.6 (C11), 49.9 
(C16), 48.8 (C19), 48.5 (C15), 45.1 (C12), 40.4 (C19), 17.7 (C20), 14.3 (C23), 14.2 (C23); HRMS (ES+) 
m/z: [M + H]+ calculated for C48H66N9O14S 1024.445 found 1024.459. 
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(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-4-[7-methoxycarbonyl-2-
chloromethylcarbonylmethyl-1-azaxanthone]-10-[2’-(4-
trifluoromethylphenylsulfonylamino)ethyl]-1,4,7,10-tetraazacyclododecane, (L8) 
 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-4-[7-methoxycarbonyl-2-chloromethylcarbonylmethyl-1-
azaxanthone]-1,4,7,10-tetraazacyclododecane (68 mg, 84 µmol), 2-
paramethoxyphenylsulfonate-N-methanesulfonylethylamine (60 mg, 126 µmol) and K2CO3 (13 
mg, 92.4 µmol) were stirred in MeCN (3 ml), under argon, at 65 °C for 24 h.  Solvent was 
removed under reduced pressure and the residue dissolved in DCM (5 ml) allowing the insoluble 
salts to be removed by centrifugation.  Solvent was again removed under reduced pressure 
before purification by column chromatography on silica gel (DCM  10% MeOH) to yield a pale 
orange glassy solid (23 mg, 22 µmol, 26%). 
1H-NMR (CDCl3, 700 MHz) δ 8.93 (1H, d, J = 1.5, H6), 8.65 (1H, d, J = 8.0, H4), 8.36 (1H, dd, J = 9.0, 
1.5, H8), 7.75 (2H, d, J = 9.0, H29), 7.62 (1H, d, J = 9.0, H9), 7.59 (1H, d, J = 8.0, H3), 6.95 (2H, d, J = 
9.0, H28), 4.65-4.70 (2H, m, H12), 4.43-4.49 (1H, m, H19), 4.38-4.42 (1H, m, H19), 4.02-4.10 (2H, m, 
H25), 3.97 (3H, s, H11), 3.85 (3H, s, H31), 1.85 – 3.45 (24H, br, H15,16,24,32), 1.14 (3H, t, J = 7.0, H23), 
1.12 (3H, t, J = 7.0, H23); 13C-NMR (CDCl3, 126 MHz) δ 176.8 (C5), 173.2 (C14), 172.4 (C21), 165.8 
(C10), 165.2 (C17), 163.0 (C2), 159.7 (C1’), 158.3 (C9’), 138.3 (C4), 136.0 (C8), 129.4 (C29), 129.2 (C6), 
126.8 (C7), 121.5 (C5’), 120.3 (C3), 118.9 (C9), 115.3 (C4’), 114.4 (C28), 61.7 (C22), 61.5 (C22), 57.5 
(C24), 55.8 (C31), 55.4 (C11), 52.6 (C11), 49.9 (C16), 48.8 (C19), 48.5 (C15), 45.1 (C12), 40.4 (C19), 17.7 
(C20), 14.3 (C23), 14.2 (C23); HRMS (ES+) (m/z): [M+H]+ calculated for C48H63F3N9O13S 1062.4218 
found, 1062.4231. 
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[Eu·L6]Cl3 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-4-[7-methoxycarbonyl-2-chloromethylcarbonylmethyl-1-
azaxanthone]-10-[2’-(methylsulfonylamino)ethyl]-1,4,7,10-tetraazacyclododecane (18.1 mg,. 
17.6 μmol) was added to Eu(OTf)3 (11.9 mg, 20.0 μmol) and dissolved in MeCN (1 ml).  The 
reaction was stirred for 48 h at 80 ˚C.  The reaction was then cooled to room temperature and 
the solvents removed under reduced pressure. The remaining residue was dissolved in dry 
MeCN (0.1 ml) and the mixture dropped onto anhydrous Et2O (5 ml) which resulted in the 
precipitation of the title compound as a triflate salt. The precipitate was centrifuged and 
dissolved in aqueous MeOH : H2O (50 : 50, 3 ml).  The pH was then adjusted carefully to 10 by 
addition of conc. NaOH solution to remove the excess Eu as Eu(OH)3, in a white precipitate which 
was removed by centrifugation.  The pH was adjusted back to neutral and the mixture lyophlised 
to give a bright yellow solid which was loaded onto a DOWEX 1-X8(Cl) anion exchange resin.  
The column was eluted with water and the fractions combined and lyophilized to yield the Eu-
complex as its chloride salt, as a light yellow glassy solid (7.8 mg, 7.2 μmol, 41%). 
HRMS (ES+) m/z: [M-H]2+ calculated for 151EuC42H61N9O13S 540.6615 found, 540.6590; τH2O (pH 
3) = 0.61 ms, τD2O (pH 3) = 0.98 ms, τH2O (pH 9) = 0.46 ms, τH2O (pH 9) 0.96 ms; qpH3 = 0.2, qpH9 = 
0.8. 
 
[Tb·L6]Cl3 
The complex was prepared by an analogous method as for [Eu.L6]Cl3 using L6 (18.1 mg,. 17.6 
μmol) and Tb(OTf)3 (11.9 mg, 20.0 μmol) to yield the Tb-complex as its chloride salt (8.9 mg, 8.2 
μmol, 47%). 
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HRMS (ES+) (+m/z): [M - H]2+ calculated for TbC42H61N9O13S 544.6642 found, 544.6635; τH2O (pH 
3) = 1.24 ms, τD2O (pH 3) = 1.56 ms, τH2O (pH 9) = 1.58 ms, τH2O (pH 9) 1.32 ms; qpH3 = 0.5, qpH9 = 
0.3. 
 
[Eu·L7]Cl3 
 
The complex was prepared by an analogous method as for [Eu.L6]Cl3 using L7 (18.5 mg, 
18.0µmol) and Eu(OTf)3 (11.9 mg, 20.0 µmol) to yield the Eu-complex as its chloride salt (10.8 
mg, 9.1 µmol, 52%) 
HRMS (ES+) m/z: [M - H]2+ calculated for 151EuC48H65N9O13S 587.6748 found, 587.6750; τH2O (pH 
3) = 0.48 ms, τD2O (pH 3) = 1.28 ms, τH2O (pH 9) = 1.37 ms, τH2O (pH 9) 1.96 ms; qpH3 = 1.0, qpH9 = -
0.1. 
 
[Tb·L7]Cl3 
The complex was prepared by an analogous method as for [Eu.L6]Cl3 using L7 (10.4 mg, 9.9 
µmol) and Tb(OTf)3 (11.9 mg, 20.0 µmol) to yield the Tb-complex as its chloride salt (6.7 mg, 5.6 
µmol, 57%) 
HRMS (ES+) m/z: [M - H]2+ calculated for TbC48H65N9O13S 590.6774 found, 590.6763; τH2O (pH 3) 
= 1.37 ms, τD2O (pH 3) = 1.96 ms, τH2O (pH 9) = 1.72 ms, τH2O (pH 9) 1.89 ms; qpH3 = 0.8, qpH9 = -0.1. 
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 [Eu·L8]Cl3 
 
The complex was prepared by an analogous method as for [Eu.L6]Cl3 using L8 (10.4 mg, 9.9 
µmol) and Eu(OTf)3 (6.0 mg, 10.0 µmol) to yield the Eu-complex as its chloride salt (3.2 mg, 2.7 
µmol, 27%) 
HRMS (ES+) m/z: [M - H]2+ calculated for 151EuC48H61F3N9O13S 606.6632 found, 606.6641; τH2O 
(pH 3) = 0.49 ms, τD2O (pH 3) = 0.98 ms, τH2O (pH 9) = 0.49 ms, τH2O (pH 9) 0.98 ms; qpH3 = 0.6, 
qpH9 = 0.7. 
 
 [Tb·L8]Cl3 
The complex was prepared by an analogous method as for [Eu.L6]Cl3 using L8 (10.4 mg, 9.9 
µmol) and Tb(OTf)3 (6.0 mg, 10.0 µmol) to yield the Tb-complex as its chloride salt (2.8 mg, 2.3 
µmol, 23%) 
HRMS (ES+) m/z: [M - H]2+ calculated for TbC48H61F3N9O13S 609.6652 found, 609.6648; τH2O (pH 
3) = 1.34 ms, τD2O (pH 3) = 2.06 ms, τH2O (pH 9) = 1.34 ms, τH2O (pH 9) 1.81 ms; qpH3 = 0.7 qpH9 = -
0.6. 
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5-Benzyl 1-tert-butyl 2-4,7-bis[5-(benzyloxy)-1-(tert-butoxy)-1,5-dioxopentan-2-yl]-
1,4,7,10-tetraazacyclododecan-1-yl}pentanedioate 
 
5-Benzyl 1-tert-butyl 2-bromopentanedioate (511 mg, 1.41 mmol), 1,4,7,10-
tetraazacyclododecane (81 mg, 0.470 mmol) and K2CO3 (99 mg, 0.716 mmol) were stirred 
together in dry MeCN under argon for 24 h at 60 °C.  The reaction was halted and solvents 
removed under reduced pressure. The residue was redissolved in DCM (10 ml) and filtered to 
remove potassium salts, the solvent was again removed under reduced pressure.  The brown 
residue was purified by column chromatography (silica, DCM  7 % MeOH) to yield a glassy 
pale orange solid (343 mg, 0.343 mmol, 73%). 
1H-NMR (CDCl3, 700 MHz) δ 9.61 (1H, s, br, H11), 7.28-7.38 (15H, m, H7), 5.02 - 5.16 (6H, m, H6), 
2.62 – 3.32 (16H, br m, H10), 2.26 – 2.59 (9H, br m, H2,4), 1.80 – 2.16 (6H, br m, H3), 1.44 (27H, s, 
H9); 13H-NMR (CDCl3, 176 MHz) δ 172.6 (C5),  172.5 (C5),  172.3 (C5),  171.3 (C1),  177.1 (C1),  
170.7 (C1),  135.6 (C7q),  135.8 (C7q),  128.5 (C7),  128.5 (C7),  128.5 (C7),  128.5 (C7),  82.0 (C8),  
66.4 (C6),  66.3 (C6),  66.3 (C6),  60.1 (C2),  45.8 – 52.3 (C10),  30.5 (C4),  28.4 (C9),  24.7 (C3);  MS 
(ES+) m/z 1002.0 [M + H]+; HRMS (ES+) m/z: C56H81N4O12 requires 1001.5851, found 1001.5842. 
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5-Benzyl 1-tert-butyl 2-4,7-bis[5-(benzyloxy)-1-(tert-butoxy)-1,5-dioxopentan-2-yl]-10-
(5-oxo-5H-thiochromeno[2,3-b]pyridin-7yl)methyl)-1,4,7,10-tetraazacyclododecan-1-
yl}pentanedioate 
 
5-Benzyl 1-tert-butyl 2-4,7-bis[5-(benzyloxy)-1-(tert-butoxy)-1,5-dioxopentan-2-yl]-1,4,7,10-
tetraazacyclododecan-1-yl)pentanedioate (237 mg, 0.237 mmol), 7-bromomethyl-1-
azathioxanthone (100 mg, 0.327 mmol) and K2CO3 (50 mg, 0.368 mmol) were stirred together in 
dry MeCN (5 ml) under argon for 24 h at 70 ˚C.  The reaction was halted and solvents removed 
under reduced pressure. The residue was redissolved in DCM (10 ml) and filtered to remove 
salts, the solvent was again removed.  The brown residue was purified by column 
chromatography (silica, DCM  7 % MeOH) to a glassy orange solid (81 mg, 0.066 mmol, 58%). 
1H-NMR (CDCl3, 400 MHz) δ 8.82 (1H, s, br, H14), 8.77-8.81 (1H, m, H18), 8.51 (1H, s, H20), 7.80-
7.85 (1H, m, H23), 7.49-7.53 (1H, m, H24), 7.41-7.48 (1H, m, H19),  7.28-7.38 (15H, m, H6-9), 5.02-
5.17 (6H, m, H5), 1.75-3.51 (33H, m, H1,2,3,13), 1.44 (27H, s, H12); MS (ES+) m/z 1226.7 [M + H]+; 
HRMS (ES+) m/z [M + H]+ C69H88O13N5S requires 1226.6094, found 1226.6114. 
 
7-(1,4,7,10-Tetraazacyclododecan-1-ylnethyl)-5H-thiochromeno[2,3-bi]pyridine-5-one 
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7-Bromomethyl-1-azathioxanthone (0.206 g, 0.673 mmol) was added to a stirred solution of 
1,4,7,10-tetraazacycloododecane (1.12 g, 6.53 mmol) and K2CO3 (93 mg, 0.673 mmol) in dry 
MeCN (10 ml) at 55 ˚C under argon.  After 20 h, the solvent was removed under reduced 
pressure and the residue dissolved in DCM (20 ml).   The solution was repeatedly washed with 
H2O (5 x 20 ml), dried over MgSO4, and the solvent removed under reduced pressure to yield the 
title compound as a light yellow oil (0.179 mg, 0.195 mmol, 29%). 
1H-NMR (CDCl3, 700 MHz) δ 8.80 (1H, dd, J = 8.5, 2.0, H5), 8.77 (1H, dd, J = 4.5, 2.0, H7), 8.48 (1H, 
d, J = 2.0, H1), 7.70 (1H, dd, J = 8.5, 2.0, H11), 7.60 (1H, d, J = 8.5, H10), 7.41 (1H, dd, J = 8.5, 4.5, H6), 
3.73 (1H, dd, J = 8.5, 6.0, H13), 2.81 (1H, br s, H17), 2.68 (1H, t, J = 5.0, H15), 2.61 (1H, br s, H14), 
2.56 (1H, t, J = 5.0, H16); 13C-NMR (CDCl3, 176 MHz) δ 180.7 (C3), 158.9 (C4), 153.3 (C7), 138.6 
(C12), 137.8 (C5), 136.4 (C2), 133.9 (C11), 130.0 (C1), 128.7 (C9), 126.9 (C10), 126.5 (C8), 121.6 (C6), 
58.9 (C13), 51.6 (C14), 47.5 (C16), 46.5 (C17), 45.4 (C15); MS (ES+) m/z 398.3 [M + H]+; HRMS (ES+) 
m/z found 397.1943 [M + H]+ C21H27ON5S requires 397.1936. 
 
(SS)-1,7-Bis(ethyl-N-acetyl-S-alanine)-4-[1-azaxanthone)-2-methyl]-10-
[methylsulfonylaminoethyl]-1,4,7,10-tetraazacyclododecane 
 
2-Methanesulfonate-N-methanesulfonylethylamine (12.8 mg, 58.7 μmol) and K2CO3 (8.1 mg, 
58.7 μmol) were stirred in dry MeCN (1 ml) at room temperature under argon.  (SS)-1,7-
bis(ethoxycarbonyl-2-ethylcarbamoylmethyl)-4-[(1-azaxanthone)-2-methyl]-1,4,7,10-
tetraazacylcododecane (34 mg, 49 μmol) was added after 10 min and the solution heated at 50 
˚C.  After 24 hr, a further addition of 2-methanesulfonate-N-methanesulfonylethylamine (3.2 mg, 
14.7 μmol) and K2CO3 (2.0 mg, 14.7 μmol) was made and the temperature increased to 60 ˚C.  
The reaction was stopped after 4 days and the solvent removed under reduced pressure.  The 
resulting solid dissolved in a small amount of DCM (2 ml) and the potassium salts removed by 
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filtration.  The crude mixture was purified by column chromatography (alumina, DCM : 2.5% 
MeOH); to yield a light yellow glassy solid (24.0 mg, 28.0 μmol, 57%). 
1H-NMR (CDCl3, 400 MHz) δ 8.68 (1H, d, J = 8.0, H6), 8.24 (1H, d, J = 8.0, H4), 8.22 (2H, br s, H13), 
7.79 (1H, t, J = 8.0, H7), 7.60 (1H, d, J = 8.0, H9), 7.33-7.46 (2H, m, H3,8), 4.31-4.37 (2H, m, H14), 
4.09-4.13 (4H, m, H17), 3.81-4.03 (6H, m, br, H10, 19, 20), 2.90-3.30 (16H, br, H23), 3.03 (3H, s, H22), 
1.44 (6H, d, J = 7.0, H15), 1.20 (6H, t, J = 7.0, H18);  13C-NMR (CDCl3), 101 MHz) δ 177.3 (C5), 175.5 
(C16), 172.6 (C12), 163.3 (C2), 160.1 (C1’), 138.2 (C4), 135.7 (C4’), 126.8 (C9), 124.9 (C6), 121.7 (C6’), 
121.1 (C5’), 118.5 (C8), 115.8 (C9’), 61.2 (C17), 55.8 (C23), 55.0 (C23), 54.5 (C23), 53.2 (C10), 49.8 
(C19), 48.5 (C14), 39.0 (C22), 21.3 (C20), 20.0 (C15), 14.1 (C18); MS (ES+) m/z 817.5 [M + H]+; HRMS 
(ES+) m/z found 817.3922 [M + H]+ C38H57O10N8S requires 817.3918. 
 
(SS)-1,7-Bis-(N-acetyl-S-alanine)-4-[1-azaxanthone)-2-methyl]-10-
[methylsulfonylaminoethyl]-1,4,7,10-tetraazacyclododecane 
 
Freshly made aqueous KOD solution (0.6 ml, 0.1 M) was added to (SS)-1,7-bis(ethyl-N-acetyl-S-
alanine)-4-[2-chloromethylcarbonylmethyl-1-azaxanthone]-1,4,7,10-tetraazacyclododecane (24 
mg, 29.4 μmol).  Progress was monitored by NMR.  After 1 h, no ethyl group signals were 
observed in the 1H-NMR spectrum.  The pH of the mixture was increased (pH ~ 6) with conc. HCl 
and the solution loaded onto a DOWEX 50X4-100 strong cation exchange resin.  The column was 
eluted with water  10% NH4OH.  The fractions were combined and lyophilized to yield the title 
compound as a red oil (17.9 mg, 21.9 μmol, 75%) which was used immediately in the 
complexation reaction. 
1H-NMR (D2O, 400 MHz) δ 8.30 (1H, br, H6), 7.81 (1H, br, H4), 7.63 (1H, br, H7), 7.38 (1H, br, H9), 
7.31 (1H, br, H3), 7.24 (1H, br, H8), 3.96 (2H, m, H10), 2.90 (6H, br, H17, 18, 20), 2.50-2.90 (16H, br, 
H22), 2.58 (3H, br, H22), 1.17 (6H, br, H15). 
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N-((S)-1-Phenyl-ethyl-2-[7-[((S)-1-phenyl-ethylcarbomyl)-methyl]-4-(10,11,12,13-
tetrahydro-4,5,9,14-tetraaza-benzo[b]triphenylen-6-ylmethyl)-10-
[methylsulfonylaminoethyl]-1,4,7,10-tetraaza-cyclododec-1-yl]-acetamide 
 
2-(4-Methoxybenzenesulfonate)-N-methoxyphenylsulfonylethylamine (49 mg, 0.121 mmol) and 
Na2CO3 (17 mg, 0.152 mmol) were stirred in dry MeCN (5 ml) under argon). (N-((S)-1-Phenyl-
ethyl)-2-[7-[((S)-1-phenyl-ethylcarbamoyl)-methyl]-4-(10,11,12,13-tetrahydro-4,5,9,14-tetraaz-
benzo[b]triphenylen-6-ylmethyl)-10-[methylsulfonylaminoethyl]-1,4,7,10-tetraazacyclododec-
1-yl]-acetamide (80 mg, 0.101 mmol) was added and the solution heated to 60 ˚C.  The reaction 
was stopped after 3 days.  The solvent was removed under reduced pressure and the resulting 
solid was dissolved in a small volume of DCM (5 ml) and the potassium salts removed by 
filtration.  The crude mixture was purified by column chromatography (alumina, DCM   2.5% 
MeOH, 2.5% NEt3).  The residue was washed with water (3 x 10 ml) and the solid dried under 
reduced pressure to yield a glassy orange solid (43 mg, 43 μmol, 43%). 
1H-NMR (CDCl3, 400 MHz) δ 9.47 (1H, d, J = 8.0, H15), 9.39 (1H, d, J = 8.0, H1), 9.21 (1H, s, H13), 
7.85 (1H, m, H14), 7.71-7.73 (2H, m, H27), 7.51 (1H, d, J = 8.0, H2), 7.20 - 7.30 (10H, br m, H25), 
5.13-5.21 (2H, m, H24), 3.78 (3H, s, H30), 3.24 (8H, br, H10,18,23), 2.20 - 2.80 (16H, br, H31), 4.10-
4.21 (4H, m, H7, 8), 3.77-3.82 (4H, m, H6,9), 1.07 (6H, q, H22).  HRMS (ES+) m/z found 1006.5113 
[M + H]+ C56H68O5N11S requires 1006.5126. 
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[Eu·L9]Cl3 
 
N-((S)-1-Phenyl-ethyl-2-[7-[((S)-1-phenyl-ethylcarbomyl)-methyl]-4-(10,11,12,13-tetrahydro-
4,5,9,14-tetraaza-benzo[b]triphenylen-6-ykmethyl)-10-[methylsulfonylaminoethyl]-1,4,7,10-
tetraaza-cyclododec-1-yl]-acetamide (43 mg, 43 µmol) was added to Eu(CF3SO3)3 (31 mg, 52 
µmol) and the solids dissolved in dry MeCN (1 ml) and the reaction left to stir at 80 °C for 76 h.  
After the reaction was cooled to room temperature, the solvents were removed under reduced 
pressure and the remaining residue was dissolved in dry MeCN (0.1 ml) and the mixture 
dropped onto anhydrous Et2O (5 ml) resulting in the precipitation of the title compound as a 
triflate salt.  The precipitate was centrifuged and dissolved in aqueous MeOH:H2O (50 : 50, 3 ml).  
The pH was adjusted carefully to 10 by addition of conc. NaOH solution and the resultant 
precipitate removed by centrifugation.  The pH was adjusted back to neutral and the mixture 
lyophilised to give a bright yellow solid which was loaded onto a DOWEX 1-X8(Cl) anion 
exchange resin.  The column was eluted with water   10% NH4OH.  The fractions were 
combined and lyophilised to yield a colourless glassy solid (30 mg, 24 µmol, 55%). 
HRMS (ES+) m/z: [M - H]2+ calculated for 151EuC50H66N11O9S 574.6984 found, 574.6992; τH2O (pH 
3) = 0.49 ms, τD2O (pH 3) = 0.98 ms, τH2O (pH 9) = 0.49 ms, τH2O (pH 9) 0.98 ms; qpH3 = 0.6, qpH9 = 
0.7. 
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[Eu·L10]Cl3 
 
(SS)-1,7-Bis(carboxy-2-ethylcarbamoylmethyl)-4-[(1-azathioxanthone)-2-methyl]-1,4,7,10-
tetraazacyclododecane (17.9 mg, 21.9 µmol) was added to Eu(OAc)3.4H2O (10.8 mg, 1.2 eq.) and 
the solids dissolved in 1 ml H2O.  The pH was carefully adjusted to 6 by the addition of acetic acid 
and the reaction left to stir at 75°C for 60 h.  After the reaction was cooled to room temperature, 
the pH was then adjusted carefully to 10 by addition of conc. NaOH solution  resulting in a white 
precipitate that was removed by centrifugation.  The pH was adjusted back to neutral with acetic 
acid and the sample lyophilised to yield a light red glassy solid (15.8 mg, 11.8 µmol, 54%). 
HRMS (ES+) m/z: [M - H]2+ calculated for 151EuC34H45N8O10S 910.2186 found, 910.2181; τH2O (pH 
3) = 0.42 ms, τD2O (pH 3) = 1.08 ms, τH2O (pH 9) = 1.4 ms, τH2O (pH 9) 0.52 ms; qpH3 = 1.34, qpH9 = 
0.5. 
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[Ln·L1]3+ 
[Ln·L2]3+ 
[Ln·L3] 
[Ln·L5]2- 
[Ln·L4]3+ 
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List of Complexes 
 
 
 
 
 
 
[Eu·L11]3- 
[Ln·L6]3+ [Ln·L
7]3+ 
[Ln·L8]3+ [Eu·L9]3+ 
[Eu·L10]+ 
